| 1 |
Moya NA, Yun S, Fleps SW, Martin MM, Nadel JA, Beutler LR, Zweifel LS, Parker JG. The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia. Neuropsychopharmacology 2023;48:690-9. [PMID: 36380221 DOI: 10.1038/s41386-022-01492-1] [Reference Citation Analysis]
|
| 2 |
van Hooijdonk CFM, van der Pluijm M, Bosch I, van Amelsvoort TAMJ, Booij J, de Haan L, Selten JP, Giessen EV. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings. Eur Neuropsychopharmacol 2023;68:57-77. [PMID: 36640734 DOI: 10.1016/j.euroneuro.2022.12.008] [Reference Citation Analysis]
|
| 3 |
Thiagarajan SK, Mok SY, Ogawa S, Parhar IS, Tang PY. Integrative Roles of Dopamine Pathway and Calcium Channels Reveal a Link between Schizophrenia and Opioid Use Disorder. Int J Mol Sci 2023;24. [PMID: 36835497 DOI: 10.3390/ijms24044088] [Reference Citation Analysis]
|
| 4 |
Maness EB, Blumenthal SA, Burk JA. Dual orexin/hypocretin receptor antagonism attenuates attentional impairments in an NMDA receptor hypofunction model of schizophrenia. bioRxiv 2023:2023. [PMID: 36778441 DOI: 10.1101/2023.02.05.527043] [Reference Citation Analysis]
|
| 5 |
Boruah PK, Borthakur P, Neog G, Le Ouay B, Afzal NU, Manna P, Das MR. Porous Nitrogen-Doped Crumpled Graphene Nanoparticles: A Metal-Free Nanozyme for Selective Detection of Dopamine in Aqueous Medium and Human Serum. ACS Appl Nano Mater 2023. [DOI: 10.1021/acsanm.2c04582] [Reference Citation Analysis]
|
| 6 |
McCutcheon RA, Keefe RSE, McGuire PK. Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment. Mol Psychiatry 2023. [PMID: 36690793 DOI: 10.1038/s41380-023-01949-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Fišar Z. Biological hypotheses, risk factors, and biomarkers of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2023;120:110626. [PMID: 36055561 DOI: 10.1016/j.pnpbp.2022.110626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Yang G, Tan K, Yang J, Yuan R, Chen S. Coreactant-free polyfluorene nanoparticles for the electrochemiluminescence quantitative analysis of dopamine and norepinephrine. Sens Diagn 2023. [DOI: 10.1039/d2sd00172a] [Reference Citation Analysis]
|
| 9 |
Juza R, Musilek K, Mezeiova E, Soukup O, Korabecny J. Recent advances in dopamine D(2) receptor ligands in the treatment of neuropsychiatric disorders. Med Res Rev 2023;43:55-211. [PMID: 36111795 DOI: 10.1002/med.21923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Bansal V, Chatterjee I. Understanding the Chemical Interactions in the Brain of Schizophrenia Patients. Cognizance of Schizophrenia:: A Profound Insight into the Psyche 2023. [DOI: 10.1007/978-981-19-7022-1_3] [Reference Citation Analysis]
|
| 11 |
Xue K, Chen J, Wei Y, Chen Y, Han S, Wang C, Zhang Y, Song X, Cheng J. Altered static and dynamic functional connectivity of habenula in first-episode, drug-naïve schizophrenia patients, and their association with symptoms including hallucination and anxiety. Front Psychiatry 2023;14:1078779. [PMID: 36741115 DOI: 10.3389/fpsyt.2023.1078779] [Reference Citation Analysis]
|
| 12 |
Hoglund BK, Carfagno V, Olive MF, Leyrer-Jackson JM. Metabotropic glutamate receptors and cognition: From underlying plasticity and neuroprotection to cognitive disorders and therapeutic targets. Int Rev Neurobiol 2023;168:367-413. [PMID: 36868635 DOI: 10.1016/bs.irn.2022.10.004] [Reference Citation Analysis]
|
| 13 |
Nuh S, Numnuam A, Thavarungkul P, Phairatana T. A Novel Microfluidic-Based OMC-PEDOT-PSS Composite Electrochemical Sensor for Continuous Dopamine Monitoring. Biosensors (Basel) 2022;13. [PMID: 36671903 DOI: 10.3390/bios13010068] [Reference Citation Analysis]
|
| 14 |
Chang X, Zhao W, Kang J, Xiang S, Xie C, Corona-hernández H, Palaniyappan L, Feng J. Language abnormalities in schizophrenia: binding core symptoms through contemporary empirical evidence. Schizophr 2022;8:95. [DOI: 10.1038/s41537-022-00308-x] [Reference Citation Analysis]
|
| 15 |
Xu H, Yang F. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia. Transl Psychiatry 2022;12:464. [PMID: 36344514 DOI: 10.1038/s41398-022-02233-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Dokuz G, Kani AS, Uysal Ö, Kuşcu MK. The impact of childhood trauma and daily life experiences on emotional and psychotic symptom intensity in psychosis: An experience sampling study. Psychiatry Res 2022;317:114872. [PMID: 36265192 DOI: 10.1016/j.psychres.2022.114872] [Reference Citation Analysis]
|
| 17 |
Esumi S, Ushio S, Zamami Y. Polypharmacy in Older Adults with Alzheimer’s Disease. Medicina 2022;58:1445. [DOI: 10.3390/medicina58101445] [Reference Citation Analysis]
|
| 18 |
Pierre C, Callebert J, Launay J, Rétaux S. The enzymatic and neurochemical outcomes of a mutation in Mexican cavefish MAO reveal teleost-specific aspects of brain monoamine homeostasis.. [DOI: 10.1101/2022.10.10.511577] [Reference Citation Analysis]
|
| 19 |
Mandal PK, Gaur S, Roy RG, Samkaria A, Ingole R, Goel A. Schizophrenia, Bipolar and Major Depressive Disorders: Overview of Clinical Features, Neurotransmitter Alterations, Pharmacological Interventions, and Impact of Oxidative Stress in the Disease Process. ACS Chem Neurosci 2022;13:2784-802. [PMID: 36125113 DOI: 10.1021/acschemneuro.2c00420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Chen KC, Yang YK, Howes OD, Lee IH, Yeh TL, Chiu NT, Chen PS, David AS, Bramon E. Striatal dopamine D(2/3) receptors in medication-naïve schizophrenia: an [(123)I] IBZM SPECT study. Psychol Med 2022;52:3251-9. [PMID: 33682657 DOI: 10.1017/S0033291720005413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Rambaud V, Marzo A, Chaumette B. Oxidative Stress and Emergence of Psychosis. Antioxidants 2022;11:1870. [DOI: 10.3390/antiox11101870] [Reference Citation Analysis]
|
| 22 |
Moya NA, Yun S, Fleps SW, Martin MM, Nadel JA, Beutler LR, Zweifel LS, Parker JG. Selective Nigrostriatal Dopamine Excess Impairs Behaviors Linked to the Cognitive and Negative Symptoms of Psychosis.. [DOI: 10.1101/2022.08.09.503421] [Reference Citation Analysis]
|
| 23 |
Duan L, Tian C, Fu C, He J, Dai J, Shao X, Zhu G. Analysis of color vision and cognitive function in first-episode schizophrenia before and after antipsychotic treatment. J Psychiatr Res 2022;152:278-88. [PMID: 35759980 DOI: 10.1016/j.jpsychires.2022.06.012] [Reference Citation Analysis]
|
| 24 |
Wang X, Xiu M, Wang K, Su X, Li X, Wu F. Plasma linoelaidyl carnitine levels positively correlated with symptom improvement in olanzapine-treated first-episode drug-naïve schizophrenia. Metabolomics 2022;18:50. [PMID: 35819637 DOI: 10.1007/s11306-022-01909-4] [Reference Citation Analysis]
|
| 25 |
Liu J, Hua Y, Yang R, Luo Y, Lu H, Wang Y, Yang S, Ding X. Bio-Inspired Autonomous Learning Algorithm With Application to Mobile Robot Obstacle Avoidance. Front Neurosci 2022;16:905596. [DOI: 10.3389/fnins.2022.905596] [Reference Citation Analysis]
|
| 26 |
Seidisarouei M, Schäble S, van Wingerden M, Trossbach SV, Korth C, Kalenscher T. Social anhedonia as a Disrupted-in-Schizophrenia 1-dependent phenotype. Sci Rep 2022;12:10182. [PMID: 35715502 DOI: 10.1038/s41598-022-14102-3] [Reference Citation Analysis]
|
| 27 |
Jamal M, Ito A, Miki T, Suzuki S, Ohta K, Kinoshita H. Ethanol concentration induces production of 3,4-dihydroxyphenylacetic acid and homovanillic acid in mouse brain through activation of monoamine oxidase pathway. Neuroscience Letters 2022. [DOI: 10.1016/j.neulet.2022.136689] [Reference Citation Analysis]
|
| 28 |
Nordio G, Easmin R, Giacomel A, Dipasquale O, Martins D, Williams S, Turkheimer F, Howes O, Veronese M. Digital data repository and automatic analysis framework for FDOPA PET neuroimaging.. [DOI: 10.1101/2022.04.14.488129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 29 |
Sabe M, Pillinger T, Kaiser S, Chen C, Taipale H, Tanskanen A, Tiihonen J, Leucht S, Correll CU, Solmi M. Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev 2022;136:104608. [PMID: 35303594 DOI: 10.1016/j.neubiorev.2022.104608] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 30 |
Li XJ, Yu JH, Wu X, Zhu XM, Lv P, Du Z, Lu Y, Wu X, Yao J. Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model. Neurotoxicol Teratol 2022;:107079. [PMID: 35202796 DOI: 10.1016/j.ntt.2022.107079] [Reference Citation Analysis]
|
| 31 |
Juza R, Vojtechova I, Stefkova-mazochova K, Dehaen W, Petrasek T, Prchal L, Kobrlova T, Janousek J, Vlcek P, Mezeiova E, Svozil D, Karasova JZ, Pejchal J, Stark H, Satala G, Bojarski AJ, Kubacka M, Mogilski S, Randakova A, Musilek K, Soukup O, Korabecny J. Novel D2/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatment. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Millard SJ, Bearden CE, Karlsgodt KH, Sharpe MJ. The prediction-error hypothesis of schizophrenia: new data point to circuit-specific changes in dopamine activity. Neuropsychopharmacology 2022;47:628-40. [PMID: 34588607 DOI: 10.1038/s41386-021-01188-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 33 |
Sotoyama H, Inaba H, Iwakura Y, Namba H, Takei N, Sasaoka T, Nawa H. The dual role of dopamine in the modulation of information processing in the prefrontal cortex underlying social behavior. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202101637r] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 34 |
Salter MD, Gunja N. Arylcyclohexamines. Novel Psychoactive Substances 2022. [DOI: 10.1016/b978-0-12-818788-3.00011-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Foley P. Psychopharmacology: A Brief Overview of Its History. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_12] [Reference Citation Analysis]
|
| 36 |
Kiss B, Krámos B, Laszlovszky I. Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D(3) Receptors in the Brain in vivo. Front Psychiatry 2022;13:785592. [PMID: 35401257 DOI: 10.3389/fpsyt.2022.785592] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Hommers L. Mood Stabilizers: Pharmacology and Biochemistry. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_37] [Reference Citation Analysis]
|
| 38 |
Yonezawa K, Kanegae S, Ozawa H. Antipsychotics/Neuroleptics: Pharmacology and Biochemistry. NeuroPsychopharmacotherapy 2022. [DOI: 10.1007/978-3-030-62059-2_52] [Reference Citation Analysis]
|
| 39 |
Bernardin F, Schwitzer T, Schwan R, Angioi-Duprez K, Ligier F, Bourion-Bedes S, Jansen C, Giersch A, Laprevote V. Altered central vision and amacrine cells dysfunction as marker of hypodopaminergic activity in treated patients with schizophrenia. Schizophr Res 2022;239:134-41. [PMID: 34891077 DOI: 10.1016/j.schres.2021.11.049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 40 |
Xie Y, Cai Y, Guan M, Wang Z, Ma Z, Fang P, Wang H. The alternations of nucleus accumbent in schizophrenia patients with auditory verbal hallucinations during low-frequency rTMS treatment. Front Psychiatry 2022;13:971105. [PMID: 36147981 DOI: 10.3389/fpsyt.2022.971105] [Reference Citation Analysis]
|
| 41 |
Muguruza C, Callado LF. Glutamate, Glutamatergic Drugs and Schizophrenia. Glutamate and Neuropsychiatric Disorders 2022. [DOI: 10.1007/978-3-030-87480-3_17] [Reference Citation Analysis]
|
| 42 |
Smith BJ, Carregari VC. Known and Unexplored Post-Translational Modification Pathways in Schizophrenia. Advances in Experimental Medicine and Biology 2022. [DOI: 10.1007/978-3-030-97182-3_6] [Reference Citation Analysis]
|
| 43 |
Mätlik K, Garton DR, Montaño-Rodríguez AR, Olfat S, Eren F, Casserly L, Damdimopoulos A, Panhelainen A, Porokuokka LL, Kopra JJ, Turconi G, Schweizer N, Bereczki E, Piehl F, Engberg G, Cervenka S, Piepponen TP, Zhang FP, Sipilä P, Jakobsson J, Sellgren CM, Erhardt S, Andressoo JO. Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. Mol Psychiatry 2022;27:3247-61. [PMID: 35618883 DOI: 10.1038/s41380-022-01554-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 44 |
Cho JM, Ko YJ, Lee HJ, Choi HJ, Baik YJ, Park JK, Kwak JY, Kim J, Park J, Jeong Y, Kim I, Lee KS, Lee WS. Bottom-Up Evolution of Diamond-Graphite Hybrid Two-Dimensional Nanostructure: Underlying Picture and Electrochemical Activity. Small 2021;:e2105087. [PMID: 34894074 DOI: 10.1002/smll.202105087] [Reference Citation Analysis]
|
| 45 |
Lee D, Seo J, Jeong HC, Lee H, Lee SB. The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons. Front Mol Neurosci 2021;14:756613. [PMID: 34867186 DOI: 10.3389/fnmol.2021.756613] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Kleppe R, Waheed Q, Ruoff P. DOPA Homeostasis by Dopamine: A Control-Theoretic View. Int J Mol Sci 2021;22:12862. [PMID: 34884667 DOI: 10.3390/ijms222312862] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Sahu AK, Mishra AK. Interaction of Dopamine with Zwitterionic DMPC and Anionic DMPS Multilamellar Vesicle Membranes. Langmuir 2021;37:13430-43. [PMID: 34732050 DOI: 10.1021/acs.langmuir.1c02184] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 48 |
Sykes DA, Lochray J, Comfort HM, Jain P, Charlton SJ. Exploring the kinetic selectivity of antipsychotics for dopamine D2 and 5-HT2A receptors: implications for the prevalence of EPS and receptor occupancy.. [DOI: 10.1101/2021.11.14.468520] [Reference Citation Analysis]
|
| 49 |
Tsujimoto Y, Nakamura Y, Banno M, Kohmura K, Tsujimoto H, Kataoka Y. Humour-based interventions for people with schizophrenia. Cochrane Database Syst Rev 2021;10:CD013367. [PMID: 34644398 DOI: 10.1002/14651858.CD013367.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 50 |
Seidisarouei M, van Wingerden M, Schäble S, Trossbach SV, Korth C, Kalenscher T. Reduced motivation for social contact in Disrupted-in-schizophrenia transgenic rats.. [DOI: 10.1101/2021.09.29.462172] [Reference Citation Analysis]
|
| 51 |
Dutra-Tavares AC, Manhães AC, Semeão KA, Maia JG, Couto LA, Filgueiras CC, Ribeiro-Carvalho A, Abreu-Villaça Y. Does nicotine exposure during adolescence modify the course of schizophrenia-like symptoms? Behavioral analysis in a phencyclidine-induced mice model. PLoS One 2021;16:e0257986. [PMID: 34587208 DOI: 10.1371/journal.pone.0257986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 52 |
Pagano R, Syrgiannis Z, Bettini S, Ingrosso C, Valli L, Giancane G, Prato M. Localized and Surface Plasmons Coupling for Ultrasensitive Dopamine Detection by means of SPR‐Based Perylene Bisimide/Au Nanostructures Thin Film. Adv Mater Interfaces 2021;8:2101023. [DOI: 10.1002/admi.202101023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 53 |
Saleh Y, Jarratt-Barnham I, Fernandez-Egea E, Husain M. Mechanisms Underlying Motivational Dysfunction in Schizophrenia. Front Behav Neurosci 2021;15:709753. [PMID: 34566594 DOI: 10.3389/fnbeh.2021.709753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 54 |
Hu C, Zuo H, Li Y. Effects of Radiofrequency Electromagnetic Radiation on Neurotransmitters in the Brain. Front Public Health 2021;9:691880. [PMID: 34485223 DOI: 10.3389/fpubh.2021.691880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 55 |
Nayeri T, Sarvi S, Daryani A. Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders. Metab Brain Dis 2021. [PMID: 34476718 DOI: 10.1007/s11011-021-00824-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Varga TG, de Toledo Simões JG, Siena A, Henrique E, da Silva RCB, Dos Santos Bioni V, Ramos AC, Rosenstock TR. Haloperidol rescues the schizophrenia-like phenotype in adulthood after rotenone administration in neonatal rats. Psychopharmacology (Berl) 2021;238:2569-85. [PMID: 34089344 DOI: 10.1007/s00213-021-05880-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 57 |
Gasnier M, Ellul P, Plaze M, Ahad PA. A New Look on an Old Issue: Comprehensive Review of Neurotransmitter Studies in Cerebrospinal Fluid of Patients with Schizophrenia and Antipsychotic Effect on Monoamine's Metabolism. Clin Psychopharmacol Neurosci 2021;19:395-410. [PMID: 34294610 DOI: 10.9758/cpn.2021.19.3.395] [Reference Citation Analysis]
|
| 58 |
F.m. A, J.o A. Assessment of the Challenges Experienced by Nurses Caring for Patients Diagnosed with Psychotic Disorders in Neuro-Psychiatric Hospitals, from South-West, Nigeria. African Journal of Health, Nursing and Midwifery 2021;4:49-58. [DOI: 10.52589/ajhnm-w3pyvg78] [Reference Citation Analysis]
|
| 59 |
Almulla AF, Al-Hakeim HK, Maes M. Schizophrenia phenomenology revisited: positive and negative symptoms are strongly related reflective manifestations of an underlying single trait indicating overall severity of schizophrenia. CNS Spectr 2021;26:368-77. [PMID: 32431263 DOI: 10.1017/S1092852920001182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 60 |
Cioates Negut C, Gheorghe SS, Stefan-van Staden RI, van Staden JF. Fast screening test for molecular recognition of levodopa and dopamine in biological samples using 3D printed stochastic microsensors. J Pharm Biomed Anal 2021;205:114292. [PMID: 34375784 DOI: 10.1016/j.jpba.2021.114292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Sun L, You J, Sun F, Cui M, Wang J, Wang W, Wang D, Liu D, Xu Z, Qiu C, Liu B, Yan H. Reactivating a positive feedback loop VTA-BLA-NAc circuit associated with positive experience ameliorates the attenuated reward sensitivity induced by chronic stress. Neurobiol Stress 2021;15:100370. [PMID: 34381852 DOI: 10.1016/j.ynstr.2021.100370] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 62 |
Ľupták M, Michaličková D, Fišar Z, Kitzlerová E, Hroudová J. Novel approaches in schizophrenia-from risk factors and hypotheses to novel drug targets. World J Psychiatr 2021; 11(7): 277-296 [PMID: 34327122 DOI: 10.5498/wjp.v11.i7.277] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 63 |
Seeman MV. History of the dopamine hypothesis of antipsychotic action. World J Psychiatr 2021; 11(7): 355-364 [PMID: 34327128 DOI: 10.5498/wjp.v11.i7.355] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 64 |
Davidson M, Gabos-Grecu C. Do DSM classifications help or hinder
drug development?
. Dialogues Clin Neurosci 2020;22:73-9. [PMID: 32699507 DOI: 10.31887/DCNS.2020.22.1/mdavidson] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 65 |
Takeuchi Y, Nagy AJ, Barcsai L, Li Q, Ohsawa M, Mizuseki K, Berényi A. The Medial Septum as a Potential Target for Treating Brain Disorders Associated With Oscillopathies. Front Neural Circuits 2021;15:701080. [PMID: 34305537 DOI: 10.3389/fncir.2021.701080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 66 |
Fyfe TJ, Scammells PJ, Lane JR, Capuano B. Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D1 Receptor. Molecules 2021;26:3799. [PMID: 34206465 DOI: 10.3390/molecules26133799] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 67 |
Plataki ME, Diskos K, Sougklakos C, Velissariou M, Georgilis A, Stavroulaki V, Sidiropoulou K. Effect of Neonatal Treatment With the NMDA Receptor Antagonist, MK-801, During Different Temporal Windows of Postnatal Period in Adult Prefrontal Cortical and Hippocampal Function. Front Behav Neurosci 2021;15:689193. [PMID: 34177484 DOI: 10.3389/fnbeh.2021.689193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 68 |
Lech MA, Leśkiewicz M, Kamińska K, Rogóż Z, Lorenc-Koci E. Glutathione Deficiency during Early Postnatal Development Causes Schizophrenia-Like Symptoms and a Reduction in BDNF Levels in the Cortex and Hippocampus of Adult Sprague-Dawley Rats. Int J Mol Sci 2021;22:6171. [PMID: 34201038 DOI: 10.3390/ijms22126171] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 69 |
Girgis RR, Slifstein M, Brucato G, Kegeles LS, Colibazzi T, Lieberman JA, Abi-Dargham A. Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [(11)C]-(+)-PHNO PET with methylphenidate challenge study. Mol Psychiatry 2021;26:2504-13. [PMID: 33154566 DOI: 10.1038/s41380-020-00934-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 70 |
Li L, Lu Y, Qian Z, Yang Z, Yang K, Zong S, Wang Z, Cui Y. Ultra-sensitive surface enhanced Raman spectroscopy sensor for in-situ monitoring of dopamine release using zipper-like ortho-nanodimers. Biosensors and Bioelectronics 2021;180:113100. [DOI: 10.1016/j.bios.2021.113100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 71 |
Veronese M, Santangelo B, Jauhar S, D'Ambrosio E, Demjaha A, Salimbeni H, Huajie J, McCrone P, Turkheimer F, Howes O. A potential biomarker for treatment stratification in psychosis: evaluation of an [(18)F] FDOPA PET imaging approach. Neuropsychopharmacology 2021;46:1122-32. [PMID: 32961543 DOI: 10.1038/s41386-020-00866-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 72 |
Soder HE, Cooper JA, Lopez-Gamundi P, Hoots JK, Nunez C, Lawlor VM, Lane SD, Treadway MT, Wardle MC. Dose-response effects of d-amphetamine on effort-based decision-making and reinforcement learning. Neuropsychopharmacology 2021;46:1078-85. [PMID: 32722661 DOI: 10.1038/s41386-020-0779-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 73 |
Acharya S, Kim KM. Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease. Int J Mol Sci 2021;22:4299. [PMID: 33919025 DOI: 10.3390/ijms22094299] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 74 |
Rampino A, Torretta S, Gelao B, Veneziani F, Iacoviello M, Marakhovskaya A, Masellis R, Andriola I, Sportelli L, Pergola G, Minelli A, Magri C, Gennarelli M, Vita A, Beaulieu JM, Bertolino A, Blasi G. Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics. Eur Psychiatry 2021;64:e39. [PMID: 33866994 DOI: 10.1192/j.eurpsy.2021.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 75 |
Jones DN, Raghanti MA. The role of monoamine oxidase enzymes in the pathophysiology of neurological disorders. J Chem Neuroanat 2021;114:101957. [PMID: 33836221 DOI: 10.1016/j.jchemneu.2021.101957] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 76 |
D'Ambrosio E, Jauhar S, Kim S, Veronese M, Rogdaki M, Pepper F, Bonoldi I, Kotoula V, Kempton MJ, Turkheimer F, Kwon JS, Kim E, Howes OD. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal (18)F-DOPA PET and voxel-based morphometry study. Mol Psychiatry 2021;26:1332-45. [PMID: 31690805 DOI: 10.1038/s41380-019-0570-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 77 |
Kim J, Barath AS, Rusheen AE, Rojas Cabrera JM, Price JB, Shin H, Goyal A, Yuen JW, Jondal DE, Blaha CD, Lee KH, Jang DP, Oh Y. Automatic and Reliable Quantification of Tonic Dopamine Concentrations In Vivo Using a Novel Probabilistic Inference Method. ACS Omega 2021;6:6607-13. [PMID: 33748573 DOI: 10.1021/acsomega.0c05217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 78 |
Kandratsenka HS, Danilenko NG, Haylaenka IM, Skugarevsky OA, Marshe V, Kennedy JL, Davydenko OG. Association of СОМТ, DRD2/ANKK1, MTHFR, MIR 137, DNMT3B polymorphisms with the clinical features of schizophrenia patients in acute stage and remission. Dokl Akad nauk 2021;65:76-86. [DOI: 10.29235/1561-8323-2021-65-1-76-86] [Reference Citation Analysis]
|
| 79 |
Sun L, You J, Cui M, Sun F, Wang J, Wang W, Wang D, Liu D, Xu Z, Qiu C, Liu B, Yan H. The VTA-BLA-NAc circuit for sex reward inhibited by VTA GABAergic neurons under stress in male mice.. [DOI: 10.1101/2021.01.20.427537] [Reference Citation Analysis]
|
| 80 |
Babić Leko M, Hof PR, Šimić G. Alterations and interactions of subcortical modulatory systems in Alzheimer's disease. Prog Brain Res 2021;261:379-421. [PMID: 33785136 DOI: 10.1016/bs.pbr.2020.07.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 81 |
Sakayori T, Tateno A, Arakawa R, Kim WC, Okubo Y. Evaluation of dopamine D(3) receptor occupancy by blonanserin using [(11)C]-(+)-PHNO in schizophrenia patients. Psychopharmacology (Berl) 2021;238:1343-50. [PMID: 33180175 DOI: 10.1007/s00213-020-05698-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 82 |
Kim Y. Implications of Adult Neural Stem Cell Abnormalities in the Pathophysiological Mechanism of Schizophrenia. J Korean Neuropsychiatr Assoc 2021;60:28. [DOI: 10.4306/jknpa.2021.60.1.28] [Reference Citation Analysis]
|
| 83 |
Gao R. Snapshot of Schizophrenia: Current Knowledge and Prospects. E3S Web Conf 2021;271:03004. [DOI: 10.1051/e3sconf/202127103004] [Reference Citation Analysis]
|
| 84 |
Klein HC, Doorduin J, van Berckel BN. Molecular Imaging in Schizophrenia Spectrum Disorders. PET and SPECT in Psychiatry 2021. [DOI: 10.1007/978-3-030-57231-0_16] [Reference Citation Analysis]
|
| 85 |
Brydges CR, Ozolnieks KL, Roberts G. Working Memory and Intraindividual Variability in Response Time Mediate Fluid Intelligence Deficits Associated With ADHD Symptomology. J Atten Disord 2021;25:63-72. [PMID: 29708000 DOI: 10.1177/1087054718772143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 86 |
Jonusiene G. Schizophrenia and Other Psychotic Disorders. Psychiatry and Sexual Medicine 2021. [DOI: 10.1007/978-3-030-52298-8_15] [Reference Citation Analysis]
|
| 87 |
Ntephe CU, Demjaha A. Dopamine and Response to Antipsychotic Medication. PET and SPECT in Psychiatry 2021. [DOI: 10.1007/978-3-030-57231-0_14] [Reference Citation Analysis]
|
| 88 |
Khamcharoen W, Siangproh W. A multilayer microfluidic paper coupled with an electrochemical platform developed for sample separation and detection of dopamine. New J Chem 2021;45:12886-12894. [DOI: 10.1039/d1nj02271g] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 89 |
Yonezawa K, Kanegae S, Ozawa H. Antipsychotics/Neuroleptics: Pharmacology and Biochemistry. NeuroPsychopharmacotherapy 2021. [DOI: 10.1007/978-3-319-56015-1_52-1] [Reference Citation Analysis]
|
| 90 |
Williams M. The Basal Ganglia. The Neuropathology of Schizophrenia 2021. [DOI: 10.1007/978-3-030-68308-5_9] [Reference Citation Analysis]
|
| 91 |
Rojas Cabrera JM, Price JB, Rusheen AE, Goyal A, Jondal D, Barath AS, Shin H, Chang SY, Bennet KE, Blaha CD, Lee KH, Oh Y. Advances in neurochemical measurements: A review of biomarkers and devices for the development of closed-loop deep brain stimulation systems. Rev Anal Chem 2020;39:188-99. [PMID: 33883813 DOI: 10.1515/revac-2020-0117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 92 |
Inserra A, De Gregorio D, Gobbi G. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacol Rev 2021;73:202-77. [PMID: 33328244 DOI: 10.1124/pharmrev.120.000056] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 93 |
Kirschner M, Schmidt A, Hodzic-Santor B, Burrer A, Manoliu A, Zeighami Y, Yau Y, Abbasi N, Maatz A, Habermeyer B, Abivardi A, Avram M, Brandl F, Sorg C, Homan P, Riecher-Rössler A, Borgwardt S, Seifritz E, Dagher A, Kaiser S. Orbitofrontal-Striatal Structural Alterations Linked to Negative Symptoms at Different Stages of the Schizophrenia Spectrum. Schizophr Bull 2021;47:849-63. [PMID: 33257954 DOI: 10.1093/schbul/sbaa169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 94 |
Webber HE, Lopez-Gamundi P, Stamatovich SN, de Wit H, Wardle MC. Using pharmacological manipulations to study the role of dopamine in human reward functioning: A review of studies in healthy adults. Neurosci Biobehav Rev 2021;120:123-58. [PMID: 33202256 DOI: 10.1016/j.neubiorev.2020.11.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 95 |
Mackintosh AJ, de Bock R, Lim Z, Trulley VN, Schmidt A, Borgwardt S, Andreou C. Psychotic disorders, dopaminergic agents and EEG/MEG resting-state functional connectivity: A systematic review. Neurosci Biobehav Rev 2021;120:354-71. [PMID: 33171145 DOI: 10.1016/j.neubiorev.2020.10.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 96 |
Torrisi SA, Laudani S, Contarini G, De Luca A, Geraci F, Managò F, Papaleo F, Salomone S, Drago F, Leggio GM. Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments. Pharmaceuticals (Basel) 2020;13:E365. [PMID: 33167370 DOI: 10.3390/ph13110365] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 97 |
Wang Y, Wang S, Huang M, Chen F. Bifunctionalized Prussian blue analogue particles oxidize luminol to produce chemiluminescence without other oxidants. Microchemical Journal 2020;158:105213. [DOI: 10.1016/j.microc.2020.105213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 98 |
Issy AC, Pedrazzi JFC, van Oosten ABS, Checheto T, Silva RR, Noël F, Del-Bel E. Effects of Doxycycline in Swiss Mice Predictive Models of Schizophrenia. Neurotox Res 2020;38:1049-60. [PMID: 32929685 DOI: 10.1007/s12640-020-00268-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 99 |
Stępnicki P, Kondej M, Koszła O, Żuk J, Kaczor AA. Multi-targeted drug design strategies for the treatment of schizophrenia. Expert Opin Drug Discov 2021;16:101-14. [PMID: 32915109 DOI: 10.1080/17460441.2020.1816962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 100 |
de Boer JN, Voppel AE, Brederoo SG, Wijnen FNK, Sommer IEC. Language disturbances in schizophrenia: the relation with antipsychotic medication. NPJ Schizophr 2020;6:24. [PMID: 32895389 DOI: 10.1038/s41537-020-00114-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 101 |
Forster L, Grätz L, Mönnich D, Bernhardt G, Pockes S. A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D2-Like Receptors. Int J Mol Sci 2020;21:E6103. [PMID: 32847148 DOI: 10.3390/ijms21176103] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 102 |
Abo-Al-Ela HG. Toxoplasmosis and Psychiatric and Neurological Disorders: A Step toward Understanding Parasite Pathogenesis. ACS Chem Neurosci 2020;11:2393-406. [PMID: 31268676 DOI: 10.1021/acschemneuro.9b00245] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 103 |
Blair Thies M, DeRosse P, Sarpal DK, Argyelan M, Fales CL, Gallego JA, Robinson DG, Lencz T, Homan P, Malhotra AK. Interaction of Cannabis Use Disorder and Striatal Connectivity in Antipsychotic Treatment Response. Schizophr Bull Open 2020;1:sgaa014. [PMID: 32803161 DOI: 10.1093/schizbullopen/sgaa014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 104 |
Mancuso L, Fornito A, Costa T, Ficco L, Liloia D, Manuello J, Duca S, Cauda F. A meta-analytic approach to mapping co-occurrent grey matter volume increases and decreases in psychiatric disorders. Neuroimage 2020;222:117220. [PMID: 32777357 DOI: 10.1016/j.neuroimage.2020.117220] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 105 |
Mäki-Marttunen V, Andreassen OA, Espeseth T. The role of norepinephrine in the pathophysiology of schizophrenia. Neurosci Biobehav Rev 2020;118:298-314. [PMID: 32768486 DOI: 10.1016/j.neubiorev.2020.07.038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 106 |
Vostrikov VM. Neuromorphological Aspects of the GABAergic Hypothesis of the Pathogenesis of Schizophrenia. Neurosci Behav Physi 2020;50:663-668. [DOI: 10.1007/s11055-020-00952-9] [Reference Citation Analysis]
|
| 107 |
Fountoulakis KN, Moeller HJ, Kasper S, Tamminga C, Yamawaki S, Kahn R, Tandon R, Correll CU, Javed A. The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia. CNS Spectr 2020;:1-25. [PMID: 32594935 DOI: 10.1017/S1092852920001546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 108 |
Kamal Eddin FB, Fen YW. The Principle of Nanomaterials Based Surface Plasmon Resonance Biosensors and Its Potential for Dopamine Detection. Molecules 2020;25:E2769. [PMID: 32549390 DOI: 10.3390/molecules25122769] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 109 |
Desai A, Benner L, Wu R, Gertsik L, Uz T, Marek GJ, Zhu T. Pharmacokinetics of ASP4345 from Single Ascending-Dose and Multiple Ascending-Dose Phase I Studies. Clin Pharmacokinet 2021;60:79-88. [PMID: 32533536 DOI: 10.1007/s40262-020-00911-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 110 |
Khater SI, El-sharawy DM, El Refaye MS, Farrag NS. Optimization and tissue distribution of [125I]iododomperidone as a radiotracer for D2-receptor imaging. J Radioanal Nucl Chem 2020;325:343-55. [DOI: 10.1007/s10967-020-07236-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 111 |
Mallya AP, Wang HD, Lee HNR, Deutch AY. Microglial Pruning of Synapses in the Prefrontal Cortex During Adolescence. Cereb Cortex 2019;29:1634-43. [PMID: 29668872 DOI: 10.1093/cercor/bhy061] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 19.7] [Reference Citation Analysis]
|
| 112 |
Mancuso L, Fornito A, Costa T, Ficco L, Liloia D, Manuello J, Duca S, Cauda F. A meta-analytic approach to mapping co-occurrent grey matter volume increases and decreases in psychiatric disorders.. [DOI: 10.1101/2020.05.18.101436] [Reference Citation Analysis]
|
| 113 |
Venkataramaiah C, Lakshmi Priya B, Rajendra W. Perturbations in the catecholamine metabolism and protective effect of "3-(3, 4-dimethoxy phenyl)-1-4(methoxy phenyl) prop-2-en-1-one" during ketamine-induced schizophrenia: an in vivo and in silico studies. J Biomol Struct Dyn 2021;39:3523-32. [PMID: 32375600 DOI: 10.1080/07391102.2020.1765875] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Schönfeldt-Lecuona C, Kregel T, Schmidt A, Kassubek J, Dreyhaupt J, Freudenmann RW, Connemann BJ, Gahr M, Pinkhardt EH. Retinal single-layer analysis with optical coherence tomography (OCT) in schizophrenia spectrum disorder. Schizophr Res 2020;219:5-12. [PMID: 30981598 DOI: 10.1016/j.schres.2019.03.022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 115 |
Yeap S, Thakore J. Stress axis dysfunction in schizophrenia. Eur psychiatr 2005;20:S307-12. [DOI: 10.1016/s0924-9338(05)80181-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 116 |
Shi W, Wang Y, Wu C, Yang F, Zheng W, Wu S, Liu Y, Wang Z, He Y, Shen J. Synthesis and biological investigation of triazolopyridinone derivatives as potential multireceptor atypical antipsychotics. Bioorg Med Chem Lett 2020;30:127027. [PMID: 32122737 DOI: 10.1016/j.bmcl.2020.127027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 117 |
Hori H, Matsuo J, Teraishi T, Sasayama D, Kawamoto Y, Kinoshita Y, Ota M, Hattori K, Kunugi H. Moderating effect of schizotypy on the relationship between smoking and neurocognition. Eur psychiatr 2013;28:457-62. [DOI: 10.1016/j.eurpsy.2012.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 118 |
Magioncalda P, Martino M, Conio B, Lee HC, Ku HL, Chen CJ, Inglese M, Amore M, Lane TJ, Northoff G. Intrinsic brain activity of subcortical-cortical sensorimotor system and psychomotor alterations in schizophrenia and bipolar disorder: A preliminary study. Schizophr Res 2020;218:157-65. [PMID: 32029353 DOI: 10.1016/j.schres.2020.01.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 119 |
Erşan EE. Hospitalization and Some Sociodemographic Characteristics of Patients Registered with a Community Mental Health Center. Community Ment Health J 2020;56:498-505. [PMID: 31734764 DOI: 10.1007/s10597-019-00506-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 120 |
Addicott MA, Wardle MC, Selig JP. Effort-based decision making varies by smoking status. Psychopharmacology (Berl) 2020;237:1081-90. [PMID: 31900525 DOI: 10.1007/s00213-019-05437-3] [Reference Citation Analysis]
|
| 121 |
Ward HB, Greenberg JA, Almeida M. Perimenstrual psychiatric hospitalization: case report and literature review. Arch Womens Ment Health 2020;23:141-7. [PMID: 31161260 DOI: 10.1007/s00737-019-00967-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 122 |
Guo X, Yue H, Huang S, Gao X, Chen H, Wu P, Zhang T, Wang Z. A sensitive method to determine dopamine in the presence of uric acid based on In2O3 nanosheet arrays grown on 3D graphene. Mikrochim Acta 2020;187:218. [PMID: 32166530 DOI: 10.1007/s00604-020-4199-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 123 |
Holloway ZR, Paige NB, Comstock JF, Nolen HG, Sable HJ, Lester DB. Cerebellar Modulation of Mesolimbic Dopamine Transmission Is Functionally Asymmetrical. Cerebellum 2019;18:922-31. [PMID: 31478166 DOI: 10.1007/s12311-019-01074-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 124 |
Mueller TM, Meador-Woodruff JH. Post-translational protein modifications in schizophrenia. NPJ Schizophr 2020;6:5. [PMID: 32123175 DOI: 10.1038/s41537-020-0093-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 125 |
Punchaichira TJ, Mukhopadhyay A, Kukshal P, Bhatia T, Deshpande SN, Thelma BK. Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects. J Psychopharmacol 2020;34:358-69. [PMID: 31913053 DOI: 10.1177/0269881119895539] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 126 |
Amoah SK, Rodriguez BA, Logothetis CN, Chander P, Sellgren CM, Weick JP, Sheridan SD, Jantzie LL, Webster MJ, Mellios N. Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics. Neuropsychopharmacology 2020;45:656-65. [PMID: 31775160 DOI: 10.1038/s41386-019-0579-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 127 |
Kamal Eddin FB, Wing Fen Y. Recent Advances in Electrochemical and Optical Sensing of Dopamine. Sensors (Basel) 2020;20:E1039. [PMID: 32075167 DOI: 10.3390/s20041039] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 128 |
Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort. Schizophr Res 2020;216:357-66. [PMID: 31796306 DOI: 10.1016/j.schres.2019.11.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 129 |
Takahashi S, Okamura A, Yamazaki M, Ni K. ASP2905, a specific inhibitor of the potassium channel Kv12.2 encoded by the Kcnh3 gene, is psychoactive in mice. Behav Brain Res 2020;378:112315. [PMID: 31654662 DOI: 10.1016/j.bbr.2019.112315] [Reference Citation Analysis]
|
| 130 |
Weidenauer A, Bauer M, Sauerzopf U, Bartova L, Nics L, Pfaff S, Philippe C, Berroterán-Infante N, Pichler V, Meyer BM, Rabl U, Sezen P, Cumming P, Stimpfl T, Sitte HH, Lanzenberger R, Mossaheb N, Zimprich A, Rusjan P, Dorffner G, Mitterhauser M, Hacker M, Pezawas L, Kasper S, Wadsak W, Praschak-Rieder N, Willeit M. On the relationship of first-episode psychosis to the amphetamine-sensitized state: a dopamine D(2/3) receptor agonist radioligand study. Transl Psychiatry 2020;10:2. [PMID: 32066718 DOI: 10.1038/s41398-019-0681-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 131 |
MacQueen DA, Young JW. The D2-family receptor agonist bromocriptine but, not nicotine, reverses NMDA receptor antagonist-induced working memory deficits in the radial arm maze in mice. Neurobiol Learn Mem 2020;168:107159. [PMID: 31911198 DOI: 10.1016/j.nlm.2020.107159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 132 |
Conio B, Martino M, Magioncalda P, Escelsior A, Inglese M, Amore M, Northoff G. Opposite effects of dopamine and serotonin on resting-state networks: review and implications for psychiatric disorders. Mol Psychiatry 2020;25:82-93. [PMID: 30953003 DOI: 10.1038/s41380-019-0406-4] [Cited by in Crossref: 107] [Cited by in F6Publishing: 106] [Article Influence: 35.7] [Reference Citation Analysis]
|
| 133 |
Aguilar-Valles A, Rodrigue B, Matta-Camacho E. Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses. Front Psychiatry 2020;11:852. [PMID: 33061910 DOI: 10.3389/fpsyt.2020.00852] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 134 |
Foley P. Psychopharmacology: A Brief Overview of Its History. NeuroPsychopharmacotherapy 2020. [DOI: 10.1007/978-3-319-56015-1_12-1] [Reference Citation Analysis]
|
| 135 |
Hommers L. Mood Stabilizers: Pharmacology and Biochemistry. NeuroPsychopharmacotherapy 2020. [DOI: 10.1007/978-3-319-56015-1_37-1] [Reference Citation Analysis]
|
| 136 |
陈 默. Parvalbumin Interneuron Damage Plays a Central Role in the Pathogenesis of Schizophrenia. IJPN 2020;09:1-11. [DOI: 10.12677/ijpn.2020.91001] [Reference Citation Analysis]
|
| 137 |
Harvey C. Medical Perspective on Mental Health. Mental Health and Social Work 2020. [DOI: 10.1007/978-981-13-6975-9_4] [Reference Citation Analysis]
|
| 138 |
Ichinose M, Park S. Models of Schizophrenia. A Selective Review of Genetic, Neuropharmacological, Cognitive, and Social Approaches. A Clinical Introduction to Psychosis 2020. [DOI: 10.1016/b978-0-12-815012-2.00002-x] [Reference Citation Analysis]
|
| 139 |
Frangou S, Kahn RS. Gray Matter Involvement in Schizophrenia: Evidence from Magnetic Resonance Imaging Studies. Neuroimaging in Schizophrenia 2020. [DOI: 10.1007/978-3-030-35206-6_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 140 |
Li R, Guo W, Lei L, Zhang L, Liu Y, Han J, Chen L, Zhou B. Early-life exposure to the organophosphorus flame-retardant tris (1,3-dichloro-2-propyl) phosphate induces delayed neurotoxicity associated with DNA methylation in adult zebrafish. Environment International 2020;134:105293. [DOI: 10.1016/j.envint.2019.105293] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 141 |
Pallanti S, Salerno L. Adult ADHD in Schizophrenia Spectrum and Other Psychotic Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders 2020. [DOI: 10.1007/978-3-030-39051-8_8] [Reference Citation Analysis]
|
| 142 |
Pearce BD, Massa N, Goldsmith DR, Gandhi ZH, Hankus A, Alrohaibani A, Goel N, Cuthbert B, Fargotstein M, Barr DB, Panuwet P, Brown VM, Duncan E. Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects. Front Psychiatry 2020;11:552743. [PMID: 33329089 DOI: 10.3389/fpsyt.2020.552743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 143 |
Wengler K, He X, Abi-Dargham A, Horga G. Reproducibility assessment of neuromelanin-sensitive magnetic resonance imaging protocols for region-of-interest and voxelwise analyses. Neuroimage 2020;208:116457. [PMID: 31841683 DOI: 10.1016/j.neuroimage.2019.116457] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 144 |
Russo M, Carrarini C, Dono F, Rispoli MG, Di Pietro M, Di Stefano V, Ferri L, Bonanni L, Sensi SL, Onofrj M. The Pharmacology of Visual Hallucinations in Synucleinopathies. Front Pharmacol 2019;10:1379. [PMID: 31920635 DOI: 10.3389/fphar.2019.01379] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 145 |
Li Q, Zhang B, Cao H, Liu W, Guo F, Shen F, Ye B, Liu H, Li Y, Liu Z. Oxytocin Exerts Antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC. Neuropharmacology 2020;162:107836. [PMID: 31682854 DOI: 10.1016/j.neuropharm.2019.107836] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 146 |
Yoshikawa A, Li J, Meltzer HY. A functional HTR1A polymorphism, rs6295, predicts short-term response to lurasidone: confirmation with meta-analysis of other antipsychotic drugs. Pharmacogenomics J 2020;20:260-70. [PMID: 31636356 DOI: 10.1038/s41397-019-0101-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 147 |
Vostrikov VM. [Neuromorphological aspect of the GABAergic hypothesis of the pathogenesis of schizophrenia]. Zh Nevrol Psikhiatr Im S S Korsakova 2019;119:124-9. [PMID: 31626180 DOI: 10.17116/jnevro2019119081124] [Reference Citation Analysis]
|
| 148 |
Zádor F, Nagy-Grócz G, Kekesi G, Dvorácskó S, Szűcs E, Tömböly C, Horvath G, Benyhe S, Vécsei L. Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions. Molecules 2019;24:E3709. [PMID: 31619006 DOI: 10.3390/molecules24203709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 149 |
Tong KY, Zhao J, Tse CW, Wan PK, Rong J, Au-Yeung HY. Selective catecholamine detection in living cells by a copper-mediated oxidative bond cleavage. Chem Sci 2019;10:8519-26. [PMID: 31762971 DOI: 10.1039/c9sc03338f] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 150 |
Yao L, Li F, Liu J, Liao W, Li X, Li M, Meng Y, Liang S, Zhang C, Yang X, Wang Q, Ma X, Guo W, Sweeney JA, Gong Q, Lui S, Deng W, Li T. Functional brain networks in never-treated and treated long-term Ill schizophrenia patients. Neuropsychopharmacology 2019;44:1940-7. [PMID: 31163450 DOI: 10.1038/s41386-019-0428-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 151 |
D'Ambrosio E, Dahoun T, Pardiñas AF, Veronese M, Bloomfield MAP, Jauhar S, Bonoldi I, Rogdaki M, Froudist-Walsh S, Walters JTR, Howes OD. The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study. Psychiatry Res Neuroimaging 2019;291:34-41. [PMID: 31386983 DOI: 10.1016/j.pscychresns.2019.07.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 152 |
Wengler K, He X, Abi-dargham A, Horga G. Reproducibility Assessment of Neuromelanin-Sensitive Magnetic Resonance Imaging Protocols for Region-of-Interest and Voxelwise Analyses.. [DOI: 10.1101/781815] [Reference Citation Analysis]
|
| 153 |
Martini ML, Ray C, Yu X, Liu J, Pogorelov VM, Wetsel WC, Huang XP, McCorvy JD, Caron MG, Jin J. Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity. ACS Chem Neurosci 2019;10:4160-82. [PMID: 31387346 DOI: 10.1021/acschemneuro.9b00410] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 154 |
Chan NK, Kim J, Shah P, Brown EE, Plitman E, Carravaggio F, Iwata Y, Gerretsen P, Graff-Guerrero A. Resting-state functional connectivity in treatment response and resistance in schizophrenia: A systematic review. Schizophr Res 2019;211:10-20. [PMID: 31331784 DOI: 10.1016/j.schres.2019.07.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 155 |
Shukla DK, Chiappelli JJ, Sampath H, Kochunov P, Hare SM, Wisner K, Rowland LM, Hong LE. Aberrant Frontostriatal Connectivity in Negative Symptoms of Schizophrenia. Schizophr Bull 2019;45:1051-9. [PMID: 30576563 DOI: 10.1093/schbul/sby165] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 156 |
Bertolini F, Chinchilla-Vargas J, Khadse JR, Juneja A, Deshpande PD, Bhave K, Potdar V, Kakramkar PM, Karlekar AR, Pande AB, Fernando RL, Rothschild MF. Marker discovery and associations with β-carotene content in Indian dairy cattle and buffalo breeds. J Dairy Sci 2019;102:10039-55. [PMID: 31477308 DOI: 10.3168/jds.2019-16361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 157 |
Leonard CJ, Robinson BM, Hahn B, Luck SJ, Gold JM. Altered spatial profile of distraction in people with schizophrenia. J Abnorm Psychol 2017;126:1077-86. [PMID: 29154568 DOI: 10.1037/abn0000314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 158 |
Perez de la Mora M, Hernandez-Mondragon C, Crespo-Ramirez M, Rejon-Orantes J, Borroto-Escuela DO, Fuxe K. Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia. Neuroscience 2020;439:301-18. [PMID: 31349007 DOI: 10.1016/j.neuroscience.2019.07.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 159 |
Shah UH, González-Maeso J. Serotonin and Glutamate Interactions in Preclinical Schizophrenia Models. ACS Chem Neurosci 2019;10:3068-77. [PMID: 30807107 DOI: 10.1021/acschemneuro.9b00044] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 160 |
Paudel P, Seong SH, Jung HA, Choi JS. Characterizing fucoxanthin as a selective dopamine D3/D4 receptor agonist: Relevance to Parkinson's disease. Chem Biol Interact 2019;310:108757. [PMID: 31323226 DOI: 10.1016/j.cbi.2019.108757] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 161 |
Healy-Stoffel M, Levant B. N-3 (Omega-3) Fatty Acids: Effects on Brain Dopamine Systems and Potential Role in the Etiology and Treatment of Neuropsychiatric Disorders. CNS Neurol Disord Drug Targets 2018;17:216-32. [PMID: 29651972 DOI: 10.2174/1871527317666180412153612] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 162 |
Kaar SJ, Natesan S, McCutcheon R, Howes OD. Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology. Neuropharmacology. 2020;172:107704. [PMID: 31299229 DOI: 10.1016/j.neuropharm.2019.107704] [Cited by in Crossref: 95] [Cited by in F6Publishing: 105] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 163 |
Kohmura K, Banno M, Tsujimoto H, Tsujimoto Y, Kataoka Y. Humour-based interventions for people with schizophrenia. Cochrane Database of Systematic Reviews 2019. [DOI: 10.1002/14651858.cd013367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 164 |
Abela AR, Li Z, Lê AD, Fletcher PJ. Clozapine reduces nicotine self-administration, blunts reinstatement of nicotine-seeking but increases responding for food. Addict Biol 2019;24:565-76. [PMID: 29575323 DOI: 10.1111/adb.12619] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 165 |
Komatsu H, Fukuchi M, Habata Y. Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders. Int J Mol Sci 2019;20:E3207. [PMID: 31261897 DOI: 10.3390/ijms20133207] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 166 |
Turk KW, Flanagan ME, Josephson S, Keene CD, Jayadev S, Bird TD. Psychosis in Spinocerebellar Ataxias: a Case Series and Study of Tyrosine Hydroxylase in Substantia Nigra. Cerebellum 2018;17:143-51. [PMID: 28887803 DOI: 10.1007/s12311-017-0882-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 167 |
Addicott MA, Schechter JC, Sapyta JJ, Selig JP, Kollins SH, Weiss MD. Methylphenidate increases willingness to perform effort in adults with ADHD. Pharmacol Biochem Behav 2019;183:14-21. [PMID: 31226260 DOI: 10.1016/j.pbb.2019.06.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 168 |
Zhou Z, Liu X, Chen S, Zhang Z, Liu Y, Montardy Q, Tang Y, Wei P, Liu N, Li L, Song R, Lai J, He X, Chen C, Bi G, Feng G, Xu F, Wang L. A VTA GABAergic Neural Circuit Mediates Visually Evoked Innate Defensive Responses. Neuron 2019;103:473-488.e6. [PMID: 31202540 DOI: 10.1016/j.neuron.2019.05.027] [Cited by in Crossref: 88] [Cited by in F6Publishing: 65] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 169 |
Esmaeeli S, Murphy K, Swords GM, Ibrahim BA, Brown JW, Llano DA. Visual hallucinations, thalamocortical physiology and Lewy body disease: A review. Neurosci Biobehav Rev 2019;103:337-51. [PMID: 31195000 DOI: 10.1016/j.neubiorev.2019.06.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 170 |
Allebone J, Kanaan R, Maller J, O'Brien T, Mullen SA, Cook M, Adams SJ, Vogrin S, Vaughan DN, Connelly A, Kwan P, Berkovic SF, D'Souza WJ, Jackson G, Velakoulis D, Wilson SJ. Bilateral volume reduction in posterior hippocampus in psychosis of epilepsy. J Neurol Neurosurg Psychiatry 2019;90:688-94. [PMID: 30796132 DOI: 10.1136/jnnp-2018-319396] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 171 |
Martini A, Cordella A, Pisani A, Mercuri NB, Guatteo E. Neurotensin receptors inhibit mGluR I responses in nigral dopaminergic neurons via a process that undergoes functional desensitization by G-protein coupled receptor kinases. Neuropharmacology 2019;155:76-88. [PMID: 31128122 DOI: 10.1016/j.neuropharm.2019.05.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 172 |
Holloway ZR, Paige NB, Comstock JF, Nolen HG, Sable HJ, Lester DB. Cerebellar Modulation of Mesolimbic Dopamine Transmission is Functionally Asymmetrical.. [DOI: 10.1101/615815] [Reference Citation Analysis]
|
| 173 |
Ye J, Ji F, Jiang D, Lin X, Chen G, Zhang W, Shan P, Zhang L, Zhuo C. Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment. Front Neurosci 2019;13:355. [PMID: 31057354 DOI: 10.3389/fnins.2019.00355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 174 |
Gerelkhuu Z, Jung D, The Huy B, Tawfik SM, Conte ML, Conte ED, Lee Y. Highly selective and sensitive detection of catecholamines using NaLuGdF4:Yb3+/Er3+ upconversion nanoparticles decorated with metal ions. Sensors and Actuators B: Chemical 2019;284:172-8. [DOI: 10.1016/j.snb.2018.12.135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 175 |
Li Y, He R, Niu Y, Li F. Paper-Based Electrochemical Biosensors for Point-of-Care Testing of Neurotransmitters. J Anal Test 2019;3:19-36. [DOI: 10.1007/s41664-019-00085-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 176 |
Ruiz MJ, Colzato LS, Bajo MT, Paolieri D. Increased picture-word interference in chronic and recreational users of cocaine. Hum Psychopharmacol 2019;34:e2689. [PMID: 30762913 DOI: 10.1002/hup.2689] [Reference Citation Analysis]
|
| 177 |
Foley PB. Dopamine in psychiatry: a historical perspective. J Neural Transm 2019;126:473-9. [DOI: 10.1007/s00702-019-01987-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 178 |
Kaefer K, Malagon-Vina H, Dickerson DD, O'Neill J, Trossbach SV, Korth C, Csicsvari J. Disrupted-in-schizophrenia 1 overexpression disrupts hippocampal coding and oscillatory synchronization. Hippocampus 2019;29:802-16. [PMID: 30723982 DOI: 10.1002/hipo.23076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 179 |
Graham K, Zhang J, Qiao H, Wu Y, Zhou Y. Region-specific inhibition of 14-3-3 proteins induces psychomotor behaviors in mice. NPJ Schizophr 2019;5:1. [PMID: 30643138 DOI: 10.1038/s41537-018-0069-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 180 |
McCutcheon RA, Abi-Dargham A, Howes OD. Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms. Trends Neurosci 2019;42:205-20. [PMID: 30621912 DOI: 10.1016/j.tins.2018.12.004] [Cited by in Crossref: 272] [Cited by in F6Publishing: 223] [Article Influence: 68.0] [Reference Citation Analysis]
|
| 181 |
Lin Y, Fusar-poli P, Borgwardt S. Neuroimaging and the At-Risk Mental State. Neuroimaging of Schizophrenia and Other Primary Psychotic Disorders 2019. [DOI: 10.1007/978-3-319-97307-4_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 182 |
Fountoulakis KN, Nimatoudis I, Stahl SM. Biological Psychiatry and Psychopharmacology. Psychobiology of Behaviour 2019. [DOI: 10.1007/978-3-030-18323-3_13] [Reference Citation Analysis]
|
| 183 |
Jauhar S, Veronese M, Nour MM, Rogdaki M, Hathway P, Natesan S, Turkheimer F, Stone J, Egerton A, McGuire P, Kapur S, Howes OD. The Effects of Antipsychotic Treatment on Presynaptic Dopamine Synthesis Capacity in First-Episode Psychosis: A Positron Emission Tomography Study. Biol Psychiatry 2019;85:79-87. [PMID: 30122287 DOI: 10.1016/j.biopsych.2018.07.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 184 |
Chalkiadaki K, Velli A, Kyriazidis E, Stavroulaki V, Vouvoutsis V, Chatzaki E, Aivaliotis M, Sidiropoulou K. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function. Neuropharmacology 2019;144:193-207. [DOI: 10.1016/j.neuropharm.2018.10.026] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 185 |
Tarakita N, Yoshida K, Sugawara N, Kubo K, Furukori H, Fujii A, Nakamura K, Yasui-Furukori N. Differences in etiological beliefs about schizophrenia among patients, family, and medical staff. Neuropsychiatr Dis Treat 2019;15:137-42. [PMID: 30643412 DOI: 10.2147/NDT.S185483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 186 |
Amato D, Kruyer A, Samaha AN, Heinz A. Hypofunctional Dopamine Uptake and Antipsychotic Treatment-Resistant Schizophrenia. Front Psychiatry 2019;10:314. [PMID: 31214054 DOI: 10.3389/fpsyt.2019.00314] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 187 |
Harvey C. Medical Perspective on Mental Health. Mental Health and Social Work 2019. [DOI: 10.1007/978-981-13-0440-8_4-1] [Reference Citation Analysis]
|
| 188 |
Kim SH. New Insights into the Molecular and Cellular Mechanism of Antipsychotics. J Korean Neuropsychiatr Assoc 2019;58:12. [DOI: 10.4306/jknpa.2019.58.1.12] [Reference Citation Analysis]
|
| 189 |
Koreki A, Maeda T, Okimura T, Terasawa Y, Kikuchi T, Umeda S, Nishikata S, Yagihashi T, Kasahara M, Nagai C, Moriyama Y, Den R, Watanabe T, Kikumoto H, Kato M, Mimura M. Dysconnectivity of the Agency Network in Schizophrenia: A Functional Magnetic Resonance Imaging Study. Front Psychiatry 2019;10:171. [PMID: 31001152 DOI: 10.3389/fpsyt.2019.00171] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 190 |
Davoren JE, Nason D, Coe J, Dlugolenski K, Helal C, Harris AR, LaChapelle E, Liang S, Liu Y, O'Connor R, Orozco CC, Rai BK, Salafia M, Samas B, Xu W, Kozak R, Gray D. Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization. J Med Chem 2018;61:11384-97. [PMID: 30431269 DOI: 10.1021/acs.jmedchem.8b01622] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 191 |
Zhou Z, Liu X, Chen S, Zhang Z, Liu Y, Montardy Q, Tang Y, Wei P, Liu N, Li L, He X, Chen C, Bi G, Feng G, Xu F, Wang L. A VTA GABAergic neural circuit mediates visually evoked innate defensive responses.. [DOI: 10.1101/493007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 192 |
Uzuneser TC, Schindehütte M, Dere E, von Hörsten S, Kornhuber J, Grömer TW, Müller CP. Schizophrenia dimension-specific antipsychotic drug action and failure in amphetamine-sensitized psychotic-like rats. Eur Neuropsychopharmacol 2018;28:1382-93. [PMID: 30243682 DOI: 10.1016/j.euroneuro.2018.09.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 193 |
Taheri RA, Eskandari K, Negahdary M. An electrochemical dopamine aptasensor using the modified Au electrode with spindle-shaped gold nanostructure. Microchemical Journal 2018;143:243-51. [DOI: 10.1016/j.microc.2018.08.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 194 |
Kim SW, Stewart R, Park WY, Jhon M, Lee JY, Kim SY, Kim JM, Amminger P, Chung YC, Yoon JS. Latent Iron Deficiency as a Marker of Negative Symptoms in Patients with First-Episode Schizophrenia Spectrum Disorder. Nutrients 2018;10:E1707. [PMID: 30412998 DOI: 10.3390/nu10111707] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 195 |
Deng X, Guo J. Parvalbumin阳性中间神经元缺陷在精神分裂症病理机制中的作用. Adv Psychol Sci 2018;26:1992-2002. [DOI: 10.3724/sp.j.1042.2018.01992] [Reference Citation Analysis]
|
| 196 |
Holloway ZR, Freels TG, Comstock JF, Nolen HG, Sable HJ, Lester DB. Comparing phasic dopamine dynamics in the striatum, nucleus accumbens, amygdala, and medial prefrontal cortex. Synapse 2018;:e22074. [PMID: 30317673 DOI: 10.1002/syn.22074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 197 |
McCutcheon R, Beck K, Jauhar S, Howes OD. Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis. Schizophr Bull 2018;44:1301-11. [PMID: 29301039 DOI: 10.1093/schbul/sbx180] [Cited by in Crossref: 144] [Cited by in F6Publishing: 146] [Article Influence: 28.8] [Reference Citation Analysis]
|
| 198 |
Datta D, Arnsten AFT. Unique Molecular Regulation of Higher-Order Prefrontal Cortical Circuits: Insights into the Neurobiology of Schizophrenia. ACS Chem Neurosci 2018;9:2127-45. [PMID: 29470055 DOI: 10.1021/acschemneuro.7b00505] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 199 |
Lipina TV, Beregovoy NA, Tkachenko AA, Petrova ES, Starostina MV, Zhou Q, Li S. Uncoupling DISC1 × D2R Protein-Protein Interactions Facilitates Latent Inhibition in Disc1-L100P Animal Model of Schizophrenia and Enhances Synaptic Plasticity via D2 Receptors. Front Synaptic Neurosci 2018;10:31. [PMID: 30245624 DOI: 10.3389/fnsyn.2018.00031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 200 |
Taylor N, Hollis JP, Corcoran S, Gross R, Cuthbert B, Swails LW, Duncan E. Impaired reward responsiveness in schizophrenia. Schizophr Res 2018;199:46-52. [PMID: 29526451 DOI: 10.1016/j.schres.2018.02.057] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 201 |
Issy AC, Dos-Santos-Pereira M, Pedrazzi JFC, Kubrusly RCC, Del-Bel E. The role of striatum and prefrontal cortex in the prevention of amphetamine-induced schizophrenia-like effects mediated by nitric oxide compounds. Prog Neuropsychopharmacol Biol Psychiatry 2018;86:353-62. [PMID: 29555252 DOI: 10.1016/j.pnpbp.2018.03.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 202 |
Stępnicki P, Kondej M, Kaczor AA. Current Concepts and Treatments of Schizophrenia. Molecules 2018;23:E2087. [PMID: 30127324 DOI: 10.3390/molecules23082087] [Cited by in Crossref: 160] [Cited by in F6Publishing: 169] [Article Influence: 32.0] [Reference Citation Analysis]
|
| 203 |
Stefanowicz J, Słowiński T, Wróbel MZ, Ślifirski G, Dawidowski M, Stefanowicz Z, Jastrzębska-Więsek M, Partyka A, Wesołowska A, Turło J. Synthesis and biological investigations of 3β-aminotropane arylamide derivatives with atypical antipsychotic profile. Med Chem Res 2018;27:1906-28. [PMID: 30100693 DOI: 10.1007/s00044-018-2203-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 204 |
Burk JA, Blumenthal SA, Maness EB. Neuropharmacology of attention. Eur J Pharmacol 2018;835:162-8. [PMID: 30092180 DOI: 10.1016/j.ejphar.2018.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 205 |
Arioka Y, Shishido E, Kubo H, Kushima I, Yoshimi A, Kimura H, Ishizuka K, Aleksic B, Maeda T, Ishikawa M, Kuzumaki N, Okano H, Mori D, Ozaki N. Single-cell trajectory analysis of human homogenous neurons carrying a rare RELN variant. Transl Psychiatry 2018;8:129. [PMID: 30022058 DOI: 10.1038/s41398-018-0177-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 206 |
Qin Y, Wang N, Zhang X, Han X, Zhai X, Lu Y. IDO and TDO as a potential therapeutic target in different types of depression. Metab Brain Dis 2018;33:1787-800. [PMID: 30014175 DOI: 10.1007/s11011-018-0290-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 207 |
Huang SY, Chen LH, Wang MF, Hsu CC, Chan CH, Li JX, Huang HY. Lactobacillus paracasei PS23 Delays Progression of Age-Related Cognitive Decline in Senescence Accelerated Mouse Prone 8 (SAMP8) Mice. Nutrients 2018;10:E894. [PMID: 30002347 DOI: 10.3390/nu10070894] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 208 |
Tan L, Yan W, McCorvy JD, Cheng J. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. J Med Chem 2018;61:9841-78. [PMID: 29939744 DOI: 10.1021/acs.jmedchem.8b00435] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 209 |
Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C. Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention. CNS Drugs 2018;32:605-19. [PMID: 30022465 DOI: 10.1007/s40263-018-0539-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 210 |
Ben-Azu B, Aderibigbe AO, Eneni AO, Ajayi AM, Umukoro S, Iwalewa EO. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms. Neurochem Res 2018;43:1745-55. [PMID: 29956036 DOI: 10.1007/s11064-018-2590-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 211 |
Bernhardt LK, Bairy KL, Madhyastha S. Neuroprotective Role of N-acetylcysteine against Learning Deficits and Altered Brain Neurotransmitters in Rat Pups Subjected to Prenatal Stress. Brain Sci 2018;8:E120. [PMID: 29958412 DOI: 10.3390/brainsci8070120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 212 |
Ben-Azu B, Aderibigbe AO, Omogbiya IA, Ajayi AM, Owoeye O, Olonode ET, Iwalewa EO. Probable mechanisms involved in the antipsychotic-like activity of morin in mice. Biomed Pharmacother 2018;105:1079-90. [PMID: 30021344 DOI: 10.1016/j.biopha.2018.06.057] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 213 |
Searles S, Makarewicz JA, Dumas JA. The role of estradiol in schizophrenia diagnosis and symptoms in postmenopausal women. Schizophr Res 2018;196:35-8. [PMID: 28587815 DOI: 10.1016/j.schres.2017.05.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 214 |
Farah R, Haraty H, Salame Z, Fares Y, Ojcius DM, Said Sadier N. Salivary biomarkers for the diagnosis and monitoring of neurological diseases. Biomed J 2018;41:63-87. [PMID: 29866603 DOI: 10.1016/j.bj.2018.03.004] [Cited by in Crossref: 79] [Cited by in F6Publishing: 80] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 215 |
Xu Y, Zhu X, Wang H, Sun S, Yue X, Tian J. In Vitro and In Vivo Characterization of PCC0104005, a Novel Modulator of Serotonin-Dopamine Activity, as an Atypical Antipsychotic Drug. Sci Rep 2018;8:6892. [PMID: 29720711 DOI: 10.1038/s41598-018-25036-0] [Reference Citation Analysis]
|
| 216 |
Lambert C, Da Silva S, Ceniti AK, Rizvi SJ, Foussias G, Kennedy SH. Anhedonia in depression and schizophrenia: A transdiagnostic challenge. CNS Neurosci Ther 2018;24:615-23. [PMID: 29687627 DOI: 10.1111/cns.12854] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 217 |
Fyfe TJ, Zarzycka B, Lim HD, Kellam B, Mistry SN, Katrich V, Scammells PJ, Lane JR, Capuano B. A Thieno[2,3- d ]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D 2 Receptor. J Med Chem 2019;62:174-206. [DOI: 10.1021/acs.jmedchem.7b01565] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 218 |
Chalkiadaki K, Velli A, Kyriazidis E, Stavroulaki V, Vouvoutsis V, Chatzaki E, Aivaliotis M, Sidiropoulou K. Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function.. [DOI: 10.1101/295741] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 219 |
Zhang K, Liu Y, Wang Y, Zhang R, Liu J, Wei J, Qian H, Qian K, Chen R, Liu B. Quantitative SERS Detection of Dopamine in Cerebrospinal Fluid by Dual-Recognition-Induced Hot Spot Generation. ACS Appl Mater Interfaces 2018;10:15388-94. [DOI: 10.1021/acsami.8b01063] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 220 |
Atbasoglu EC, Gumus-Akay G, Guloksuz S, Saka MC, Ucok A, Alptekin K, Gullu S, van Os J. Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia. Psychopharmacology (Berl) 2018;235:1029-39. [PMID: 29306964 DOI: 10.1007/s00213-017-4818-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 221 |
Rabin RA, Dermody SS, George TP. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug Alcohol Depend 2018;185:181-8. [PMID: 29459327 DOI: 10.1016/j.drugalcdep.2017.12.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 222 |
Murphy MJM, Deutch AY. Organization of afferents to the orbitofrontal cortex in the rat. J Comp Neurol 2018;526:1498-526. [PMID: 29524205 DOI: 10.1002/cne.24424] [Cited by in Crossref: 46] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 223 |
Tomasella E, Bechelli L, Ogando MB, Mininni C, Di Guilmi MN, De Fino F, Zanutto S, Elgoyhen AB, Marin-Burgin A, Gelman DM. Deletion of dopamine D2 receptors from parvalbumin interneurons in mouse causes schizophrenia-like phenotypes. Proc Natl Acad Sci U S A 2018;115:3476-81. [PMID: 29531031 DOI: 10.1073/pnas.1719897115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 224 |
Dubol M, Trichard C, Leroy C, Sandu AL, Rahim M, Granger B, Tzavara ET, Karila L, Martinot JL, Artiges E. Dopamine Transporter and Reward Anticipation in a Dimensional Perspective: A Multimodal Brain Imaging Study. Neuropsychopharmacology 2018;43:820-7. [PMID: 28829051 DOI: 10.1038/npp.2017.183] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 8.2] [Reference Citation Analysis]
|
| 225 |
Shontz EC, Souders CL, Schmidt JT, Martyniuk CJ. Domperidone upregulates dopamine receptor expression and stimulates locomotor activity in larval zebrafish ( Danio rerio ). Genes, Brain and Behavior 2018;17:e12460. [DOI: 10.1111/gbb.12460] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 226 |
Borkar CD, Bharne AP, Nagalakshmi B, Sakharkar AJ, Subhedar NK, Kokare DM. Cocaine- and Amphetamine-Regulated Transcript Peptide (CART) Alleviates MK-801-Induced Schizophrenic Dementia-Like Symptoms. Neuroscience 2018;375:94-107. [PMID: 29425773 DOI: 10.1016/j.neuroscience.2018.01.056] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 227 |
Martino M, Magioncalda P, Yu H, Li X, Wang Q, Meng Y, Deng W, Li Y, Li M, Ma X, Lane T, Duncan NW, Northoff G, Li T. Abnormal Resting-State Connectivity in a Substantia Nigra-Related Striato-Thalamo-Cortical Network in a Large Sample of First-Episode Drug-Naïve Patients With Schizophrenia. Schizophr Bull 2018;44:419-31. [PMID: 28605528 DOI: 10.1093/schbul/sbx067] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 11.2] [Reference Citation Analysis]
|
| 228 |
Amato D, Vernon AC, Papaleo F. Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability. Neuroscience & Biobehavioral Reviews 2018;85:146-59. [DOI: 10.1016/j.neubiorev.2017.09.027] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 229 |
Del Guerra A, Ahmad S, Avram M, Belcari N, Berneking A, Biagi L, Bisogni MG, Brandl F, Cabello J, Camarlinghi N, Cerello P, Choi CH, Coli S, Colpo S, Fleury J, Gagliardi V, Giraudo G, Heekeren K, Kawohl W, Kostou T, Lefaucheur JL, Lerche C, Loudos G, Morrocchi M, Muller J, Mustafa M, Neuner I, Papadimitroulas P, Pennazio F, Rajkumar R, Brambilla CR, Rivoire J, Kops ER, Scheins J, Schimpf R, Shah NJ, Sorg C, Sportelli G, Tosetti M, Trinchero R, Wyss C, Ziegler S; TRIMAGE Consortium. TRIMAGE: A dedicated trimodality (PET/MR/EEG) imaging tool for schizophrenia. Eur Psychiatry 2018;50:7-20. [PMID: 29358016 DOI: 10.1016/j.eurpsy.2017.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 230 |
Olney JJ, Warlow SM, Naffziger EE, Berridge KC. Current perspectives on incentive salience and applications to clinical disorders. Curr Opin Behav Sci 2018;22:59-69. [PMID: 29503841 DOI: 10.1016/j.cobeha.2018.01.007] [Cited by in Crossref: 46] [Cited by in F6Publishing: 93] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 231 |
Tateno A, Sakayori T, Kim WC, Honjo K, Nakayama H, Arakawa R, Okubo Y. Comparison of Dopamine D3 and D2 Receptor Occupancies by a Single Dose of Blonanserin in Healthy Subjects: A Positron Emission Tomography Study With [11C]-(+)-PHNO. Int J Neuropsychopharmacol 2018;21:522-7. [PMID: 29346639 DOI: 10.1093/ijnp/pyy004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 232 |
Moustafa AA, Garami JK, Mahlberg J, Golembieski J, Keri S, Misiak B, Frydecka D. Cognitive function in schizophrenia: conflicting findings and future directions. Rev Neurosci 2016;27:435-48. [PMID: 26756090 DOI: 10.1515/revneuro-2015-0060] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 233 |
Ohnuma T, Nishimon S, Takeda M, Sannohe T, Katsuta N, Arai H. Carbonyl Stress and Microinflammation-Related Molecules as Potential Biomarkers in Schizophrenia. Front Psychiatry 2018;9:82. [PMID: 29593588 DOI: 10.3389/fpsyt.2018.00082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 234 |
Ho JH, Dargan PI. Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues. Critical Care Toxicology 2018. [DOI: 10.1007/978-3-319-20790-2_124-2] [Reference Citation Analysis]
|
| 235 |
Chen X, Li D, Pan G, Zhou D, Xu W, Zhu J, Wang H, Chen C, Song H. All-inorganic perovskite quantum dot/TiO 2 inverse opal electrode platform: stable and efficient photoelectrochemical sensing of dopamine under visible irradiation. Nanoscale 2018;10:10505-13. [DOI: 10.1039/c8nr02115e] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 236 |
Jha O, Yadav T, Yadav R. Structural and vibrational study of a neurotransmitter molecule: Dopamine [4-(2-aminoethyl) benzene-1,2-diol]. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2018;189:473-84. [DOI: 10.1016/j.saa.2017.07.067] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 237 |
Lucatch AM, Lowe DJE, Clark RC, Kozak K, George TP. Neurobiological Determinants of Tobacco Smoking in Schizophrenia. Front Psychiatry 2018;9:672. [PMID: 30574101 DOI: 10.3389/fpsyt.2018.00672] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 238 |
Yu J, Kim TH. A Facile Electrochemical Fabrication of Reduced Graphene Oxide-Modified Glassy Carbon Electrode for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid. J Electrochem Sci Technol 2017;8:274-81. [DOI: 10.33961/jecst.2017.8.4.274] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 239 |
Lee CS, Yu SH, Kim TH. One-Step Electrochemical Fabrication of Reduced Graphene Oxide/Gold Nanoparticles Nanocomposite-Modified Electrode for Simultaneous Detection of Dopamine, Ascorbic Acid, and Uric Acid. Nanomaterials (Basel) 2017;8:E17. [PMID: 29301209 DOI: 10.3390/nano8010017] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 240 |
Schifani C, Hafizi S, Da Silva T, Watts JJ, Khan MS, Mizrahi R. Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies. Int Rev Psychiatry 2017;29:555-66. [PMID: 29219634 DOI: 10.1080/09540261.2017.1396205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Jauhar S, Nour MM, Veronese M, Rogdaki M, Bonoldi I, Azis M, Turkheimer F, McGuire P, Young AH, Howes OD. A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia. JAMA Psychiatry 2017;74:1206-13. [PMID: 29049482 DOI: 10.1001/jamapsychiatry.2017.2943] [Cited by in Crossref: 137] [Cited by in F6Publishing: 158] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 242 |
He S, Xiao L, Wang Y, Liu X, Yang C, Lu J, Gui W, Sun Y. A novel fault diagnosis method based on optimal relevance vector machine. Neurocomputing 2017;267:651-63. [DOI: 10.1016/j.neucom.2017.06.024] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 243 |
Zhang L, Xu S, Huang Q, Xu H. N-acetylcysteine attenuates the cuprizone-induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti-inflammation actions. J Neuro Res 2018;96:803-16. [DOI: 10.1002/jnr.24189] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 244 |
Forray C, Buller R. Challenges and opportunities for the development of new antipsychotic drugs. Biochemical Pharmacology 2017;143:10-24. [DOI: 10.1016/j.bcp.2017.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 245 |
Birnbaum R, Weinberger DR. Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci 2017;18:727-40. [DOI: 10.1038/nrn.2017.125] [Cited by in Crossref: 267] [Cited by in F6Publishing: 280] [Article Influence: 44.5] [Reference Citation Analysis]
|
| 246 |
Hanafi I, Arafat S, Al Zayed L, Sukkar M, Albeirakdar A, Krayem D, Essali A. Haloperidol (route of administration) for people with schizophrenia. Cochrane Database of Systematic Reviews 2017. [DOI: 10.1002/14651858.cd012833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 247 |
Donegan JJ, Tyson JA, Branch SY, Beckstead MJ, Anderson SA, Lodge DJ. Stem cell-derived interneuron transplants as a treatment for schizophrenia: preclinical validation in a rodent model. Mol Psychiatry 2017;22:1492-501. [PMID: 27480492 DOI: 10.1038/mp.2016.121] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 248 |
Tabor A, Möller D, Hübner H, Kornhuber J, Gmeiner P. Visualization of ligand-induced dopamine D2S and D2L receptor internalization by TIRF microscopy. Sci Rep 2017;7:10894. [PMID: 28883522 DOI: 10.1038/s41598-017-11436-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 249 |
Taherpour AA, Jahanian F. Theoretical Study of Diffusion Flow of Neurotransmitters Through Single-Wall Armchair(10,10) and Zigzag(18,0) Carbon Nanotubes. Iran J Sci Technol Trans Sci 2017;41:787-808. [DOI: 10.1007/s40995-016-0082-z] [Reference Citation Analysis]
|
| 250 |
Artiges E, Leroy C, Dubol M, Prat M, Pepin A, Mabondo A, de Beaurepaire R, Beaufils B, Korwin JP, Galinowski A, D'Albis MA, Santiago-Ribeiro MJ, Granger B, Tzavara ET, Martinot JL, Trichard C. Striatal and Extrastriatal Dopamine Transporter Availability in Schizophrenia and Its Clinical Correlates: A Voxel-Based and High-Resolution PET Study. Schizophr Bull 2017;43:1134-42. [PMID: 28177089 DOI: 10.1093/schbul/sbw192] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 251 |
Servonnet A, Minogianis E, Bouchard C, Bédard A, Lévesque D, Rompré P, Samaha A. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment. Neuropharmacology 2017;123:10-21. [DOI: 10.1016/j.neuropharm.2017.05.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 252 |
Hoonakker M, Doignon-camus N, Marques-carneiro JE, Bonnefond A. Sustained attention ability in schizophrenia: Investigation of conflict monitoring mechanisms. Clinical Neurophysiology 2017;128:1599-607. [DOI: 10.1016/j.clinph.2017.06.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 253 |
Chapman CAR, Goshi N, Seker E. Multifunctional Neural Interfaces for Closed‐Loop Control of Neural Activity. Adv Funct Mater 2018;28:1703523. [DOI: 10.1002/adfm.201703523] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 254 |
Amoateng P, Adjei S, Osei-Safo D, Kukuia KKE, Bekoe EO, Karikari TK, Kombian SB. Extract of Synedrella nodiflora (L) Gaertn exhibits antipsychotic properties in murine models of psychosis. BMC Complement Altern Med 2017;17:389. [PMID: 28784133 DOI: 10.1186/s12906-017-1901-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 255 |
Foster DJ, Conn PJ. Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders. Neuron 2017;94:431-46. [PMID: 28472649 DOI: 10.1016/j.neuron.2017.03.016] [Cited by in Crossref: 154] [Cited by in F6Publishing: 160] [Article Influence: 25.7] [Reference Citation Analysis]
|
| 256 |
Kubota M, Nagashima T, Takano H, Kodaka F, Fujiwara H, Takahata K, Moriguchi S, Kimura Y, Higuchi M, Okubo Y, Takahashi H, Ito H, Suhara T. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia. Int J Neuropsychopharmacol 2017;20:928-35. [PMID: 29016872 DOI: 10.1093/ijnp/pyx063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 257 |
Xavier RM, Vorderstrasse A. Genetic Basis of Positive and Negative Symptom Domains in Schizophrenia. Biol Res Nurs 2017;19:559-75. [PMID: 28691507 DOI: 10.1177/1099800417715907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 258 |
Ruggiero RN, Rossignoli MT, De Ross JB, Hallak JEC, Leite JP, Bueno-Junior LS. Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research. Front Pharmacol 2017;8:399. [PMID: 28680405 DOI: 10.3389/fphar.2017.00399] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 259 |
Zhang B, Guo F, Ma Y, Song Y, Lin R, Shen FY, Jin GZ, Li Y, Liu ZQ. Activation of D1R/PKA/mTOR signaling cascade in medial prefrontal cortex underlying the antidepressant effects of l-SPD. Sci Rep 2017;7:3809. [PMID: 28630404 DOI: 10.1038/s41598-017-03680-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 260 |
Annafi OS, Aluko OM, Eduviere AT, Omorogbe O, Umukoro S. Probable mechanisms involved in the antipsychotic-like activity of methyl jasmonate in mice. Naunyn Schmiedebergs Arch Pharmacol 2017;390:883-92. [PMID: 28612111 DOI: 10.1007/s00210-017-1386-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 261 |
Yadav P, Manivannan S, Kim H, Pandey K, Kim K, Kim J. Electrochemical Properties of Highly Sensitive and Selective CuO Nanostructures Based Neurotransmitter Dopamine Sensor. Electroanalysis 2017;29:2106-13. [DOI: 10.1002/elan.201700195] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 262 |
Florescu M, David M. Tyrosinase-Based Biosensors for Selective Dopamine Detection. Sensors (Basel) 2017;17:E1314. [PMID: 28590453 DOI: 10.3390/s17061314] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 263 |
Xu J, Kurup P, Nairn AC, Lombroso PJ. Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61. Mol Neurobiol 2018;55:3096-111. [PMID: 28466270 DOI: 10.1007/s12035-017-0555-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 264 |
Wurfel BE, Drevets WC, Bliss SA, McMillin JR, Suzuki H, Ford BN, Morris HM, Teague TK, Dantzer R, Savitz JB. Serum kynurenic acid is reduced in affective psychosis. Transl Psychiatry 2017;7:e1115. [PMID: 28463241 DOI: 10.1038/tp.2017.88] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 265 |
Maksymetz J, Moran SP, Conn PJ. Targeting metabotropic glutamate receptors for novel treatments of schizophrenia. Mol Brain. 2017;10:15. [PMID: 28446243 DOI: 10.1186/s13041-017-0293-z] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 266 |
Broyd A, Balzan RP, Woodward TS, Allen P. Dopamine, cognitive biases and assessment of certainty: A neurocognitive model of delusions. Clin Psychol Rev 2017;54:96-106. [PMID: 28448827 DOI: 10.1016/j.cpr.2017.04.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 267 |
Katsel P, Roussos P, Pletnikov M, Haroutunian V. Microvascular anomaly conditions in psychiatric disease. Schizophrenia - angiogenesis connection. Neurosci Biobehav Rev 2017;77:327-39. [PMID: 28396239 DOI: 10.1016/j.neubiorev.2017.04.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 268 |
Hui L, Han M, Yin GZ, Zhang Y, Huang XF, Qian ZK, Gu WG, Gu XC, Zhu XM, Soares JC, Ning Y, Zheng Y, Du XD, Zhang XY. Association between DBH 19bp insertion/deletion polymorphism and cognition in schizophrenia with and without tardive dyskinesia. Schizophr Res 2017;182:104-9. [PMID: 27776953 DOI: 10.1016/j.schres.2016.10.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 269 |
Stip E, Cherbal A, Luck D, Zhornitsky S, Bentaleb LA, Lungu O. A neuroimaging study of emotion-cognition interaction in schizophrenia: the effect of ziprasidone treatment. Psychopharmacology (Berl) 2017;234:1045-58. [PMID: 28210783 DOI: 10.1007/s00213-017-4533-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 270 |
Perkovic MN, Erjavec GN, Strac DS, Uzun S, Kozumplik O, Pivac N. Theranostic Biomarkers for Schizophrenia. Int J Mol Sci 2017;18:E733. [PMID: 28358316 DOI: 10.3390/ijms18040733] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 271 |
Stojanovic T, Orlova M, Sialana FJ, Höger H, Stuchlik S, Milenkovic I, Aradska J, Lubec G. Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice. Amino Acids 2017;49:1101-9. [PMID: 28316027 DOI: 10.1007/s00726-017-2408-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 272 |
Ejaz A, Joo Y, Jeon S. Fabrication of 1,4-bis(aminomethyl)benzene and cobalt hydroxide @ graphene oxide for selective detection of dopamine in the presence of ascorbic acid and serotonin. Sensors and Actuators B: Chemical 2017;240:297-307. [DOI: 10.1016/j.snb.2016.08.171] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 273 |
Eisenstein SA, Bogdan R, Chen L, Moerlein SM, Black KJ, Perlmutter JS, Hershey T, Barch DM. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia. J Psychiatr Res 2017;86:9-17. [PMID: 27886638 DOI: 10.1016/j.jpsychires.2016.11.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 274 |
Liu W, Wang D, Hong W, Yu Y, Tang J, Wang J, Liu F, Xu X, Tan L, Chen X. Psychotomimetic effects of different doses of MK-801 and the underlying mechanisms in a selective memory impairment model. Behavioural Brain Research 2017;320:517-25. [DOI: 10.1016/j.bbr.2016.10.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 275 |
Rosen C, Jones N, Chase KA, Melbourne JK, Grossman LS, Sharma RP. Immersion in altered experience: An investigation of the relationship between absorption and psychopathology. Conscious Cogn 2017;49:215-26. [PMID: 28219788 DOI: 10.1016/j.concog.2017.01.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 276 |
Dandash O, Pantelis C, Fornito A. Dopamine, fronto-striato-thalamic circuits and risk for psychosis. Schizophr Res 2017;180:48-57. [PMID: 27595552 DOI: 10.1016/j.schres.2016.08.020] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 277 |
Liu C, Bousman CA, Pantelis C, Skafidas E, Zhang D, Yue W, Everall IP. Pathway-wide association study identifies five shared pathways associated with schizophrenia in three ancestral distinct populations. Transl Psychiatry 2017;7:e1037. [PMID: 28221366 DOI: 10.1038/tp.2017.8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 278 |
Schneider S, Götz K, Birchmeier C, Schwegler H, Roskoden T. Neuregulin-1 mutant mice indicate motor and sensory deficits, indeed few references for schizophrenia endophenotype model. Behav Brain Res 2017;322:177-85. [PMID: 28089851 DOI: 10.1016/j.bbr.2017.01.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 279 |
Bas A, Gultekin G, Incir S, Bas TO, Emul M, Duran A. Level of serum thioredoxin and correlation with neurocognitive functions in patients with schizophrenia using clozapine and other atypical antipsychotics. Psychiatry Res 2017;247:84-9. [PMID: 27871032 DOI: 10.1016/j.psychres.2016.11.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 280 |
Ho JH, Dargan PI. Arylcyclohexamines: Ketamine, Phencyclidine, and Analogues. Critical Care Toxicology 2017. [DOI: 10.1007/978-3-319-17900-1_124] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 281 |
Cartágenes S, Fernandes L, de Andrade EF, Prediger R, Maia C. Ketamine. Addictive Substances and Neurological Disease 2017. [DOI: 10.1016/b978-0-12-805373-7.00032-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 282 |
Urs NM, Peterson SM, Caron MG. New Concepts in Dopamine D(2) Receptor Biased Signaling and Implications for Schizophrenia Therapy. Biol Psychiatry 2017;81:78-85. [PMID: 27832841 DOI: 10.1016/j.biopsych.2016.10.011] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 283 |
Arnsten AF, Girgis RR, Gray DL, Mailman RB. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia. Biol Psychiatry 2017;81:67-77. [PMID: 26946382 DOI: 10.1016/j.biopsych.2015.12.028] [Cited by in Crossref: 105] [Cited by in F6Publishing: 107] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 284 |
Erhardt S, Schwieler L, Imbeault S, Engberg G. The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 2017;112:297-306. [DOI: 10.1016/j.neuropharm.2016.05.020] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 22.5] [Reference Citation Analysis]
|
| 285 |
Snyder GL, Vanover KE. PDE Inhibitors for the Treatment of Schizophrenia. Advances in Neurobiology 2017. [DOI: 10.1007/978-3-319-58811-7_14] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 286 |
Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A. Pathway-Specific Dopamine Abnormalities in Schizophrenia. Biol Psychiatry 2017;81:31-42. [PMID: 27206569 DOI: 10.1016/j.biopsych.2016.03.2104] [Cited by in Crossref: 185] [Cited by in F6Publishing: 186] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 287 |
Leweke FM, Rohleder C. Putative Role of Endocannabinoids in Schizophrenia. The Endocannabinoid System 2017. [DOI: 10.1016/b978-0-12-809666-6.00004-6] [Reference Citation Analysis]
|
| 288 |
Howes OD, McCutcheon R, Owen MJ, Murray RM. The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia. Biol Psychiatry 2017;81:9-20. [PMID: 27720198 DOI: 10.1016/j.biopsych.2016.07.014] [Cited by in Crossref: 335] [Cited by in F6Publishing: 332] [Article Influence: 55.8] [Reference Citation Analysis]
|
| 289 |
Falkai P, Schennach R, Lincoln T, Schaub A, Hasan A. Schizophrene Psychosen. Psychiatrie, Psychosomatik, Psychotherapie 2017. [DOI: 10.1007/978-3-662-49295-6_64] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 290 |
Tsou JY. Pharmacological Interventions and the Neurobiological Basis of Mental Disorders. The Physics of the Mind and Brain Disorders 2017. [DOI: 10.1007/978-3-319-29674-6_27] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 291 |
Vijeepallam K, Pandy V, Kunasegaran T, Murugan DD, Naidu M. Mitragyna speciosa Leaf Extract Exhibits Antipsychotic-Like Effect with the Potential to Alleviate Positive and Negative Symptoms of Psychosis in Mice. Front Pharmacol 2016;7:464. [PMID: 27999544 DOI: 10.3389/fphar.2016.00464] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 292 |
De Gregorio D, Comai S, Posa L, Gobbi G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. Int J Mol Sci 2016;17:E1953. [PMID: 27886063 DOI: 10.3390/ijms17111953] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 293 |
Chen X, McCorvy JD, Fischer MG, Butler KV, Shen Y, Roth BL, Jin J. Discovery of G Protein-Biased D2 Dopamine Receptor Partial Agonists. J Med Chem 2016;59:10601-18. [PMID: 27805392 DOI: 10.1021/acs.jmedchem.6b01208] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 294 |
Goodman MS, Bridgman AC, Rabin RA, Blumberger DM, Rajji TK, Daskalakis ZJ, George TP, Barr MS. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain Stimul 2017;10:275-82. [PMID: 27964871 DOI: 10.1016/j.brs.2016.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 295 |
Dhami K, Mackay M, Maia-de-oliveira JP, Hallak J, Todd K, Baker G, Dursun S. Novel Targets for Development of Drugs for Treating Schizophrenia: Focus on Glycine, D-Serine and Nitric Oxide. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2016;23:129-37. [DOI: 10.5455/bcp.20130629042437] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 296 |
Thomas R, Baker G, Dursun S, Todd K, Dhami K, Chue J, Chue P. Glycine Reuptake Inhibitors in the Treatment of Negative Symptoms of Schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 2016;24:195-200. [DOI: 10.5455/bcp.20140918102748] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 297 |
Chen DC, Du XD, Yin GZ, Yang KB, Nie Y, Wang N, Li YL, Xiu MH, He SC, Yang FD, Cho RY, Kosten TR, Soares JC, Zhao JP, Zhang XY. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits. Psychol Med 2016;46:3219-30. [PMID: 27604840 DOI: 10.1017/S0033291716001902] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 298 |
Slifstein M, Abi-Dargham A. Recent Developments in Molecular Brain Imaging of Neuropsychiatric Disorders. Semin Nucl Med 2017;47:54-63. [PMID: 27987558 DOI: 10.1053/j.semnuclmed.2016.09.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 299 |
de Montalembert M, Tordjman S, Bonnot O, Coulon N. [Time perception and schizophrenia: Phenomenological and neuropsychological approach]. Encephale 2015;41:S56-61. [PMID: 26746324 DOI: 10.1016/S0013-7006(15)30008-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 300 |
Sokoloff P, Le Foll B, Herman J. The dopamine D3 receptor, a quarter century later. Eur J Neurosci 2017;45:2-19. [DOI: 10.1111/ejn.13390] [Cited by in Crossref: 146] [Cited by in F6Publishing: 150] [Article Influence: 20.9] [Reference Citation Analysis]
|
| 301 |
Edwards AC, Bacanu SA, Bigdeli TB, Moscati A, Kendler KS. Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study. Schizophr Res 2016;176:136-40. [PMID: 27338758 DOI: 10.1016/j.schres.2016.06.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 302 |
Locklear MN, Michaelos M, Collins WF, Kritzer MF. Gonadectomy but not biological sex affects burst-firing in dopamine neurons of the ventral tegmental area and in prefrontal cortical neurons projecting to the ventral tegmentum in adult rats. Eur J Neurosci 2017;45:106-20. [PMID: 27564091 DOI: 10.1111/ejn.13380] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 303 |
Tabor A, Weisenburger S, Banerjee A, Purkayastha N, Kaindl JM, Hübner H, Wei L, Grömer TW, Kornhuber J, Tschammer N, Birdsall NJ, Mashanov GI, Sandoghdar V, Gmeiner P. Visualization and ligand-induced modulation of dopamine receptor dimerization at the single molecule level. Sci Rep 2016;6:33233. [PMID: 27615810 DOI: 10.1038/srep33233] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 304 |
Lin F, Gui C, Wen W, Bao T, Zhang X, Wang S. Dopamine assay based on an aggregation-induced reversed inner filter effect of gold nanoparticles on the fluorescence of graphene quantum dots. Talanta 2016;158:292-8. [DOI: 10.1016/j.talanta.2016.05.062] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 305 |
Amitai N, Powell S, Weber M, Swerdlow NR, Young JW. Negative visuospatial priming in isolation-reared rats: Evidence of resistance to the disruptive effects of amphetamine. Cogn Affect Behav Neurosci 2015;15:901-14. [PMID: 26220402 DOI: 10.3758/s13415-015-0369-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 306 |
Keshavan MS, Lawler AN, Nasrallah HA, Tandon R. New drug developments in psychosis: Challenges, opportunities and strategies. Prog Neurobiol 2017;152:3-20. [PMID: 27519538 DOI: 10.1016/j.pneurobio.2016.07.004] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 307 |
Root DH, Wang HL, Liu B, Barker DJ, Mód L, Szocsics P, Silva AC, Maglóczky Z, Morales M. Glutamate neurons are intermixed with midbrain dopamine neurons in nonhuman primates and humans. Sci Rep 2016;6:30615. [PMID: 27477243 DOI: 10.1038/srep30615] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 308 |
Brady LJ, Bartley AF, Li Q, McMeekin LJ, Hablitz JJ, Cowell RM, Dobrunz LE. Transcriptional dysregulation causes altered modulation of inhibition by haloperidol. Neuropharmacology 2016;111:304-13. [PMID: 27480797 DOI: 10.1016/j.neuropharm.2016.07.034] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 309 |
Michels L, Scherpiet S, Stämpfli P, Herwig U, Brühl AB. Baseline Perfusion Alterations Due to Acute Application of Quetiapine and Pramipexole in Healthy Adults. Int J Neuropsychopharmacol 2016;19:pyw067. [PMID: 27466220 DOI: 10.1093/ijnp/pyw067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 310 |
Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, Girinelli G, Carano A, Fornaro M, Gambi F, Martinotti G, Di Giannantonio M. Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators Inflamm 2016;2016:3476240. [PMID: 27524864 DOI: 10.1155/2016/3476240] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 311 |
Kopinathan A, Scammells PJ, Lane JR, Capuano B. Multivalent approaches and beyond: novel tools for the investigation of dopamine D 2 receptor pharmacology. Future Medicinal Chemistry 2016;8:1349-72. [DOI: 10.4155/fmc-2016-0010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 312 |
Mitterauer B. Nonfunctional Glial Proteins in Tripartite Synapses: A Pathophysiological Model of Schizophrenia. Neuroscientist 2005;11:192-8. [DOI: 10.1177/1073858404265745] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 313 |
Jentsch JD, Taylor JR, Roth RH. Phencyclidine Model of Frontal Cortical Dysfunction in Nonhuman Primates. Neuroscientist 2000;6:263-70. [DOI: 10.1177/107385840000600409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 314 |
Goto Y, Lee YA, Yamaguchi Y, Jas E. Biological mechanisms underlying evolutionary origins of psychotic and mood disorders. Neurosci Res 2016;111:13-24. [PMID: 27230505 DOI: 10.1016/j.neures.2016.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 315 |
Kennedy JL, Xiong N, Yu J, Zai CC, Pouget JG, Li J, Liu K, Qing H, Wang T, Martin E, Levy DL, Lin Z. Increased Nigral SLC6A3 Activity in Schizophrenia Patients: Findings From the Toronto-McLean Cohorts. Schizophr Bull 2016;42:772-81. [PMID: 26707863 DOI: 10.1093/schbul/sbv191] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 316 |
Vink M, de Leeuw M, Luykx JJ, van Eijk KR, van den Munkhof HE, van Buuren M, Kahn RS. DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients. Schizophr Bull 2016;42:843-50. [PMID: 26598739 DOI: 10.1093/schbul/sbv166] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 317 |
Girgis RR, Van Snellenberg JX, Glass A, Kegeles LS, Thompson JL, Wall M, Cho RY, Carter CS, Slifstein M, Abi-Dargham A, Lieberman JA. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. J Psychopharmacol 2016;30:428-35. [PMID: 26966119 DOI: 10.1177/0269881116636120] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 318 |
Ekem S, Taşçılar N, Acıman Demirel E, Özen Barut B, Ankaralı H, Atasoy H. Tipik ve Atipik Antipsikotik İlaç Kullanımına Bağlı EEG Anormallikleri. Anadolu Kliniği Tıp Bilimleri Dergisi 2016;21:97-97. [DOI: 10.21673/anadoluklin.180733] [Reference Citation Analysis]
|
| 319 |
Peeters MM, van Grinsven B, Foster CW, Cleij TJ, Banks CE. Introducing Thermal Wave Transport Analysis (TWTA): A Thermal Technique for Dopamine Detection by Screen-Printed Electrodes Functionalized with Molecularly Imprinted Polymer (MIP) Particles. Molecules 2016;21:E552. [PMID: 27128891 DOI: 10.3390/molecules21050552] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 320 |
Borroto-Escuela DO, Pintsuk J, Schäfer T, Friedland K, Ferraro L, Tanganelli S, Liu F, Fuxe K. Multiple D2 heteroreceptor complexes: new targets for treatment of schizophrenia. Ther Adv Psychopharmacol 2016;6:77-94. [PMID: 27141290 DOI: 10.1177/2045125316637570] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 321 |
Lerner V, McCaffery PJ, Ritsner MS. Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date. CNS Drugs 2016;30:269-80. [PMID: 26968404 DOI: 10.1007/s40263-016-0316-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 322 |
Alpár A, Di Marzo V, Harkany T. At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring. Biol Psychiatry 2016;79:e33-45. [PMID: 26549491 DOI: 10.1016/j.biopsych.2015.09.009] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 323 |
Leung C, Jia Z. Mouse Genetic Models of Human Brain Disorders. Front Genet 2016;7:40. [PMID: 27047540 DOI: 10.3389/fgene.2016.00040] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 324 |
De Deurwaerdère P, Di Giovanni G. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. Prog Neurobiol 2017;151:175-236. [PMID: 27013075 DOI: 10.1016/j.pneurobio.2016.03.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 15.7] [Reference Citation Analysis]
|
| 325 |
Kim SW, Jhon M, Kim JM, Smesny S, Rice S, Berk M, Klier CM, McGorry PD, Schäfer MR, Amminger GP. Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study. PLoS One 2016;11:e0151417. [PMID: 26963912 DOI: 10.1371/journal.pone.0151417] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 326 |
Heilbronner SR, Safadi Z, Haber SN. Neurocircuits commonly involved in psychiatric disorders and their stimulation and lesion therapies. Neuromodulation in Psychiatry 2016. [DOI: 10.1002/9781118801086.ch3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 327 |
Edwards AC, Bigdeli TB, Docherty AR, Bacanu S, Lee D, de Candia TR, Moscati A, Thiselton DL, Maher BS, Wormley BK, Walsh D, O'Neill FA, Kendler KS, Riley BP, Fanous AH; Molecular Genetics of Schizophrenia Collaboration (MGS). Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. Schizophr Bull 2016;42:279-87. [PMID: 26316594 DOI: 10.1093/schbul/sbv119] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 328 |
Chen CY, Yeh YW, Kuo SC, Ho PS, Liang CS, Yen CH, Lu RB, Huang SY. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment. Psychoneuroendocrinology 2016;65:67-75. [PMID: 26724569 DOI: 10.1016/j.psyneuen.2015.12.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 329 |
Taherpour AA, Rizehbandi M, Jahanian F, Naghibi E, Mahdizadeh NA. Theoretical study of electron transfer process between fullerenes and neurotransmitters; acetylcholine, dopamine, serotonin and epinephrine in nanostructures [neurotransmitters].C n complexes. J Chem Biol 2016;9:19-29. [PMID: 26855678 DOI: 10.1007/s12154-015-0139-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 330 |
Rajagopal L, Massey BW, Michael E, Meltzer HY. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice. Psychopharmacology (Berl) 2016;233:649-60. [PMID: 26558619 DOI: 10.1007/s00213-015-4137-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 331 |
Gründer G, Cumming P. The Dopamine Hypothesis of Schizophrenia. The Neurobiology of Schizophrenia 2016. [DOI: 10.1016/b978-0-12-801829-3.00015-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 332 |
Messer T, Tiltscher C, Schmauß M. Behandlung der Schizophrenie. Polypharmazie in der Behandlung psychischer Erkrankungen 2016. [DOI: 10.1007/978-3-7091-1849-8_2] [Reference Citation Analysis]
|
| 333 |
Bulayeva K, Bulayev O, Glatt S. Current Problems of Complex Disease Genes Mapping. Genomic Architecture of Schizophrenia Across Diverse Genetic Isolates 2016. [DOI: 10.1007/978-3-319-31964-3_1] [Reference Citation Analysis]
|
| 334 |
Tracy DK, Smallcombe N, Tiwana F, Fosbraey J, Sendt K, Shergill SS. The Glutamate mGluR5 Receptor as a Pharmacological Target to Enhance Cognitive Function: Emerging Evidence from Psychosis Models. Melatonin, Neuroprotective Agents and Antidepressant Therapy 2016. [DOI: 10.1007/978-81-322-2803-5_43] [Reference Citation Analysis]
|
| 335 |
Landek-Salgado MA, Faust TE, Sawa A. Molecular substrates of schizophrenia: homeostatic signaling to connectivity. Mol Psychiatry 2016;21:10-28. [PMID: 26390828 DOI: 10.1038/mp.2015.141] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 336 |
Murphy A, Dursun S, McKie S, Elliott R, Deakin JF. An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers. Psychopharmacology (Berl) 2016;233:1415-26. [PMID: 26900078 DOI: 10.1007/s00213-016-4234-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 337 |
Silverstein SM. Visual Perception Disturbances in Schizophrenia: A Unified Model. Nebr Symp Motiv 2016;63:77-132. [PMID: 27627825 DOI: 10.1007/978-3-319-30596-7_4] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 338 |
Ko CY, Liu YP. Disruptions of sensorimotor gating, cytokines, glycemia, monoamines, and genes in both sexes of rats reared in social isolation can be ameliorated by oral chronic quetiapine administration. Brain Behav Immun 2016;51:119-30. [PMID: 26254231 DOI: 10.1016/j.bbi.2015.08.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 339 |
Frohlich J, Van Horn JD. Ketamine and the Dissociatives. Neuropathology of Drug Addictions and Substance Misuse 2016. [DOI: 10.1016/b978-0-12-800212-4.00060-1] [Reference Citation Analysis]
|
| 340 |
Vink M, de Leeuw M, Pouwels R, van den Munkhof HE, Kahn RS, Hillegers M. Diminishing striatal activation across adolescent development during reward anticipation in offspring of schizophrenia patients. Schizophr Res 2016;170:73-9. [PMID: 26631365 DOI: 10.1016/j.schres.2015.11.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 341 |
Wolter S, Petrovic A, Vieker H, Melcher T, Trost S, Diekhof EK, Richter A, Zilles D, Gruber O. Dysregulation within the Prefronto-Parietal Background-Monitoring Network in Schizophrenia. JBBS 2016;06:364-376. [DOI: 10.4236/jbbs.2016.69035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 342 |
Ho JH, Dargan PI. Arylcyclohexamines (Ketamine, Phencyclidine, and Analogues). Critical Care Toxicology 2016. [DOI: 10.1007/978-3-319-20790-2_124-1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 343 |
Patel SR, Cheng JJ, Khanna AR, Desai R, Eskandar EN. Striatal Mechanisms of Associative Learning and Dysfunction in Neurological Disease. Innovations in Cognitive Neuroscience 2016. [DOI: 10.1007/978-3-319-42743-0_12] [Reference Citation Analysis]
|
| 344 |
Falkai P, Schennach R, Lincoln T, Schaub A, Hasan A. Schizophrene Psychosen. Psychiatrie, Psychosomatik, Psychotherapie 2016. [DOI: 10.1007/978-3-642-45028-0_64-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 345 |
Wang A, Shi W, Huang J, Yan Y. Adaptive soft molecular self-assemblies. Soft Matter 2016;12:337-57. [DOI: 10.1039/c5sm02397a] [Cited by in Crossref: 120] [Cited by in F6Publishing: 122] [Article Influence: 17.1] [Reference Citation Analysis]
|
| 346 |
Wen Z, Christian KM, Song H, Ming GL. Modeling psychiatric disorders with patient-derived iPSCs. Curr Opin Neurobiol 2016;36:118-27. [PMID: 26705693 DOI: 10.1016/j.conb.2015.11.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 347 |
Colombo ML, McNeil S, Iwai N, Chang A, Shen M. Electrochemical Detection of Dopamine via Assisted Ion Transfer at Nanopipet Electrode Using Cyclic Voltammetry. J Electrochem Soc 2016;163:H3072-6. [PMID: 29606735 DOI: 10.1149/2.0091604jes] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 348 |
Lodovighi M, Palomba A, Belzeaux R, Adida M, Azorin J. Symptômes négatifs de la schizophrénie : nouvelles approches pharmacologiques. L'Encéphale 2015;41:6S41-6S49. [DOI: 10.1016/s0013-7006(16)30010-0] [Reference Citation Analysis]
|
| 349 |
Kokacya MH, Inanir S, Copoglu US, Dokuyucu R, Erbas O. The Antipsychotic Effects of Omega-3 Fatty Acids in Rats. Am J Med Sci 2015;350:212-7. [PMID: 26200950 DOI: 10.1097/MAJ.0000000000000531] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 350 |
Artem'eva MS, Kovaleva IA, Kogan BM, Drozdov AZ, Filatova TS, Danilin IE. [Catecholamine excretion in patients with eating disorders]. Zh Nevrol Psikhiatr Im S S Korsakova 2015;115:36-40. [PMID: 26525813 DOI: 10.17116/jnevro20151159136-40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 351 |
Gorobets LN. [To the question of pathophysiological fundamentals of endocrine system functioning in patients with a first psychotic episode]. Zh Nevrol Psikhiatr Im S S Korsakova 2015;115:45-8. [PMID: 26525815 DOI: 10.17116/jnevro20151159145-48] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 352 |
Zhang JP, Robinson DG, Gallego JA, John M, Yu J, Addington J, Tohen M, Kane JM, Malhotra AK, Lencz T. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Schizophr Bull 2015;41:1248-55. [PMID: 26320194 DOI: 10.1093/schbul/sbv116] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 353 |
Brisch R, Bielau H, Saniotis A, Wolf R, Bogerts B, Krell D, Steiner J, Braun K, Krzyżanowska M, Krzyżanowski M, Jankowski Z, Kaliszan M, Bernstein HG, Gos T. Calretinin and parvalbumin in schizophrenia and affective disorders: a mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei. Front Cell Neurosci 2015;9:393. [PMID: 26578879 DOI: 10.3389/fncel.2015.00393] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 354 |
Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia. Nutrients 2015;7:8767-82. [PMID: 26506383 DOI: 10.3390/nu7105427] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 355 |
Jiang W, Shang S, Su Y. Genetic influences on insight problem solving: the role of catechol-O-methyltransferase (COMT) gene polymorphisms. Front Psychol 2015;6:1569. [PMID: 26528222 DOI: 10.3389/fpsyg.2015.01569] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 356 |
Galderisi S, Merlotti E, Mucci A. Neurobiological background of negative symptoms. Eur Arch Psychiatry Clin Neurosci 2015;265:543-58. [PMID: 25797499 DOI: 10.1007/s00406-015-0590-4] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 357 |
Schmack K, Rössler H, Sekutowicz M, Brandl EJ, Müller DJ, Petrovic P, Sterzer P. Linking unfounded beliefs to genetic dopamine availability. Front Hum Neurosci 2015;9:521. [PMID: 26483654 DOI: 10.3389/fnhum.2015.00521] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 358 |
Hutson PH, Rowley HL, Gosden J, Kulkarni RS, Slater N, Love PL, Wang Y, Heal D. The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue. Neuropharmacology 2016;101:24-35. [PMID: 26384654 DOI: 10.1016/j.neuropharm.2015.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 359 |
Cohen SM, Tsien RW, Goff DC, Halassa MM. The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia. Schizophr Res 2015;167:98-107. [PMID: 25583246 DOI: 10.1016/j.schres.2014.12.026] [Cited by in Crossref: 154] [Cited by in F6Publishing: 151] [Article Influence: 19.3] [Reference Citation Analysis]
|
| 360 |
Bachiller A, Lubeiro A, Díez Á, Suazo V, Domínguez C, Blanco JA, Ayuso M, Hornero R, Poza J, Molina V. Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task. Eur Arch Psychiatry Clin Neurosci 2015;265:525-35. [PMID: 25164969 DOI: 10.1007/s00406-014-0525-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 361 |
Raij TT, Mäntylä T, Kieseppä T, Suvisaari J. Aberrant functioning of the putamen links delusions, antipsychotic drug dose, and compromised connectivity in first episode psychosis--Preliminary fMRI findings. Psychiatry Res 2015;233:201-11. [PMID: 26184459 DOI: 10.1016/j.pscychresns.2015.06.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 362 |
Bu Y, Lee SW. The characteristic Ag(core)Au(shell) nanoparticles as SERS substrates in detecting dopamine molecules at various pH ranges. Int J Nanomedicine 2015;10 Spec Iss:47-54. [PMID: 26345418 DOI: 10.2147/IJN.S88308] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 363 |
Storozheva ZI, Kirenskaya AV, Proshin AT. The neuromediator mechanisms of the cognitive deficit in schizophrenia. Neurochem J 2015;9:186-200. [DOI: 10.1134/s1819712415030095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 364 |
Sami MB, Rabiner EA, Bhattacharyya S. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. Eur Neuropsychopharmacol 2015;25:1201-24. [PMID: 26068702 DOI: 10.1016/j.euroneuro.2015.03.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 365 |
Li Z, Lui SS, Geng FL, Li Y, Li WX, Wang CY, Tan SP, Cheung EF, Kring AM, Chan RC. Experiential pleasure deficits in different stages of schizophrenia. Schizophr Res 2015;166:98-103. [PMID: 26072322 DOI: 10.1016/j.schres.2015.05.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 366 |
Kirwan P, Livesey FJ. Human Stem Cell Models of Neurodevelopmental Disorders. The Genetics of Neurodevelopmental Disorders 2015. [DOI: 10.1002/9781118524947.ch10] [Reference Citation Analysis]
|
| 367 |
Vreeker A, van Bergen AH, Kahn RS. Cognitive enhancing agents in schizophrenia and bipolar disorder. Eur Neuropsychopharmacol 2015;25:969-1002. [PMID: 25957798 DOI: 10.1016/j.euroneuro.2015.04.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 368 |
Ramsay H, Barnett JH, Miettunen J, Mukkala S, Mäki P, Liuhanen J, Murray GK, Jarvelin MR, Ollila H, Paunio T, Veijola J. Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample. PLoS One 2015;10:e0127602. [PMID: 26114663 DOI: 10.1371/journal.pone.0127602] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 369 |
Lewis MA, Hunihan L, Watson J, Gentles RG, Hu S, Huang Y, Bronson J, Macor JE, Beno BR, Ferrante M, Hendricson A, Knox RJ, Molski TF, Kong Y, Cvijic ME, Rockwell KL, Weed MR, Cacace AM, Westphal RS, Alt A, Brown JM. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity. J Pharmacol Exp Ther 2015;354:340-9. [PMID: 26109678 DOI: 10.1124/jpet.115.224071] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 370 |
Shonberg J, Draper-Joyce C, Mistry SN, Christopoulos A, Scammells PJ, Lane JR, Capuano B. Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptor. J Med Chem 2015;58:5287-307. [PMID: 26052807 DOI: 10.1021/acs.jmedchem.5b00581] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 371 |
O'connor WT, O'shea SD. Clozapine and GABA transmission in schizophrenia disease models. Pharmacology & Therapeutics 2015;150:47-80. [DOI: 10.1016/j.pharmthera.2015.01.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 372 |
Ślifirski G, Słowiński T, Stefanowicz J. NOWE KIERUNKI POSZUKIWAŃ LEKÓW ANTYPSYCHOTYCZNYCH. pps 2015;13:21-27. [DOI: 10.56782/pps.112] [Reference Citation Analysis]
|
| 373 |
Ira E, De Santi K, Lasalvia A, Bonetto C, Zanatta G, Cristofalo D, Bertani M, Bissoli SS, Riolo R, Gardellin F, Morandin I, Ramon L, Tansella M, Ruggeri M, Tosato S; PICOS-Veneto Group. Positive symptoms in first-episode psychosis patients experiencing low maternal care and stressful life events: a pilot study to explore the role of the COMT gene. Stress 2014;17:410-5. [PMID: 25068285 DOI: 10.3109/10253890.2014.948841] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 374 |
Nasyrova RF, Ivashchenko DV, Ivanov MV, Neznanov NG. Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects. Front Physiol 2015;6:139. [PMID: 26029110 DOI: 10.3389/fphys.2015.00139] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 375 |
Goff DC. Drug development in schizophrenia: are glutamatergic targets still worth aiming at? Curr Opin Psychiatry 2015;28:207-15. [PMID: 25710242 DOI: 10.1097/YCO.0000000000000152] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 376 |
Kusumi I, Boku S, Takahashi Y. Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis. Psychiatry Clin Neurosci 2015;69:243-58. [PMID: 25296946 DOI: 10.1111/pcn.12242] [Cited by in Crossref: 118] [Cited by in F6Publishing: 116] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 377 |
Cocchi E, Drago A, Serretti A. Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis. Mol Neurobiol 2016;53:2065-81. [PMID: 25902861 DOI: 10.1007/s12035-015-9174-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 378 |
de Leeuw M, Bohlken MM, Mandl RC, Kahn RS, Vink M. Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study. NPJ Schizophr 2015;1:15001. [PMID: 27336028 DOI: 10.1038/npjschz.2015.1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 379 |
Hernaus D, Collip D, Kasanova Z, Winz O, Heinzel A, van Amelsvoort T, Shali SM, Booij J, Rong Y, Piel M, Pruessner J, Mottaghy FM, Myin-Germeys I. No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder. Transl Psychiatry 2015;5:e547. [PMID: 25871972 DOI: 10.1038/tp.2015.37] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 380 |
Bobo WV, Rapoport JL, Abi‐dargham A, Hossein Fatemi S, Meltzer HY. The Neurobiology of Schizophrenia. Psychiatry 2015. [DOI: 10.1002/9781118753378.ch19] [Reference Citation Analysis]
|
| 381 |
Manzella F, Maloney SE, Taylor GT. Smoking in schizophrenic patients: A critique of the self-medication hypothesis. World J Psychiatr 2015; 5(1): 35-46 [PMID: 25815253 DOI: 10.5498/wjp.v5.i1.35] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 382 |
Griffiths O, Langdon R, Le Pelley ME, Coltheart M. Delusions and prediction error: re-examining the behavioural evidence for disrupted error signalling in delusion formation. Cogn Neuropsychiatry 2014;19:439-67. [PMID: 24702287 DOI: 10.1080/13546805.2014.897601] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 383 |
Weichert D, Banerjee A, Hiller C, Kling RC, Hübner H, Gmeiner P. Molecular Determinants of Biased Agonism at the Dopamine D 2 Receptor. J Med Chem 2015;58:2703-17. [DOI: 10.1021/jm501889t] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 384 |
Hui L, Wu JQ, Ye MJ, Zheng K, He JC, Zhang X, Liu JH, Tian HJ, Gong BH, Chen DC, Lv MH, Soares JC, Zhang XY. Association of angiotensin-converting enzyme gene polymorphism with schizophrenia and depressive symptom severity in a Chinese population. Hum Psychopharmacol 2015;30:100-7. [PMID: 25694211 DOI: 10.1002/hup.2460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 385 |
Thakkar KN, Schall JD, Logan GD, Park S. Cognitive control of gaze in bipolar disorder and schizophrenia. Psychiatry Res 2015;225:254-62. [PMID: 25601802 DOI: 10.1016/j.psychres.2014.12.033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 386 |
Rangel-Barajas C, Malik M, Mach RH, Luedtke RR. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compounds. Neuropharmacology 2015;93:179-90. [PMID: 25698528 DOI: 10.1016/j.neuropharm.2014.10.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 387 |
de Castro-Catala M, Barrantes-Vidal N, Sheinbaum T, Moreno-Fortuny A, Kwapil TR, Rosa A. COMT-by-sex interaction effect on psychosis proneness. Biomed Res Int 2015;2015:829237. [PMID: 25722988 DOI: 10.1155/2015/829237] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 388 |
Steeds H, Carhart-Harris RL, Stone JM. Drug models of schizophrenia. Ther Adv Psychopharmacol 2015;5:43-58. [PMID: 25653831 DOI: 10.1177/2045125314557797] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 389 |
Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 2015;29:97-115. [PMID: 25586400 DOI: 10.1177/0269881114563634] [Cited by in Crossref: 484] [Cited by in F6Publishing: 489] [Article Influence: 60.5] [Reference Citation Analysis]
|
| 390 |
Dunn W, Marder SR. Novel Treatments of Psychosis. Curr Behav Neurosci Rep 2015;2:119-26. [DOI: 10.1007/s40473-015-0032-7] [Reference Citation Analysis]
|
| 391 |
Elsworth JD, Groman SM, Jentsch JD, Leranth C, Redmond DE Jr, Kim JD, Diano S, Roth RH. Primate phencyclidine model of schizophrenia: sex-specific effects on cognition, brain derived neurotrophic factor, spine synapses, and dopamine turnover in prefrontal cortex. Int J Neuropsychopharmacol 2014;18:pyu048. [PMID: 25522392 DOI: 10.1093/ijnp/pyu048] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 392 |
Callear SK, Johnston A, Mclain SE, Imberti S. Conformation and interactions of dopamine hydrochloride in solution. The Journal of Chemical Physics 2015;142:014502. [DOI: 10.1063/1.4904291] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 393 |
Sarpal DK, Robinson DG, Lencz T, Argyelan M, Ikuta T, Karlsgodt K, Gallego JA, Kane JM, Szeszko PR, Malhotra AK. Antipsychotic treatment and functional connectivity of the striatum in first-episode schizophrenia. JAMA Psychiatry 2015;72:5-13. [PMID: 25372846 DOI: 10.1001/jamapsychiatry.2014.1734] [Cited by in Crossref: 221] [Cited by in F6Publishing: 228] [Article Influence: 27.6] [Reference Citation Analysis]
|
| 394 |
de Leeuw M, Kahn RS, Vink M. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophr Bull 2015;41:94-103. [PMID: 25368371 DOI: 10.1093/schbul/sbu153] [Cited by in Crossref: 51] [Cited by in F6Publishing: 56] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 395 |
Kotb El-Sayed MI, Amin HK. Catha edulis chewing effects on treatment of paranoid schizophrenic patients. Neuropsychiatr Dis Treat 2015;11:1067-76. [PMID: 25926735 DOI: 10.2147/NDT.S81011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 396 |
Xu X, Weng X, Aron A. The Mesolimbic Dopamine Pathway and Romantic Love. Brain Mapping. Elsevier; 2015. pp. 631-3. [DOI: 10.1016/b978-0-12-397025-1.00057-9] [Cited by in Crossref: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 397 |
Gangadhar B, Rao N. Action of Antipsychotics. Brain Mapping 2015. [DOI: 10.1016/b978-0-12-397025-1.00115-9] [Reference Citation Analysis]
|
| 398 |
Haybaeck J, Postruznik M, Miller CL, Dulay JR, Llenos IC, Weis S. Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression. Neuropsychiatr Dis Treat 2015;11:279-89. [PMID: 25678793 DOI: 10.2147/NDT.S72536] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 399 |
Klug M, Hill R, Van den Buuse M. ‘Two Hit’ Neurodevelopmental Mechanisms in Schizophrenia: Focus on Animal Models and the Role of BDNF. Psychiatry and Neuroscience Update 2015. [DOI: 10.1007/978-3-319-17103-6_24] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 400 |
Vineesh TV, Alwarappan S, Narayanan TN. The improved electrochemical performance of cross-linked 3D graphene nanoribbon monolith electrodes. Nanoscale 2015;7:6504-9. [DOI: 10.1039/c4nr07315k] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 401 |
Rohleder C, Leweke FM. Cannabinoids and schizophrenia. Cannabinoids in Neurologic and Mental Disease 2015. [DOI: 10.1016/b978-0-12-417041-4.00008-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 402 |
Snyder GL, Vanover KE, Zhu H, Miller DB, O'Callaghan JP, Tomesch J, Li P, Zhang Q, Krishnan V, Hendrick JP, Nestler EJ, Davis RE, Wennogle LP, Mates S. Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission. Psychopharmacology (Berl) 2015;232:605-21. [PMID: 25120104 DOI: 10.1007/s00213-014-3704-1] [Cited by in Crossref: 63] [Cited by in F6Publishing: 219] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 403 |
Kim SW, Cho T, Lee S. Phospholipase C-β1 Hypofunction in the Pathogenesis of Schizophrenia. Front Psychiatry 2015;6:159. [PMID: 26635636 DOI: 10.3389/fpsyt.2015.00159] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 404 |
Saha S, Sarkar P, Sarkar M, Giri B. Electroconductive smart polyacrylamide–polypyrrole (PAC–PPY) hydrogel: a device for controlled release of risperidone. RSC Adv 2015;5:27665-73. [DOI: 10.1039/c5ra03535j] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 405 |
Kumari V, Ettinger U, Lee SE, Deuschl C, Anilkumar AP, Schmechtig A, Corr PJ, Ffytche DH, Williams SC. Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology (Berl) 2015;232:3135-47. [PMID: 25980483 DOI: 10.1007/s00213-015-3959-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 406 |
Modinos G, Allen P, Grace AA, McGuire P. Translating the MAM model of psychosis to humans. Trends Neurosci 2015;38:129-38. [PMID: 25554679 DOI: 10.1016/j.tins.2014.12.005] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 407 |
Gómez J, Jesús Marín-Méndez J, Molero P, Atakan Z, Ortuño F. Time perception networks and cognition in schizophrenia: a review and a proposal. Psychiatry Res 2014;220:737-44. [PMID: 25219610 DOI: 10.1016/j.psychres.2014.07.048] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 408 |
Cicero DC, Martin EA, Becker TM, Kerns JG. Reinforcement learning deficits in people with schizophrenia persist after extended trials. Psychiatry Res 2014;220:760-4. [PMID: 25172610 DOI: 10.1016/j.psychres.2014.08.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 409 |
Chakravarty MM, Rapoport JL, Giedd JN, Raznahan A, Shaw P, Collins DL, Lerch JP, Gogtay N. Striatal shape abnormalities as novel neurodevelopmental endophenotypes in schizophrenia: a longitudinal study. Hum Brain Mapp 2015;36:1458-69. [PMID: 25504933 DOI: 10.1002/hbm.22715] [Cited by in Crossref: 54] [Cited by in F6Publishing: 58] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 410 |
Zhuo C, Zhu J, Qin W, Qu H, Ma X, Tian H, Xu Q, Yu C. Functional connectivity density alterations in schizophrenia. Front Behav Neurosci 2014;8:404. [PMID: 25477799 DOI: 10.3389/fnbeh.2014.00404] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 411 |
Brindisi M, Butini S, Franceschini S, Brogi S, Trotta F, Ros S, Cagnotto A, Salmona M, Casagni A, Andreassi M, Saponara S, Gorelli B, Weikop P, Mikkelsen JD, Scheel-kruger J, Sandager-nielsen K, Novellino E, Campiani G, Gemma S. Targeting Dopamine D 3 and Serotonin 5-HT 1A and 5-HT 2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and Behavioral Studies. J Med Chem 2014;57:9578-97. [DOI: 10.1021/jm501119j] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 412 |
Yoon JH, Westphal AJ, Minzenberg MJ, Niendam T, Ragland JD, Lesh T, Solomon M, Carter CS. Task-evoked substantia nigra hyperactivity associated with prefrontal hypofunction, prefrontonigral disconnectivity and nigrostriatal connectivity predicting psychosis severity in medication naïve first episode schizophrenia. Schizophr Res 2014;159:521-6. [PMID: 25266549 DOI: 10.1016/j.schres.2014.09.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 413 |
Bibliography. Molecules That Amaze Us 2014. [DOI: 10.1201/b17423-69] [Reference Citation Analysis]
|
| 414 |
Momcilovic S, Dickenson R, Adams CE. Anticholinergics for neuroleptic-induced parkinsonism and tardive dyskinesia. Cochrane Database of Systematic Reviews 2014. [DOI: 10.1002/14651858.cd011262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 415 |
Moskovitz J, Walss-Bass C, Cruz DA, Thompson PM, Bortolato M. Methionine sulfoxide reductase regulates brain catechol-O-methyl transferase activity. Int J Neuropsychopharmacol 2014;17:1707-13. [PMID: 24735585 DOI: 10.1017/S1461145714000467] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 416 |
Rice MW, Roberts RC, Melendez-Ferro M, Perez-Costas E. Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia. Brain Struct Funct 2016;221:185-201. [PMID: 25269834 DOI: 10.1007/s00429-014-0901-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 417 |
Locklear MN, Cohen AB, Jone A, Kritzer MF. Sex Differences Distinguish Intracortical Glutamate Receptor-Mediated Regulation of Extracellular Dopamine Levels in the Prefrontal Cortex of Adult Rats. Cereb Cortex 2016;26:599-610. [PMID: 25260707 DOI: 10.1093/cercor/bhu222] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 418 |
Li Z, Huang J, Sun H, Zhou S, Guo L, Zhou Y, Zhen X, Liu H. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Bioorg Med Chem 2014;22:5838-46. [PMID: 25308766 DOI: 10.1016/j.bmc.2014.09.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 419 |
Arroll MA, Wilder L, Neil J. Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review. Nutr J 2014;13:91. [PMID: 25228271 DOI: 10.1186/1475-2891-13-91] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 420 |
Esterlis I, Ranganathan M, Bois F, Pittman B, Picciotto MR, Shearer L, Anticevic A, Carlson J, Niciu MJ, Cosgrove KP, D'Souza DC. In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia. Biol Psychiatry 2014;76:495-502. [PMID: 24360979 DOI: 10.1016/j.biopsych.2013.11.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 421 |
van Ruitenbeek P, Mehta MA. Potential enhancing effects of histamine H₁ agonism/H₃ antagonism on working memory assessed by performance and bold response in healthy volunteers. Br J Pharmacol 2013;170:144-55. [PMID: 23517178 DOI: 10.1111/bph.12184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 422 |
Averbeck BB, Lehman J, Jacobson M, Haber SN. Estimates of projection overlap and zones of convergence within frontal-striatal circuits. J Neurosci 2014;34:9497-505. [PMID: 25031393 DOI: 10.1523/JNEUROSCI.5806-12.2014] [Cited by in Crossref: 110] [Cited by in F6Publishing: 121] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 423 |
Fournier M, Ferrari C, Baumann PS, Polari A, Monin A, Bellier-Teichmann T, Wulff J, Pappan KL, Cuenod M, Conus P, Do KQ. Impaired metabolic reactivity to oxidative stress in early psychosis patients. Schizophr Bull 2014;40:973-83. [PMID: 24687046 DOI: 10.1093/schbul/sbu053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 424 |
Sarkanen T, Niemelä V, Landtblom AM, Partinen M. Psychosis in patients with narcolepsy as an adverse effect of sodium oxybate. Front Neurol 2014;5:136. [PMID: 25191304 DOI: 10.3389/fneur.2014.00136] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 425 |
Edut S, Rubovitch V, Rehavi M, Schreiber S, Pick CG. A study on the mechanism by which MDMA protects against dopaminergic dysfunction after minimal traumatic brain injury (mTBI) in mice. J Mol Neurosci 2014;54:684-97. [PMID: 25124230 DOI: 10.1007/s12031-014-0399-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 426 |
Mascolo L, Guccione P, Nico G, Taurisano P, Fazio L. Data driven analysis of functional brain networks in fMRI for schizophrenia investigation. Int J Imaging Syst Technol 2014;24:239-48. [DOI: 10.1002/ima.22099] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 427 |
Zheng Z, Qiu H, Zheng M, Weng S, Huang Z, Xian R, Lin X. Selective electrochemical determination of dopamine in serum in the presence of ascorbic acid and uric acid by using a CuO nanoleaf electrode. Anal Methods 2014;6:7923-7. [DOI: 10.1039/c4ay01366b] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 428 |
Clarke HF, Cardinal RN, Rygula R, Hong YT, Fryer TD, Sawiak SJ, Ferrari V, Cockcroft G, Aigbirhio FI, Robbins TW, Roberts AC. Orbitofrontal dopamine depletion upregulates caudate dopamine and alters behavior via changes in reinforcement sensitivity. J Neurosci 2014;34:7663-76. [PMID: 24872570 DOI: 10.1523/JNEUROSCI.0718-14.2014] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 429 |
Tournier BB, Ginovart N. Repeated but not acute treatment with ∆⁹-tetrahydrocannabinol disrupts prepulse inhibition of the acoustic startle: reversal by the dopamine D₂/₃ receptor antagonist haloperidol. Eur Neuropsychopharmacol 2014;24:1415-23. [PMID: 24846537 DOI: 10.1016/j.euroneuro.2014.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 430 |
Marques TR, Levine SZ, Reichenberg A, Kahn R, Derks EM, Fleischhacker WW, Rabinowitz J, Kapur S. How antipsychotics impact the different dimensions of Schizophrenia: a test of competing hypotheses. Eur Neuropsychopharmacol 2014;24:1279-88. [PMID: 24862257 DOI: 10.1016/j.euroneuro.2014.04.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 431 |
Gil-Pisa I, Cebrián C, Ortega JE, Meana JJ, Sulzer D. Cytokine pathway disruption in a mouse model of schizophrenia induced by Munc18-1a overexpression in the brain. J Neuroinflammation 2014;11:128. [PMID: 25069615 DOI: 10.1186/1742-2094-11-128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 432 |
O'sullivan S, Grey A. Adverse skeletal effects of drugs - beyond Glucocorticoids. Clin Endocrinol 2015;82:12-22. [DOI: 10.1111/cen.12549] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 433 |
Narayanan TN, Vusa CSR, Alwarappan S. Selective and efficient electrochemical biosensing of ultrathin molybdenum disulfide sheets. Nanotechnology 2014;25:335702. [DOI: 10.1088/0957-4484/25/33/335702] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 434 |
Schweimer JV, Coullon GS, Betts JF, Burnet PW, Engle SJ, Brandon NJ, Harrison PJ, Sharp T. Increased burst-firing of ventral tegmental area dopaminergic neurons in D-amino acid oxidase knockout mice in vivo. Eur J Neurosci 2014;40:2999-3009. [PMID: 25040393 DOI: 10.1111/ejn.12667] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 435 |
Samaha AN. Can antipsychotic treatment contribute to drug addiction in schizophrenia? Prog Neuropsychopharmacol Biol Psychiatry 2014;52:9-16. [PMID: 23793001 DOI: 10.1016/j.pnpbp.2013.06.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 436 |
Bonoldi I, Howes OD. Presynaptic dopaminergic function: implications for understanding treatment response in psychosis. CNS Drugs 2014;28:649-63. [PMID: 24919790 DOI: 10.1007/s40263-014-0177-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 437 |
Dai D, Wang Y, Yuan J, Zhou X, Jiang D, Li J, Zhang Y, Yin H, Duan S. Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia. Biomed Rep 2014;2:729-36. [PMID: 25054019 DOI: 10.3892/br.2014.308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 438 |
Kim E, Howes OD, Kapur S. Molecular imaging as a guide for the treatment of central nervous system disorders. Dialogues Clin Neurosci 2013;15:315-28. [PMID: 24174903 [PMID: 24174903 DOI: 10.31887/dcns.2013.15.3/ekim] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 439 |
Oganesyan GA, Aristakesyan EA, Romanova IV, Vataev SI, Kuzik VV. Phylo- and Ontogenetic Establishment of Dopamine Regulation of the Sleep–Waking Cycle in Vertebrates. Neurosci Behav Physi 2014;44:584-592. [DOI: 10.1007/s11055-014-9955-9] [Reference Citation Analysis]
|
| 440 |
Williams MR, Galvin K, O'Sullivan B, MacDonald CD, Ching EW, Turkheimer F, Howes OD, Pearce RK, Hirsch SR, Maier M. Neuropathological changes in the substantia nigra in schizophrenia but not depression. Eur Arch Psychiatry Clin Neurosci 2014;264:285-96. [PMID: 24374935 DOI: 10.1007/s00406-013-0479-z] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 441 |
Chen W, Lin Y, Chang Y, Chang K, Hsia Y. Forced degradation behavior of epidepride and development of a stability-indicating method based on liquid chromatography–mass spectrometry. Journal of Food and Drug Analysis 2014;22:248-56. [DOI: 10.1016/j.jfda.2013.09.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 442 |
Betts JF, Schweimer JV, Burnham KE, Burnet PW, Sharp T, Harrison PJ. D-amino acid oxidase is expressed in the ventral tegmental area and modulates cortical dopamine. Front Synaptic Neurosci 2014;6:11. [PMID: 24822045 DOI: 10.3389/fnsyn.2014.00011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 443 |
Hui L, Wu JQ, Zhang X, Lv J, Du WL, Kou CG, Yu YQ, Lv MH, Chen DC, Zhang XY. Association between the angiotensin-converting enzyme gene insertion/deletion polymorphism and first-episode patients with schizophrenia in a Chinese Han population. Hum Psychopharmacol 2014;29:274-9. [PMID: 24615782 DOI: 10.1002/hup.2396] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 444 |
Gardner RJ, Kersanté F, Jones MW, Bartsch U. Neural oscillations during non-rapid eye movement sleep as biomarkers of circuit dysfunction in schizophrenia. Eur J Neurosci 2014;39:1091-106. [DOI: 10.1111/ejn.12533] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 445 |
Schreiber R, Newman-tancredi A. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation. Neurobiology of Learning and Memory 2014;110:72-80. [DOI: 10.1016/j.nlm.2013.12.015] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 446 |
Tonelli HA. How semantic deficits in schizotypy help understand language and thought disorders in schizophrenia: a systematic and integrative review. Trends Psychiatry Psychother 2014;36:75-88. [DOI: 10.1590/2237-6089-2013-0053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 447 |
Bilic P, Jukic V, Vilibic M, Savic A, Bozina N. Treatment-resistant schizophrenia and DAT and SERT polymorphisms. Gene 2014;543:125-32. [PMID: 24680725 DOI: 10.1016/j.gene.2014.03.050] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 448 |
Vollbrecht PJ, Simmler LD, Blakely RD, Deutch AY. Dopamine denervation of the prefrontal cortex increases expression of the astrocytic glutamate transporter GLT-1. J Neurochem 2014;130:109-14. [PMID: 24611756 DOI: 10.1111/jnc.12697] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 449 |
Snyder GL, Hendrick JP, Nishi A. The Role of Phosphodiesterases in Dopamine Systems governing Motivated Behavior. Cyclic-Nucleotide Phosphodiesterases In The Central Nervous System 2014. [DOI: 10.1002/9781118836507.ch12] [Reference Citation Analysis]
|
| 450 |
Godar SC, Bortolato M. Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission. Front Behav Neurosci 2014;8:71. [PMID: 24639636 DOI: 10.3389/fnbeh.2014.00071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 451 |
Girgis RR, Kumar SS, Brown AS. The cytokine model of schizophrenia: emerging therapeutic strategies. Biol Psychiatry 2014;75:292-9. [PMID: 24439555 DOI: 10.1016/j.biopsych.2013.12.002] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 452 |
Laruelle M. Schizophrenia: from dopaminergic to glutamatergic interventions. Curr Opin Pharmacol. 2014;14:97-102. [PMID: 24524997 DOI: 10.1016/j.coph.2014.01.001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 12.6] [Reference Citation Analysis]
|
| 453 |
Pizza F, Magnani M, Indrio C, Plazzi G. The hypocretin system and psychiatric disorders. Curr Psychiatry Rep 2014;16:433. [PMID: 24363104 DOI: 10.1007/s11920-013-0433-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 454 |
Poels EM, Kegeles LS, Kantrowitz JT, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Glutamatergic abnormalities in schizophrenia: a review of proton MRS findings. Schizophr Res 2014;152:325-32. [PMID: 24418122 DOI: 10.1016/j.schres.2013.12.013] [Cited by in Crossref: 124] [Cited by in F6Publishing: 126] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 455 |
Rüther T, Bobes J, De Hert M, Svensson T, Mann K, Batra A, Gorwood P, Möller H. EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness. Eur psychiatr 2014;29:65-82. [DOI: 10.1016/j.eurpsy.2013.11.002] [Cited by in Crossref: 97] [Cited by in F6Publishing: 100] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 456 |
Sabioni P, Ramos AC, Galduróz JC. The effectiveness of treatments for cocaine dependence in schizophrenic patients: a systematic review. Curr Neuropharmacol 2013;11:484-90. [PMID: 24403872 DOI: 10.2174/1570159X11311050003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 457 |
Horga G, Fernández-Egea E, Mané A, Font M, Schatz KC, Falcon C, Lomeña F, Bernardo M, Parellada E. Brain metabolism during hallucination-like auditory stimulation in schizophrenia. PLoS One 2014;9:e84987. [PMID: 24416328 DOI: 10.1371/journal.pone.0084987] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 458 |
Hirvonen J, Hietala J. Dopamine Receptor Imaging in Schizophrenia. Imaging of the Human Brain in Health and Disease 2014. [DOI: 10.1016/b978-0-12-418677-4.00013-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 459 |
Lataster J, Collip D, Ceccarini J, Hernaus D, Haas D, Booij L, van Os J, Pruessner J, Van Laere K, Myin-Germeys I. Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex. Schizophr Bull 2014;40:66-77. [PMID: 23363687 DOI: 10.1093/schbul/sbs187] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 460 |
Poels EM, Kegeles LS, Kantrowitz JT, Slifstein M, Javitt DC, Lieberman JA, Abi-Dargham A, Girgis RR. Imaging glutamate in schizophrenia: review of findings and implications for drug discovery. Mol Psychiatry 2014;19:20-9. [PMID: 24166406 DOI: 10.1038/mp.2013.136] [Cited by in Crossref: 158] [Cited by in F6Publishing: 165] [Article Influence: 17.6] [Reference Citation Analysis]
|
| 461 |
Kessler RM. Dopamine Receptors and Dopamine Release. Imaging of the Human Brain in Health and Disease. Elsevier; 2014. pp. 289-339. [DOI: 10.1016/b978-0-12-418677-4.00012-9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 462 |
Hori H, Teraishi T, Sasayama D, Matsuo J, Kinoshita Y, Ota M, Hattori K, Kunugi H. A latent profile analysis of schizotypy, temperament and character in a nonclinical population: association with neurocognition. J Psychiatr Res 2014;48:56-64. [PMID: 24183242 DOI: 10.1016/j.jpsychires.2013.10.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 463 |
Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry 2014;5:47. [PMID: 24904434 DOI: 10.3389/fpsyt.2014.00047] [Cited by in Crossref: 81] [Cited by in F6Publishing: 160] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 464 |
Klein HC, Doorduin J, van Berckel BN. Molecular Imaging in Schizophrenia Spectrum Disorders. PET and SPECT in Psychiatry 2014. [DOI: 10.1007/978-3-642-40384-2_18] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 465 |
Radhakrishnan R, Wilkinson ST, D'Souza DC. Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry 2014;5:54. [PMID: 24904437 DOI: 10.3389/fpsyt.2014.00054] [Cited by in Crossref: 175] [Cited by in F6Publishing: 174] [Article Influence: 19.4] [Reference Citation Analysis]
|
| 466 |
Foster DJ, Choi DL, Conn PJ, Rook JM. Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer's disease and schizophrenia. Neuropsychiatr Dis Treat 2014;10:183-91. [PMID: 24511233 DOI: 10.2147/NDT.S55104] [Cited by in Crossref: 21] [Cited by in F6Publishing: 41] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 467 |
Mohr C, Ettinger U. An Overview of the Association between Schizotypy and Dopamine. Front Psychiatry 2014;5:184. [PMID: 25566103 DOI: 10.3389/fpsyt.2014.00184] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 468 |
Dauvermann MR, Whalley HC, Schmidt A, Lee GL, Romaniuk L, Roberts N, Johnstone EC, Lawrie SM, Moorhead TW. Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder. Front Psychiatry 2014;5:30. [PMID: 24723894 DOI: 10.3389/fpsyt.2014.00030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 469 |
Rao NP, Remington G. Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials. Expert Opinion on Pharmacotherapy 2013;15:373-83. [DOI: 10.1517/14656566.2014.873790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 470 |
Urs NM, Nicholls PJ, Caron MG. Integrated approaches to understanding antipsychotic drug action at GPCRs. Curr Opin Cell Biol 2014;27:56-62. [PMID: 24680431 DOI: 10.1016/j.ceb.2013.11.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 471 |
Abdoli A, Dalimi A, Arbabi M, Ghaffarifar F. Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring. J Matern Fetal Neonatal Med 2014;27:1368-74. [PMID: 24156764 DOI: 10.3109/14767058.2013.858685] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 472 |
Reedijk SA, Bolders A, Hommel B. The impact of binaural beats on creativity. Front Hum Neurosci 2013;7:786. [PMID: 24294202 DOI: 10.3389/fnhum.2013.00786] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 473 |
Shonberg J, Herenbrink CK, López L, Christopoulos A, Scammells PJ, Capuano B, Lane JR. A structure-activity analysis of biased agonism at the dopamine D2 receptor. J Med Chem 2013;56:9199-221. [PMID: 24138311 DOI: 10.1021/jm401318w] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 474 |
de Leeuw M, Kahn RS, Zandbelt BB, Widschwendter CG, Vink M. Working memory and default mode network abnormalities in unaffected siblings of schizophrenia patients. Schizophr Res 2013;150:555-62. [PMID: 24051015 DOI: 10.1016/j.schres.2013.08.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 475 |
Singer P, Zhang W, Yee BK. SSR504734 enhances basal expression of prepulse inhibition but exacerbates the disruption of prepulse inhibition by apomorphine. Psychopharmacology (Berl) 2013;230:309-17. [PMID: 23736281 DOI: 10.1007/s00213-013-3160-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 476 |
da Silva Alves F, Bakker G, Schmitz N, Abeling N, Hasler G, van der Meer J, Nederveen A, de Haan L, Linszen D, van Amelsvoort T. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. Eur Neuropsychopharmacol 2013;23:1577-86. [PMID: 23978392 DOI: 10.1016/j.euroneuro.2013.06.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 477 |
Yoon JH, Sheremata SL, Rokem A, Silver MA. Windows to the soul: vision science as a tool for studying biological mechanisms of information processing deficits in schizophrenia. Front Psychol 2013;4:681. [PMID: 24198792 DOI: 10.3389/fpsyg.2013.00681] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 478 |
Maeda T, Takahata K, Muramatsu T, Okimura T, Koreki A, Iwashita S, Mimura M, Kato M. Reduced sense of agency in chronic schizophrenia with predominant negative symptoms. Psychiatry Res 2013;209:386-92. [PMID: 23680465 DOI: 10.1016/j.psychres.2013.04.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 479 |
Li BR, Hsieh YJ, Chen YX, Chung YT, Pan CY, Chen YT. An ultrasensitive nanowire-transistor biosensor for detecting dopamine release from living PC12 cells under hypoxic stimulation. J Am Chem Soc 2013;135:16034-7. [PMID: 24125072 DOI: 10.1021/ja408485m] [Cited by in Crossref: 172] [Cited by in F6Publishing: 178] [Article Influence: 17.2] [Reference Citation Analysis]
|
| 480 |
Howes OD, Williams M, Ibrahim K, Leung G, Egerton A, McGuire PK, Turkheimer F. Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study. Brain. 2013;136:3242-3251. [PMID: 24097339 DOI: 10.1093/brain/awt264] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 481 |
Hui CL, Wong GH, Tang JY, Chang WC, Chan SK, Lee EH, Lam MM, Chiu CP, Law CW, Chung DW, Tso S, Pang EP, Chan KT, Wong YC, Mo FY, Chan KP, Hung SF, Honer WG, Chen EY. Predicting 1-year risk for relapse in patients who have discontinued or continued quetiapine after remission from first-episode psychosis. Schizophr Res 2013;150:297-302. [PMID: 23993865 DOI: 10.1016/j.schres.2013.08.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 482 |
Sun H, Wang F, Fan H, Yan Q, Cui K, Yuan W, Zhao F, Zhao L, Yuan J, Yang F, Kosten TR, Zhang XY. The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients. PLoS One 2013;8:e70963. [PMID: 23951054 DOI: 10.1371/journal.pone.0070963] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 483 |
Jo YS, Lee J, Mizumori SJ. Effects of prefrontal cortical inactivation on neural activity in the ventral tegmental area. J Neurosci 2013;33:8159-71. [PMID: 23658156 DOI: 10.1523/JNEUROSCI.0118-13.2013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 55] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 484 |
Badawy A. Novel nutritional treatment for manic and psychotic disorders: a review of tryptophan and tyrosine depletion studies and the potential of protein-based formulations using glycomacropeptide. Psychopharmacology (Berl) 2013;228:347-58. [PMID: 23828158 DOI: 10.1007/s00213-013-3191-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 485 |
Mahanthesha K, Kumara Swamy B. Pretreated/Carbon paste electrode based voltammetric sensors for the detection of dopamine in presence of ascorbic acid and uric acid. Journal of Electroanalytical Chemistry 2013;703:1-8. [DOI: 10.1016/j.jelechem.2013.05.004] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 486 |
Ranjbar F, Ghanepour A, Sadeghi-Bazargani H, Asadlo M, Alizadeh A. The effect of ranitidine on olanzapine-induced weight gain. Biomed Res Int 2013;2013:639391. [PMID: 23984393 DOI: 10.1155/2013/639391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 487 |
Yu Z, Fang Q, Xiao X, Wang YZ, Cai YQ, Cao H, Hu G, Chen Z, Fei J, Gong N, Xu TL. GABA transporter-1 deficiency confers schizophrenia-like behavioral phenotypes. PLoS One 2013;8:e69883. [PMID: 23922840 DOI: 10.1371/journal.pone.0069883] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 488 |
Taly A. Novel approaches to drug design for the treatment of schizophrenia. Expert Opin Drug Discov 2013;8:1285-96. [PMID: 23865981 DOI: 10.1517/17460441.2013.821108] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 489 |
Kesby JP, Cui X, Burne TH, Eyles DW. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia. Front Cell Neurosci 2013;7:111. [PMID: 23882183 DOI: 10.3389/fncel.2013.00111] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 490 |
Niijima-Yaoita F, Tsuchiya M, Saito H, Nagasawa Y, Murai S, Arai Y, Nakagawasai O, Nemoto W, Tadano T, Tan-No K. Influence of a long-term powdered diet on the social interaction test and dopaminergic systems in mice. Neurochem Int 2013;63:309-15. [PMID: 23871718 DOI: 10.1016/j.neuint.2013.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 491 |
Laruelle M. The second revision of the dopamine theory of schizophrenia: implications for treatment and drug development. Biol Psychiatry 2013;74:80-1. [PMID: 23809260 DOI: 10.1016/j.biopsych.2013.05.016] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 492 |
Yoon JH, Minzenberg MJ, Raouf S, D'Esposito M, Carter CS. Impaired prefrontal-basal ganglia functional connectivity and substantia nigra hyperactivity in schizophrenia. Biol Psychiatry 2013;74:122-9. [PMID: 23290498 DOI: 10.1016/j.biopsych.2012.11.018] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 493 |
Wyss C, Hitz K, Hengartner MP, Theodoridou A, Obermann C, Uhl I, Roser P, Grünblatt E, Seifritz E, Juckel G, Kawohl W. The loudness dependence of auditory evoked potentials (LDAEP) as an indicator of serotonergic dysfunction in patients with predominant schizophrenic negative symptoms. PLoS One 2013;8:e68650. [PMID: 23874705 DOI: 10.1371/journal.pone.0068650] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 494 |
Zigelboim I, Weissberg A, Cohen Y. Target-Specific Ligands and Gadolinium-Based Complexes for Imaging of Dopamine Receptors: Synthesis, Binding Affinity, and Relaxivity. J Org Chem 2013;78:7001-12. [DOI: 10.1021/jo400646k] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 495 |
Hui L, Zhang X, Yu YQ, Han M, Huang XF, Chen DC, Wang ZR, Du WL, Kou CG, Yu Q, Kosten TR, Zhang XY. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients. Schizophr Res 2013;147:236-40. [PMID: 23707643 DOI: 10.1016/j.schres.2013.04.035] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 496 |
Li B, Chen C, Yang W, Lin T, Pan C, Chen Y. Biomolecular recognition with a sensitivity-enhanced nanowire transistor biosensor. Biosensors and Bioelectronics 2013;45:252-9. [DOI: 10.1016/j.bios.2013.02.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 497 |
Poels EM, Girgis RR, Thompson JL, Slifstein M, Abi-Dargham A. In vivo binding of the dopamine-1 receptor PET tracers [¹¹C]NNC112 and [¹¹C]SCH23390: a comparison study in individuals with schizophrenia. Psychopharmacology (Berl) 2013;228:167-74. [PMID: 23460265 DOI: 10.1007/s00213-013-3026-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 498 |
Peterburs J, Nitsch AM, Miltner WH, Straube T. Impaired Representation of Time in Schizophrenia Is Linked to Positive Symptoms and Cognitive Demand. PLoS One 2013;8:e67615. [PMID: 23826328 DOI: 10.1371/journal.pone.0067615] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 499 |
Hernaus D, Collip D, Lataster J, Ceccarini J, Kenis G, Booij L, Pruessner J, Van Laere K, van Winkel R, van Os J, Myin-Germeys I. COMT Val158Met genotype selectively alters prefrontal [18F]fallypride displacement and subjective feelings of stress in response to a psychosocial stress challenge. PLoS One 2013;8:e65662. [PMID: 23799032 DOI: 10.1371/journal.pone.0065662] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 500 |
Tikka SK, Nizamie SH, Das B, Katshu MZ, Goyal N. Increased spontaneous gamma power and synchrony in schizophrenia patients having higher minor physical anomalies. Psychiatry Res 2013;207:164-72. [PMID: 23051885 DOI: 10.1016/j.psychres.2012.09.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 501 |
Wentz CT, Oettl LL, Kelsch W. Optogenetics in psychiatric animal models. Cell Tissue Res 2013;354:61-8. [PMID: 23695972 DOI: 10.1007/s00441-013-1651-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 502 |
Rao NP, Remington G. Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials. Expert Opinion on Investigational Drugs 2013;22:881-94. [DOI: 10.1517/13543784.2013.795945] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 503 |
Kim E, Howes OD, Turkheimer FE, Kim BH, Jeong JM, Kim JW, Lee JS, Jang IJ, Shin SG, Kapur S, Kwon JS. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : A dual [(11)C]raclopride and [(18) F]FDG imaging study with aripiprazole. Psychopharmacology (Berl) 2013;227:221-9. [PMID: 23271192 DOI: 10.1007/s00213-012-2953-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 504 |
Zhou N, Yu Q, Li X, Yu Y, Kou C, Li W, Xu H, Luo X, Zuo L, Kosten TR, Zhang XY. Association of the dopamine β-hydroxylase 19 bp insertion/deletion polymorphism with positive symptoms but not tardive dyskinesia in schizophrenia. Hum Psychopharmacol 2013;28:230-7. [PMID: 23559427 DOI: 10.1002/hup.2311] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 505 |
Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Res 2013;206:158-65. [PMID: 23246245 DOI: 10.1016/j.psychres.2012.11.019] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 506 |
Hanami K, Nakano K, Saito K, Okada Y, Yamaoka K, Kubo S, Kondo M, Tanaka Y. Dopamine D2-like receptor signaling suppresses human osteoclastogenesis. Bone 2013;56:1-8. [PMID: 23631878 DOI: 10.1016/j.bone.2013.04.019] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 507 |
Gromann PM, Heslenfeld DJ, Fett A, Joyce DW, Shergill SS, Krabbendam L. Trust versus paranoia: abnormal response to social reward in psychotic illness. Brain 2013;136:1968-75. [DOI: 10.1093/brain/awt076] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 508 |
Cole DM, Beckmann CF, Oei NY, Both S, van Gerven JM, Rombouts SA. Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity. Neuroimage 2013;78:59-67. [PMID: 23603346 DOI: 10.1016/j.neuroimage.2013.04.034] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 509 |
Robol V, Tibber MS, Anderson EJ, Bobin T, Carlin P, Shergill SS, Dakin SC. Reduced crowding and poor contour detection in schizophrenia are consistent with weak surround inhibition. PLoS One 2013;8:e60951. [PMID: 23585865 DOI: 10.1371/journal.pone.0060951] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 510 |
Lowe JA. CNS Drugs. Drug Discovery 2013. [DOI: 10.1002/9781118354483.ch7] [Reference Citation Analysis]
|
| 511 |
Levitt JJ, Rosow LK, Nestor PG, Pelavin PE, Swisher TM, McCarley RW, Shenton ME. A volumetric MRI study of limbic, associative and sensorimotor striatal subregions in schizophrenia. Schizophr Res 2013;145:11-9. [PMID: 23380548 DOI: 10.1016/j.schres.2012.08.032] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 512 |
Bupesh M, Vicario A, Abellán A, Desfilis E, Medina L. Dynamic expression of tyrosine hydroxylase mRNA and protein in neurons of the striatum and amygdala of mice, and experimental evidence of their multiple embryonic origin. Brain Struct Funct 2014;219:751-76. [PMID: 23479178 DOI: 10.1007/s00429-013-0533-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 513 |
Oyagi A, Hara H. Essential roles of heparin-binding epidermal growth factor-like growth factor in the brain. CNS Neurosci Ther 2012;18:803-10. [PMID: 23006514 DOI: 10.1111/j.1755-5949.2012.00371.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 514 |
Zheng Y, Huang Z, Zhao C, Weng S, Zheng W, Lin X. A gold electrode with a flower-like gold nanostructure for simultaneous determination of dopamine and ascorbic acid. Microchim Acta 2013;180:537-44. [DOI: 10.1007/s00604-013-0964-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 515 |
Sun H, Zhu L, Yang H, Qian W, Guo L, Zhou S, Gao B, Li Z, Zhou Y, Jiang H, Chen K, Zhen X, Liu H. Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D1, D2 and serotonin 5-HT1A multi-action profile. Bioorganic & Medicinal Chemistry 2013;21:856-68. [DOI: 10.1016/j.bmc.2012.12.016] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 516 |
Stachowiak MK, Kucinski A, Curl R, Syposs C, Yang Y, Narla S, Terranova C, Prokop D, Klejbor I, Bencherif M, Birkaya B, Corso T, Parikh A, Tzanakakis ES, Wersinger S, Stachowiak EK. Schizophrenia: a neurodevelopmental disorder--integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr Res 2013;143:367-76. [PMID: 23231877 DOI: 10.1016/j.schres.2012.11.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 517 |
Assessment and treatment of cognitive impairment and related features. Cognitive Impairment in Schizophrenia 2013. [DOI: 10.1017/cbo9781139003872.014] [Reference Citation Analysis]
|
| 518 |
Harvey PD. Pharmacological approaches to cognitive enhancement. Cognitive Impairment in Schizophrenia 2013. [DOI: 10.1017/cbo9781139003872.016] [Reference Citation Analysis]
|
| 519 |
Gross G, Drescher K. The role of dopamine D(3) receptors in antipsychotic activity and cognitive functions. Handb Exp Pharmacol 2012;:167-210. [PMID: 23027416 DOI: 10.1007/978-3-642-25758-2_7] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 520 |
Novak G, Fan T, O'dowd BF, George SR. Postnatal maternal deprivation and pubertal stress have additive effects on dopamine D2 receptor and CaMKII beta expression in the striatum. Int j dev neurosci 2013;31:189-95. [DOI: 10.1016/j.ijdevneu.2013.01.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 521 |
Rademacher L, Spreckelmeyer K. Lernen und Belohnungssystem. Funktionelle MRT in Psychiatrie und Neurologie 2013. [DOI: 10.1007/978-3-642-29800-4_25] [Reference Citation Analysis]
|
| 522 |
Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, Part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull 2013;39:22-32. [PMID: 22282456 DOI: 10.1093/schbul/sbr111] [Cited by in Crossref: 77] [Cited by in F6Publishing: 87] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 523 |
Bennett M. Brain Networks, Hormones and Genes Implicated in Depression. Virginia Woolf and Neuropsychiatry 2013. [DOI: 10.1007/978-94-007-5748-6_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 524 |
Uchida H, Kapur S. Aminergic Hypothesis for Schizophrenia. Encyclopedia of Psychopharmacology 2013. [DOI: 10.1007/978-3-642-27772-6_241-2] [Reference Citation Analysis]
|
| 525 |
Power BD, Dragovic M, Jablensky A, Stefanis NC. Does accumulating exposure to illicit drugs bring forward the age at onset in schizophrenia? Aust N Z J Psychiatry 2013;47:51-8. [PMID: 23042939 DOI: 10.1177/0004867412461957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 526 |
Bonoldi I, Howes O. The Enduring Centrality of Dopamine in the Pathophysiology of Schizophrenia. A New Era of Catecholamines in the Laboratory and Clinic 2013. [DOI: 10.1016/b978-0-12-411512-5.00010-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 527 |
Thakurathi N, Vincenzi B, Henderson DC. Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia. Expert Opin Investig Drugs 2013;22:259-65. [PMID: 23215841 DOI: 10.1517/13543784.2013.750650] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 528 |
Nunes EA, MacKenzie EM, Rossolatos D, Perez-Parada J, Baker GB, Dursun SM. D-serine and schizophrenia: an update. Expert Rev Neurother 2012;12:801-12. [PMID: 22853788 DOI: 10.1586/ern.12.65] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 529 |
Miyamoto S, Miyake N, Jarskog LF, Fleischhacker WW, Lieberman JA. Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents. Mol Psychiatry 2012;17:1206-27. [PMID: 22584864 DOI: 10.1038/mp.2012.47] [Cited by in Crossref: 401] [Cited by in F6Publishing: 412] [Article Influence: 36.5] [Reference Citation Analysis]
|
| 530 |
Maria K, Charalampos T, Vassilakopoulou D, Stavroula S, Vasiliki K, Nikolaos D. Frequency Distribution of COMT Polymorphisms in Greek Patients with Schizophrenia and Controls: A Study of SNPs rs737865, rs4680, and rs165599. ISRN Psychiatry 2012;2012:651613. [PMID: 23762769 DOI: 10.5402/2012/651613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 531 |
Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012;69:776-786. [PMID: 22474070 DOI: 10.1001/archgenpsychiatry.2012.169] [Cited by in Crossref: 619] [Cited by in F6Publishing: 675] [Article Influence: 56.3] [Reference Citation Analysis]
|
| 532 |
Hsu M, Chen Y, Lee C, Chiu H. Gold Nanostructures on Flexible Substrates as Electrochemical Dopamine Sensors. ACS Appl Mater Interfaces 2012;4:5570-5. [DOI: 10.1021/am301452b] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 9.9] [Reference Citation Analysis]
|
| 533 |
Hills TT. Animal foraging and the evolution of goal-directed cognition. Cogn Sci 2006;30:3-41. [PMID: 21702807 DOI: 10.1207/s15516709cog0000_50] [Cited by in Crossref: 150] [Cited by in F6Publishing: 204] [Article Influence: 13.6] [Reference Citation Analysis]
|
| 534 |
Ginovart N, Tournier BB, Moulin-Sallanon M, Steimer T, Ibanez V, Millet P. Chronic Δ⁹-tetrahydrocannabinol exposure induces a sensitization of dopamine D₂/₃ receptors in the mesoaccumbens and nigrostriatal systems. Neuropsychopharmacology 2012;37:2355-67. [PMID: 22692568 DOI: 10.1038/npp.2012.91] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 535 |
Koshimizu T, Nakamura K, Egashira N, Hiroyama M, Nonoguchi H, Tanoue A. Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems. Physiological Reviews 2012;92:1813-64. [DOI: 10.1152/physrev.00035.2011] [Cited by in Crossref: 237] [Cited by in F6Publishing: 250] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 536 |
Sokoloff P, Leriche L, Diaz J, Louvel J, Pumain R. Direct and indirect interactions of the dopamine D₃ receptor with glutamate pathways: implications for the treatment of schizophrenia. Naunyn Schmiedebergs Arch Pharmacol 2013;386:107-24. [PMID: 23001156 DOI: 10.1007/s00210-012-0797-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 537 |
Zierhut KC, Schulte-Kemna A, Kaufmann J, Steiner J, Bogerts B, Schiltz K. Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex 2013;49:1063-72. [PMID: 23040316 DOI: 10.1016/j.cortex.2012.08.027] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 538 |
Mackowick KM, Heishman SJ, Wehring HJ, Liu F, McMahon RP, Kelly DL. Illicit drug use in heavy smokers with and without schizophrenia. Schizophr Res 2012;139:194-200. [PMID: 22591779 DOI: 10.1016/j.schres.2012.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 539 |
Sotoing Taïwe G, Ngo Bum E, Talla E, Dawe A, Okomolo Moto FC, Temkou Ngoupaye G, Sidiki N, Dabole B, Djomeni Dzeufiet PD, Dimo T, De Waard M. Antipsychotic and sedative effects of the leaf extract of Crassocephalum bauchiense (Hutch.) Milne-Redh (Asteraceae) in rodents. Journal of Ethnopharmacology 2012;143:213-20. [DOI: 10.1016/j.jep.2012.06.026] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 540 |
Qian W, Lu W, Sun H, Li Z, Zhu L, Zhao R, Zhang L, Zhou S, Zhou Y, Jiang H, Zhen X, Liu H. Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: Selective inhibitors of dopamine D1 receptor. Bioorganic & Medicinal Chemistry 2012;20:4862-71. [DOI: 10.1016/j.bmc.2012.05.057] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 541 |
Laplante F, Zhang ZW, Huppé-Gourgues F, Dufresne MM, Vaucher E, Sullivan RM. Cholinergic depletion in nucleus accumbens impairs mesocortical dopamine activation and cognitive function in rats. Neuropharmacology 2012;63:1075-84. [PMID: 22842071 DOI: 10.1016/j.neuropharm.2012.07.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 542 |
Rattanarat P, Dungchai W, Siangproh W, Chailapakul O, Henry CS. Sodium dodecyl sulfate-modified electrochemical paper-based analytical device for determination of dopamine levels in biological samples. Anal Chim Acta 2012;744:1-7. [PMID: 22935367 DOI: 10.1016/j.aca.2012.07.003] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 543 |
Sendt KV, Giaroli G, Tracy DK. Beyond dopamine: glutamate as a target for future antipsychotics. ISRN Pharmacol 2012;2012:427267. [PMID: 22830044 DOI: 10.5402/2012/427267] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 544 |
Orliac F, Delamillieure P. Imagerie cérébrale en psychiatrie : indications et résultats. EMC - Psychiatrie 2012;9:1-11. [DOI: 10.1016/s0246-1072(12)60525-2] [Reference Citation Analysis]
|
| 545 |
Aguilar-Valles A, Jung S, Poole S, Flores C, Luheshi GN. Leptin and interleukin-6 alter the function of mesolimbic dopamine neurons in a rodent model of prenatal inflammation. Psychoneuroendocrinology 2012;37:956-69. [PMID: 22133515 DOI: 10.1016/j.psyneuen.2011.11.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 546 |
Jucaite A, Nyberg S. Dopaminergic Hypothesis of Schizophrenia: A Historical Perspective. Targets and Emerging Therapies for Schizophrenia 2012. [DOI: 10.1002/9781118309421.ch1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 547 |
Balu DT, Goff DC. Schizophrenia. Translational Neuroscience 2012. [DOI: 10.1017/cbo9780511980053.005] [Reference Citation Analysis]
|
| 548 |
Kwon S, Kim D, Park H, Yoo D, Park HJ, Hahm DH, Lee H, Kim ST. Prefrontal-limbic change in dopamine turnover by acupuncture in maternally separated rat pups. Neurochem Res 2012;37:2092-8. [PMID: 22714092 DOI: 10.1007/s11064-012-0830-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 549 |
Li YC, Wang MJ, Gao WJ. Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors. J Neurochem 2012;122:308-20. [PMID: 22676038 DOI: 10.1111/j.1471-4159.2012.07790.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 550 |
Sil’kis IG. Possible mechanisms for the effects of neuromodulators on the perception of time intervals. Neurochem J 2012;6:144-52. [DOI: 10.1134/s1819712412020109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 551 |
Behan AT, Hryniewiecka M, O'Tuathaigh CM, Kinsella A, Cannon M, Karayiorgou M, Gogos JA, Waddington JL, Cotter DR. Chronic adolescent exposure to delta-9-tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology 2012;37:1773-83. [PMID: 22434221 DOI: 10.1038/npp.2012.24] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 552 |
Tsou JY. Intervention, causal reasoning, and the neurobiology of mental disorders: Pharmacological drugs as experimental instruments. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 2012;43:542-51. [DOI: 10.1016/j.shpsc.2012.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 553 |
Ward RD, Simpson EH, Richards VL, Deo G, Taylor K, Glendinning JI, Kandel ER, Balsam PD. Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia. Neuropsychopharmacology 2012;37:1699-707. [PMID: 22414818 DOI: 10.1038/npp.2012.15] [Cited by in Crossref: 73] [Cited by in F6Publishing: 113] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 554 |
Hui L, Zhang X, Huang XF, Han M, Fernandez F, Yu Y, Sun S, Li W, Chen DC, Xiu MH, Kosten TR, Zhang XY. The dopamine b-hydroxylase 19 bp insertion/deletion polymorphism was associated with first-episode but not medicated chronic schizophrenia. J Psychiatr Res 2012;46:733-7. [PMID: 22445279 DOI: 10.1016/j.jpsychires.2012.02.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 555 |
Yasui-Furukori N. Update on the development of lurasidone as a treatment for patients with acute schizophrenia. Drug Des Devel Ther 2012;6:107-15. [PMID: 22675261 DOI: 10.2147/DDDT.S11180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 556 |
Zhang XY, Chen DC, Xiu MH, Haile CN, Sun H, Lu L, Kosten TA, Kosten TR. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study. PLoS One 2012;7:e36563. [PMID: 22570726 DOI: 10.1371/journal.pone.0036563] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 557 |
Sharma AN, Elased KM, Lucot JB. Rosiglitazone treatment reversed depression- but not psychosis-like behavior of db/db diabetic mice. J Psychopharmacol 2012;26:724-32. [PMID: 22331176 DOI: 10.1177/0269881111434620] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 558 |
Nazimek JM, Hunter MD, Woodruff PW. Auditory hallucinations: expectation-perception model. Med Hypotheses 2012;78:802-10. [PMID: 22520337 DOI: 10.1016/j.mehy.2012.03.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 559 |
Bali A, Reddy ACDK. Synthesis and evaluation of meta substituted 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics. Med Chem Res 2013;22:382-91. [DOI: 10.1007/s00044-012-0038-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 560 |
Fawzi MH, Fawzi MM. Disordered eating attitudes in Egyptian antipsychotic naive patients with schizophrenia. Compr Psychiatry 2012;53:259-68. [PMID: 21640339 DOI: 10.1016/j.comppsych.2011.04.064] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 561 |
Lyon L, Saksida LM, Bussey TJ. Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models. Psychopharmacology (Berl) 2012;220:647-72. [PMID: 22068459 DOI: 10.1007/s00213-011-2536-5] [Cited by in Crossref: 85] [Cited by in F6Publishing: 85] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 562 |
Korth C. Aggregated proteins in schizophrenia and other chronic mental diseases: DISC1opathies. Prion 2012;6:134-41. [PMID: 22421208 DOI: 10.4161/pri.18989] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 563 |
Chen KC, Lee IH, Yeh TL, Chiu NT, Chen PS, Yang YK, Lu RB, Chen CC. Schizotypy trait and striatal dopamine receptors in healthy volunteers. Psychiatry Res 2012;201:218-21. [PMID: 22429746 DOI: 10.1016/j.pscychresns.2011.07.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 564 |
Gold JM, Waltz JA, Matveeva TM, Kasanova Z, Strauss GP, Herbener ES, Collins AG, Frank MJ. Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence. Arch Gen Psychiatry 2012;69:129-38. [PMID: 22310503 DOI: 10.1001/archgenpsychiatry.2011.1269] [Cited by in Crossref: 207] [Cited by in F6Publishing: 234] [Article Influence: 18.8] [Reference Citation Analysis]
|
| 565 |
Frånberg O, Marcus MM, Svensson TH. Involvement of 5-HT2A receptor and α2-adrenoceptor blockade in the asenapine-induced elevation of prefrontal cortical monoamine outflow. Synapse 2012;66:650-60. [DOI: 10.1002/syn.21551] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 566 |
D'Souza DC, Esterlis I, Carbuto M, Krasenics M, Seibyl J, Bois F, Pittman B, Ranganathan M, Cosgrove K, Staley J. Lower ß2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia. Am J Psychiatry 2012;169:326-34. [PMID: 22193533 DOI: 10.1176/appi.ajp.2011.11020189] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 567 |
Xiao J, Kannan G, Jones-brando L, Brannock C, Krasnova I, Cadet J, Pletnikov M, Yolken R. Sex-specific changes in gene expression and behavior induced by chronic Toxoplasma infection in mice. Neuroscience 2012;206:39-48. [DOI: 10.1016/j.neuroscience.2011.12.051] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 568 |
Riemer C. Antipsychotics. Polypharmacology in Drug Discovery 2012. [DOI: 10.1002/9781118098141.ch17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 569 |
Robinson RG, Smith SM, Wolkenberg SE, Kandebo M, Yao L, Gibson CR, Harrison ST, Polsky-Fisher S, Barrow JC, Manley PJ, Mulhearn JJ, Nanda KK, Schubert JW, Trotter BW, Zhao Z, Sanders JM, Smith RF, McLoughlin D, Sharma S, Hall DL, Walker TL, Kershner JL, Bhandari N, Hutson PH, Sachs NA. Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substrates. ACS Chem Neurosci 2012;3:129-40. [PMID: 22860182 DOI: 10.1021/cn200109w] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 570 |
Essali A, Ali G. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database Syst Rev 2012;:CD004162. [PMID: 22336800 DOI: 10.1002/14651858.CD004162.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 571 |
Khomane KS, Meena CL, Jain R, Bansal AK. Novel thyrotropin-releasing hormone analogs: a patent review. Expert Opin Ther Pat 2011;21:1673-91. [PMID: 22017410 DOI: 10.1517/13543776.2011.623127] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 572 |
Vauquelin G, Bostoen S, Vanderheyden P, Seeman P. Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism. Naunyn Schmiedebergs Arch Pharmacol. 2012;385:337-372. [PMID: 22331262 DOI: 10.1007/s00210-012-0734-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 573 |
Zhang XY, Liang J, Chen da C, Xiu MH, He J, Cheng W, Wu Z, Yang FD, Haile CN, Sun H. Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes. PLoS One. 2012;7:e30937. [PMID: 22347412 DOI: 10.1371/journal.pone.0030937] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 574 |
Eyles D, Feldon J, Meyer U. Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models. Transl Psychiatry 2012;2:e81. [PMID: 22832818 DOI: 10.1038/tp.2012.6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 575 |
Wu Z, Zhang XY, Wang H, Tang W, Xia Y, Zhang F, Liu J, Fu Y, Hu J, Chen Y, Liu L, Chen DC, Xiu MH, Kosten TR, He J. Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms. Prog Neuropsychopharmacol Biol Psychiatry 2012;36:34-8. [PMID: 21896300 DOI: 10.1016/j.pnpbp.2011.08.018] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 576 |
Koob GF. Animal models of psychiatric disorders. Handb Clin Neurol 2012;106:137-66. [PMID: 22608620 DOI: 10.1016/B978-0-444-52002-9.00009-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 577 |
McKinzie DL, Bymaster FP. Muscarinic mechanisms in psychotic disorders. Handb Exp Pharmacol 2012;:233-65. [PMID: 23027418 DOI: 10.1007/978-3-642-25758-2_9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 578 |
Ginovart N, Kapur S. Role of Dopamine D2 Receptors for Antipsychotic Activity. Current Antipsychotics 2012. [DOI: 10.1007/978-3-642-25761-2_2] [Cited by in Crossref: 86] [Cited by in F6Publishing: 91] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 579 |
Harvey PD. Cognitive impairment in schizophrenia: profile, course, and neurobiological determinants. Handb Clin Neurol 2012;106:433-45. [PMID: 22608636 DOI: 10.1016/B978-0-444-52002-9.00025-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 580 |
Shimizu E, Matsuzawa D. Midkine in Psychiatric and Neurodegenerative Diseases. Midkine: From Embryogenesis to Pathogenesis and Therapy 2012. [DOI: 10.1007/978-94-007-4234-5_14] [Reference Citation Analysis]
|
| 581 |
Kuepper R, Skinbjerg M, Abi-Dargham A. The dopamine dysfunction in schizophrenia revisited: new insights into topography and course. Handb Exp Pharmacol 2012;:1-26. [PMID: 23129326 DOI: 10.1007/978-3-642-25761-2_1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 582 |
Laplante F, Brake WG, Chehab SL, Sullivan RM. Sex differences in the effects of perinatal anoxia on dopamine function in rats. Neuroscience Letters 2012;506:89-93. [DOI: 10.1016/j.neulet.2011.10.055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 583 |
Dutra SJ, Stoeckel LE, Carlini SV, Pizzagalli DA, Evins AE. Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity. Psychopharmacology (Berl) 2012;219:25-34. [PMID: 21695488 DOI: 10.1007/s00213-011-2373-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 584 |
Konings M, Stefanis N, Kuepper R, de Graaf R, ten Have M, van Os J, Bakoula C, Henquet C. Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk. Psychol Med 2012;42:149-59. [PMID: 21676285 DOI: 10.1017/S0033291711000973] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 585 |
Brown RW, Maple AM, Perna MK, Sheppard AB, Cope ZA, Kostrzewa RM. Schizophrenia and Substance Abuse Comorbidity: Nicotine Addiction and the Neonatal Quinpirole Model. Dev Neurosci 2012;34:140-51. [DOI: 10.1159/000338830] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 586 |
Kao YC, Liu YP, Cheng TH, Chou MK. Cigarette smoking in outpatients with chronic schizophrenia in Taiwan: relationships to socio-demographic and clinical characteristics. Psychiatry Res 2011;190:193-9. [PMID: 21621853 DOI: 10.1016/j.psychres.2011.05.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 587 |
Zandbelt BB, van Buuren M, Kahn RS, Vink M. Reduced proactive inhibition in schizophrenia is related to corticostriatal dysfunction and poor working memory. Biol Psychiatry 2011;70:1151-8. [PMID: 21903198 DOI: 10.1016/j.biopsych.2011.07.028] [Cited by in Crossref: 103] [Cited by in F6Publishing: 107] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 588 |
Marcus MM, Jardemark K, Malmerfelt A, Gertow J, Konradsson-geuken Å, Svensson TH. Augmentation by escitalopram, but not citalopram or R-citalopram, of the effects of low-dose risperidone: Behavioral, biochemical, and electrophysiological evidence. Synapse 2012;66:277-90. [DOI: 10.1002/syn.21510] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 589 |
Remington G, Agid O, Foussias G. Schizophrenia as a disorder of too little dopamine: implications for symptoms and treatment. Expert Rev Neurother 2011;11:589-607. [PMID: 21469931 DOI: 10.1586/ern.10.191] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 590 |
Gruber SH, Angelucci F, Nomikos GG, Mathé AA. Effects of olanzapine on extracellular concentrations and tissue content of neurotensin in rat brain regions. Eur Neuropsychopharmacol 2011;21:918-27. [PMID: 21316929 DOI: 10.1016/j.euroneuro.2011.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 591 |
Sestito RS, Trindade LB, de Souza RG, Kerbauy LN, Iyomasa MM, Rosa ML. Effect of isolation rearing on the expression of AMPA glutamate receptors in the hippocampal formation. J Psychopharmacol 2011;25:1720-9. [PMID: 20952455 DOI: 10.1177/0269881110385595] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 592 |
Howes OD, Bose SK, Turkheimer F, Valli I, Egerton A, Valmaggia LR, Murray RM, McGuire P. Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study. Am J Psychiatry 2011;168:1311-7. [PMID: 21768612 DOI: 10.1176/appi.ajp.2011.11010160] [Cited by in Crossref: 261] [Cited by in F6Publishing: 266] [Article Influence: 21.8] [Reference Citation Analysis]
|
| 593 |
Santini E, Klann E. Dysregulated mTORC1-Dependent Translational Control: From Brain Disorders to Psychoactive Drugs. Front Behav Neurosci 2011;5:76. [PMID: 22073033 DOI: 10.3389/fnbeh.2011.00076] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 594 |
Clifford J, Rowland J. The potential role of oestrogens in relapse of recurrent affective psychosis. JRSM Short Rep 2011;2:82. [PMID: 22046501 DOI: 10.1258/shorts.2011.011122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 595 |
Colzato LS, Slagter HA, de Rover M, Hommel B. Dopamine and the Management of Attentional Resources: Genetic Markers of Striatal D2 Dopamine Predict Individual Differences in the Attentional Blink. Journal of Cognitive Neuroscience 2011;23:3576-85. [DOI: 10.1162/jocn_a_00049] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 596 |
Mané A, Gallego J, Lomeña F, Mateos JJ, Fernandez-Egea E, Horga G, Cot A, Pavia J, Bernardo M, Parellada E. A 4-year dopamine transporter (DAT) imaging study in neuroleptic-naive first episode schizophrenia patients. Psychiatry Res 2011;194:79-84. [PMID: 21831607 DOI: 10.1016/j.pscychresns.2011.03.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 597 |
Morris SE, Holroyd CB, Mann-Wrobel MC, Gold JM. Dissociation of response and feedback negativity in schizophrenia: electrophysiological and computational evidence for a deficit in the representation of value. Front Hum Neurosci 2011;5:123. [PMID: 22065618 DOI: 10.3389/fnhum.2011.00123] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 598 |
Phan SV, Kreys TM. Adjunct Mirtazapine for Negative Symptoms of Schizophrenia. Pharmacotherapy 2011;31:1017-30. [DOI: 10.1592/phco.31.10.1017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 599 |
Sun Y, Farzan F, Barr MS, Kirihara K, Fitzgerald PB, Light GA, Daskalakis ZJ. Gamma oscillations in schizophrenia: Mechanisms and clinical significance. Brain Research 2011;1413:98-114. [DOI: 10.1016/j.brainres.2011.06.065] [Cited by in Crossref: 73] [Cited by in F6Publishing: 78] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 600 |
Koychev I, Barkus E, Ettinger U, Killcross S, Roiser JP, Wilkinson L, Deakin B. Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. J Psychopharmacol 2011;25:1207-25. [PMID: 21994315 DOI: 10.1177/0269881111414450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 601 |
Gong R, Ding C, Hu J, Lu Y, Liu F, Mann E, Xu F, Cohen MB, Luo M. Role for the membrane receptor guanylyl cyclase-C in attention deficiency and hyperactive behavior. Science 2011;333:1642-6. [PMID: 21835979 DOI: 10.1126/science.1207675] [Cited by in Crossref: 79] [Cited by in F6Publishing: 85] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 602 |
Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A. Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry 2011;11:124. [PMID: 21810251 DOI: 10.1186/1471-244X-11-124] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 603 |
Lataster J, Collip D, Ceccarini J, Haas D, Booij L, van Os J, Pruessner J, Van Laere K, Myin-Germeys I. Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: a positron emission tomography study using [¹⁸F]fallypride. Neuroimage 2011;58:1081-9. [PMID: 21801840 DOI: 10.1016/j.neuroimage.2011.07.030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 604 |
Li YC, Kellendonk C, Simpson EH, Kandel ER, Gao WJ. D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 2011;108:12107-12. [PMID: 21730148 DOI: 10.1073/pnas.1109718108] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 605 |
Evans S, Shergill SS, Chouhan V, Bristow E, Collier T, Averbeck BB. Patients with schizophrenia show increased aversion to angry faces in an associative learning task. Psychol Med 2011;41:1471-9. [PMID: 20961475 DOI: 10.1017/S0033291710001960] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 606 |
Xu H, Yang HJ, Rose GM, Li XM. Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs. Front Behav Neurosci 2011;5:31. [PMID: 21747763 DOI: 10.3389/fnbeh.2011.00031] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 607 |
Sonibare MA, Umukoro S, Shonibare ET. Antipsychotic property of aqueous and ethanolic extracts of Lonchocarpus cyanescens (Schumach and Thonn.) Benth. (Fabaceae) in rodents. J Nat Med 2012;66:127-32. [DOI: 10.1007/s11418-011-0562-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 608 |
Aguilar-Valles A, Luheshi GN. Alterations in cognitive function and behavioral response to amphetamine induced by prenatal inflammation are dependent on the stage of pregnancy. Psychoneuroendocrinology 2011;36:634-48. [PMID: 20934257 DOI: 10.1016/j.psyneuen.2010.09.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 609 |
Preti A, Wilson DR. Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis. Psychiatry Investig 2011;8:77-88. [PMID: 21852982 DOI: 10.4306/pi.2011.8.2.77] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 610 |
Surguladze SA, Chu EM, Marshall N, Evans A, Anilkumar AP, Timehin C, McDonald C, Ecker C, Phillips ML, David AS. Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication. J Psychopharmacol 2011;25:722-33. [PMID: 20360158 DOI: 10.1177/0269881110363316] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 611 |
Takahashi N, Sakurai T, Bozdagi-Gunal O, Dorr NP, Moy J, Krug L, Gama-Sosa M, Elder GA, Koch RJ, Walker RH, Hof PR, Davis KL, Buxbaum JD. Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Transl Psychiatry 2011;1:e8. [PMID: 22832403 DOI: 10.1038/tp.2011.8] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 612 |
Ward RD, Kellendonk C, Kandel ER, Balsam PD. Timing as a window on cognition in schizophrenia. Neuropharmacology 2012;62:1175-81. [PMID: 21530549 DOI: 10.1016/j.neuropharm.2011.04.014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 613 |
Llewellyn S. If waking and dreaming consciousness became de-differentiated, would schizophrenia result? Conscious Cogn 2011;20:1059-83. [PMID: 21498086 DOI: 10.1016/j.concog.2011.03.022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 614 |
Falkai P, Schmitt A, Cannon TD. Pathophysiology of Schizophrenia. Schizophrenia 2011. [DOI: 10.1002/9780470978672.ch2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 615 |
Kent BW, Weinstein ZA, Passarelli V, Chen Y, Siever LJ. Deficient visual sensitivity in schizotypal personality disorder. Schizophr Res 2011;127:144-50. [PMID: 20541911 DOI: 10.1016/j.schres.2010.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 616 |
Lin CH, Lane HY, Tsai GE. Glutamate signaling in the pathophysiology and therapy of schizophrenia. Pharmacol Biochem Behav 2012;100:665-77. [PMID: 21463651 DOI: 10.1016/j.pbb.2011.03.023] [Cited by in Crossref: 102] [Cited by in F6Publishing: 113] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 617 |
Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, Li R, Doop M, Kessler RM, Zald DH. Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. Am J Psychiatry 2011;168:418-26. [PMID: 21159728 DOI: 10.1176/appi.ajp.2010.10020165] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 618 |
Li JH, Vicknasingam B, Cheung YW, Zhou W, Nurhidayat AW, Jarlais DC, Schottenfeld R. To use or not to use: an update on licit and illicit ketamine use. Subst Abuse Rehabil 2011;2:11-20. [PMID: 24474851 DOI: 10.2147/SAR.S15458] [Cited by in Crossref: 88] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 619 |
Abi-dargham A, Grace AA. Dopamine and Schizophrenia. Schizophrenia 2011. [DOI: 10.1002/9781444327298.ch20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 620 |
Lipska BK, Gogos JA. Animal Models of Schizophrenia. Schizophrenia 2011. [DOI: 10.1002/9781444327298.ch22] [Reference Citation Analysis]
|
| 621 |
Waddington JL, O'tuathaigh CMP, Remington GJ. Pharmacology and Neuroscience of Antipsychotic Drugs. Schizophrenia 2011. [DOI: 10.1002/9781444327298.ch23] [Reference Citation Analysis]
|
| 622 |
Chemerinski E, Siever LJ. The Schizophrenia Spectrum Personality Disorders. Schizophrenia 2011. [DOI: 10.1002/9781444327298.ch5] [Reference Citation Analysis]
|
| 623 |
Bannai M, Kawai N, Nagao K, Nakano S, Matsuzawa D, Shimizu E. Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats. Psychiatry Clin Neurosci 2011;65:142-9. [PMID: 21414089 DOI: 10.1111/j.1440-1819.2010.02181.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 624 |
Bennett MR. The prefrontal-limbic network in depression: Modulation by hypothalamus, basal ganglia and midbrain. Prog Neurobiol 2011;93:468-87. [PMID: 21349315 DOI: 10.1016/j.pneurobio.2011.01.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 625 |
Ward RD, Simpson EH, Kandel ER, Balsam PD. Modeling motivational deficits in mouse models of schizophrenia: behavior analysis as a guide for neuroscience. Behav Processes 2011;87:149-56. [PMID: 21338658 DOI: 10.1016/j.beproc.2011.02.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 626 |
Aladeokin AC, Umukoro S. Psychopharmacological properties of an aqueous extract of Tetracarpidium conophorum Hutch. & Dalziel in mice. J Nat Med 2011;65:411-6. [PMID: 21327522 DOI: 10.1007/s11418-011-0506-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 627 |
Hanzawa R, Ohnuma T, Nagai Y, Shibata N, Maeshima H, Baba H, Hatano T, Takebayashi Y, Hotta Y, Kitazawa M, Arai H. No association between glutathione-synthesis-related genes and Japanese schizophrenia. Psychiatry Clin Neurosci 2011;65:39-46. [PMID: 21105962 DOI: 10.1111/j.1440-1819.2010.02157.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 628 |
Meltzer HY, Horiguchi M, Massey BW. The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment. Psychopharmacology (Berl) 2011;213:289-305. [PMID: 21212939 DOI: 10.1007/s00213-010-2137-8] [Cited by in Crossref: 90] [Cited by in F6Publishing: 97] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 629 |
Nakazawa K, Zsiros V, Jiang Z, Nakao K, Kolata S, Zhang S, Belforte JE. GABAergic interneuron origin of schizophrenia pathophysiology. Neuropharmacology 2012;62:1574-83. [PMID: 21277876 DOI: 10.1016/j.neuropharm.2011.01.022] [Cited by in Crossref: 329] [Cited by in F6Publishing: 360] [Article Influence: 27.4] [Reference Citation Analysis]
|
| 630 |
Chen CY, Lu RB, Yeh YW, Shih MC, Huang SY. Association study of catechol-O-methyltransferase gene polymorphisms with schizophrenia and psychopathological symptoms in Han Chinese. Genes Brain Behav 2011;10:316-24. [PMID: 21255265 DOI: 10.1111/j.1601-183X.2010.00670.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 631 |
Darvesh AS, Carroll RT, Geldenhuys WJ, Gudelsky GA, Klein J, Meshul CK, Van der Schyf CJ. In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery. Expert Opin Drug Discov 2011;6:109-27. [PMID: 21532928 DOI: 10.1517/17460441.2011.547189] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 632 |
Baker GB, Hallak JE, Dilullo AF, Burback L, Dursun SM. Amino Acids in Schizophrenia – Glycine, Serine and Arginine. Handbook of Schizophrenia Spectrum Disorders, Volume I 2011. [DOI: 10.1007/978-94-007-0837-2_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 633 |
Remschmidt H, Theisen FM. Was erklärbar ist: Ätiologie und Entwicklungspsychopathologie. Schizophrenie 2011. [DOI: 10.1007/978-3-540-36273-9_3] [Reference Citation Analysis]
|
| 634 |
Möller H, Schaub A, Riedel M. Schizophrene Psychosen. Psychiatrie, Psychosomatik, Psychotherapie 2011. [DOI: 10.1007/978-3-642-03637-8_52] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 635 |
Pitts MW, Raman AV, Berry MJ. Schizophrenia, Oxidative Stress and Selenium. Selenium 2011. [DOI: 10.1007/978-1-4614-1025-6_28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 636 |
Foussias G, Agid O, Remington G. Negative Symptoms Across the Schizophrenia Spectrum: Phenomenological and Neurobiological Perspectives. Handbook of Schizophrenia Spectrum Disorders, Volume II 2011. [DOI: 10.1007/978-94-007-0831-0_1] [Reference Citation Analysis]
|
| 637 |
Di Giovanni G, Esposito E, Di Matteo V. The 5-HT2C Receptor Subtype Controls Central Dopaminergic Systems: Evidence from Electrophysiological and Neurochemical Studies. 5-HT2C Receptors in the Pathophysiology of CNS Disease 2011. [DOI: 10.1007/978-1-60761-941-3_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 638 |
Hirvonen J, Hietala J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS Neurosci Ther 2011;17:89-96. [PMID: 21199447 DOI: 10.1111/j.1755-5949.2010.00223.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 639 |
Perreault ML, O'Dowd BF, George SR. Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther 2011;17:52-7. [PMID: 21199449 DOI: 10.1111/j.1755-5949.2010.00228.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 640 |
Meyer-Lindenberg A. From maps to mechanisms through neuroimaging of schizophrenia. Nature. 2010;468:194-202. [PMID: 21068827 DOI: 10.1038/nature09569] [Cited by in Crossref: 221] [Cited by in F6Publishing: 238] [Article Influence: 17.0] [Reference Citation Analysis]
|
| 641 |
Shuto T, Nishi A. Treatment of the psychostimulant-sensitized animal model of schizophrenia. CNS Neurosci Ther 2011;17:133-9. [PMID: 21159151 DOI: 10.1111/j.1755-5949.2010.00218.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 642 |
Dufour BD, Adeola O, Cheng H, Donkin SS, Klein JD, Pajor EA, Garner JP. Nutritional up-regulation of serotonin paradoxically induces compulsive behavior. Nutritional Neuroscience 2010;13:256-64. [DOI: 10.1179/147683010x12611460764688] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 643 |
Goff DC, Hill M, Barch D. The treatment of cognitive impairment in schizophrenia. Pharmacol Biochem Behav 2011;99:245-53. [PMID: 21115035 DOI: 10.1016/j.pbb.2010.11.009] [Cited by in Crossref: 123] [Cited by in F6Publishing: 127] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 644 |
Bitanihirwe BK, Peleg-Raibstein D, Mouttet F, Feldon J, Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010;35:2462-78. [PMID: 20736993 DOI: 10.1038/npp.2010.129] [Cited by in Crossref: 172] [Cited by in F6Publishing: 182] [Article Influence: 13.2] [Reference Citation Analysis]
|
| 645 |
Chen Y, McBain R, Norton D, Ongur D. Schizophrenia patients show augmented spatial frame illusion for visual and visuomotor tasks. Neuroscience 2011;172:419-26. [PMID: 20971162 DOI: 10.1016/j.neuroscience.2010.10.039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 646 |
Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93:13-24. [PMID: 20950668 DOI: 10.1016/j.pneurobio.2010.09.004] [Cited by in Crossref: 192] [Cited by in F6Publishing: 204] [Article Influence: 14.8] [Reference Citation Analysis]
|
| 647 |
Wang Y, Fang Y, Shen Y, Xu Q. Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia. Psychiatry Res 2010;179:147-50. [PMID: 20483479 DOI: 10.1016/j.psychres.2009.03.029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 648 |
Fabricius K, Steiniger‐brach B, Helboe L, Fink‐jensen A, Wörtwein G. Socially isolated rats exhibit changes in dopamine homeostasis pertinent to schizophrenia. Int j dev neurosci 2011;29:347-50. [DOI: 10.1016/j.ijdevneu.2010.09.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 649 |
Di Giovanni G, Esposito E, Di Matteo V. Role of serotonin in central dopamine dysfunction. CNS Neurosci Ther 2010;16:179-94. [PMID: 20557570 DOI: 10.1111/j.1755-5949.2010.00135.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 650 |
Bitanihirwe BK, Weber L, Feldon J, Meyer U. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychopharmacol 2010;13:981-96. [PMID: 20219156 DOI: 10.1017/S1461145710000192] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 651 |
Sui ZY, Li CR, Huang GB, Kwon YB, Kim KW, Lee KH, Chung YC. Age-specific effects of 6-hydroxydopamine lesions of the rat medial prefrontal cortex on stress-induced c-fos expression in subcortical areas. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1054-9. [PMID: 20677375 DOI: 10.1016/j.pnpbp.2010.05.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 652 |
Bergman O, Westberg L, Nilsson LG, Adolfsson R, Eriksson E. Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:1094-7. [PMID: 20570600 DOI: 10.1016/j.pnpbp.2010.05.032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 653 |
Ma X, Li C, Meng H, Du L, Wang Q, Wang Y, Deng W, Liu X, Hu X, Murray RM, Collier DA, Li T. Premorbid tobacco smoking is associated with later age at onset in schizophrenia. Psychiatry Res 2010;178:461-6. [PMID: 20493556 DOI: 10.1016/j.psychres.2009.08.014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 654 |
Ito HT, Smith SE, Hsiao E, Patterson PH. Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 2010;24:930-41. [PMID: 20227486 DOI: 10.1016/j.bbi.2010.03.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 655 |
Krummenacher P, Mohr C, Haker H, Brugger P. Dopamine, Paranormal Belief, and the Detection of Meaningful Stimuli. Journal of Cognitive Neuroscience 2010;22:1670-81. [DOI: 10.1162/jocn.2009.21313] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 656 |
Kumar SA, Wang S, Yang TC, Yeh C. Acid yellow 9 as a dispersing agent for carbon nanotubes: Preparation of redox polymer–carbon nanotube composite film and its sensing application towards ascorbic acid and dopamine. Biosensors and Bioelectronics 2010;25:2592-7. [DOI: 10.1016/j.bios.2010.04.024] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 657 |
Bossong MG, Niesink RJ. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 2010;92:370-85. [PMID: 20624444 DOI: 10.1016/j.pneurobio.2010.06.010] [Cited by in Crossref: 207] [Cited by in F6Publishing: 179] [Article Influence: 15.9] [Reference Citation Analysis]
|
| 658 |
Kim T, Kim HJ, Park JK, Kim JW, Chung JH. Association between polymorphisms of arachidonate 12-lipoxygenase (ALOX12) and schizophrenia in a Korean population. Behav Brain Funct 2010;6:44. [PMID: 20626912 DOI: 10.1186/1744-9081-6-44] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 659 |
Tenback DE, van Harten PN, Slooff CJ, van Os J. Incidence and persistence of tardive dyskinesia and extrapyramidal symptoms in schizophrenia. J Psychopharmacol 2010;24:1031-5. [PMID: 19487321 DOI: 10.1177/0269881109106306] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 660 |
Yang K, Jin G, Wu J. The neuropharmacology of (-)-stepholidine and its potential applications. Curr Neuropharmacol 2007;5:289-94. [PMID: 19305745 DOI: 10.2174/157015907782793649] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 661 |
Siuta MA, Robertson SD, Kocalis H, Saunders C, Gresch PJ, Khatri V, Shiota C, Kennedy JP, Lindsley CW, Daws LC, Polley DB, Veenstra-Vanderweele J, Stanwood GD, Magnuson MA, Niswender KD, Galli A. Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 2010;8:e1000393. [PMID: 20543991 DOI: 10.1371/journal.pbio.1000393] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 662 |
Li CR, Huang GB, Sui ZY, Han EH, Chung YC. Effects of 6-hydroxydopamine lesioning of the medial prefrontal cortex on social interactions in adolescent and adult rats. Brain Res 2010;1346:183-9. [PMID: 20513371 DOI: 10.1016/j.brainres.2010.05.064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 663 |
Bali A, Sharma K, Bhalla A, Bala S, Reddy D, Singh A, Kumar A. Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics. European Journal of Medicinal Chemistry 2010;45:2656-62. [DOI: 10.1016/j.ejmech.2010.02.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 664 |
Jones CR, Jahanshahi M. The substantia nigra, the basal ganglia, dopamine and temporal processing. J Neural Transm Suppl 2009;:161-71. [PMID: 20411776 DOI: 10.1007/978-3-211-92660-4_13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 665 |
Watari M, Hamazaki K, Hirata T, Hamazaki T, Okubo Y. Hostility of drug-free patients with schizophrenia and n-3 polyunsaturated fatty acid levels in red blood cells. Psychiatry Res 2010;177:22-6. [PMID: 20227767 DOI: 10.1016/j.psychres.2010.02.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 666 |
Aubele T, Kritzer MF. Gonadectomy and hormone replacement affects in vivo basal extracellular dopamine levels in the prefrontal cortex but not motor cortex of adult male rats. Cereb Cortex 2011;21:222-32. [PMID: 20466748 DOI: 10.1093/cercor/bhq083] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 667 |
McClure MM, Harvey PD, Goodman M, Triebwasser J, New A, Koenigsberg HW, Sprung LJ, Flory JD, Siever LJ. Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology 2010;35:1356-62. [PMID: 20130535 DOI: 10.1038/npp.2010.5] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 668 |
Hayashi-Takagi A, Sawa A. Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment. Brain Res Bull 2010;83:140-6. [PMID: 20433911 DOI: 10.1016/j.brainresbull.2010.04.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 669 |
Kantrowitz JT, Javitt DC. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 2010;83:108-21. [PMID: 20417696 DOI: 10.1016/j.brainresbull.2010.04.006] [Cited by in Crossref: 272] [Cited by in F6Publishing: 298] [Article Influence: 20.9] [Reference Citation Analysis]
|
| 670 |
Simpson EH, Kellendonk C, Kandel E. A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 2010;65:585-96. [PMID: 20223196 DOI: 10.1016/j.neuron.2010.02.014] [Cited by in Crossref: 322] [Cited by in F6Publishing: 341] [Article Influence: 24.8] [Reference Citation Analysis]
|
| 671 |
Chermahini SA, Hommel B. The (b)link between creativity and dopamine: spontaneous eye blink rates predict and dissociate divergent and convergent thinking. Cognition 2010;115:458-65. [PMID: 20334856 DOI: 10.1016/j.cognition.2010.03.007] [Cited by in Crossref: 204] [Cited by in F6Publishing: 248] [Article Influence: 15.7] [Reference Citation Analysis]
|
| 672 |
Patel NH, Vyas NS, Puri BK, Nijran KS, Al-Nahhas A. Positron emission tomography in schizophrenia: a new perspective. J Nucl Med 2010;51:511-20. [PMID: 20237027 DOI: 10.2967/jnumed.109.066076] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 673 |
O'Tuathaigh CM, Kirby BP, Moran PM, Waddington JL. Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia. Schizophr Bull 2010;36:271-88. [PMID: 19934211 DOI: 10.1093/schbul/sbp125] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 674 |
Knott V, Millar A, Fisher D, Albert P. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Neuroscience 2010;166:145-56. [DOI: 10.1016/j.neuroscience.2009.11.053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 675 |
Arib O, Rat P, Molimard R, Chait A, Faure P, de Beaurepaire R. Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons. European Journal of Pharmacology 2010;629:47-52. [DOI: 10.1016/j.ejphar.2009.12.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 676 |
Miotto P, Pollini B, Restaneo A, Favaretto G, Sisti D, Rocchi MB, Preti A. Symptoms of psychosis in anorexia and bulimia nervosa. Psychiatry Res 2010;175:237-43. [PMID: 20022383 DOI: 10.1016/j.psychres.2009.03.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 677 |
Schnider A, Guggisberg A, Nahum L, Gabriel D, Morand S. Dopaminergic modulation of rapid reality adaptation in thinking. Neuroscience 2010;167:583-7. [PMID: 20219638 DOI: 10.1016/j.neuroscience.2010.02.044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 678 |
Ben-Shachar D. The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia. J Neural Transm (Vienna). 2009;116:1383-1396. [PMID: 19784753 DOI: 10.1007/s00702-009-0319-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 679 |
Shashi V, Berry MN. Velocardiofacial syndrome (chromosome 22q11.2 deletion syndrome) as a model of schizophrenia. Secondary Schizophrenia 2010. [DOI: 10.1017/cbo9780511789977.025] [Reference Citation Analysis]
|
| 680 |
Leung S, Croft RJ, Guille V, Scholes K, O'Neill BV, Phan KL, Nathan PJ. Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology (Berl) 2010;208:233-44. [PMID: 20012022 DOI: 10.1007/s00213-009-1723-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 681 |
Brüne M, Basilowski M, Bömmer I, Juckel G, Assion H. Machiavellianism and Executive Functioning in Patients with Delusional Disorder. Psychol Rep 2010;106:205-15. [DOI: 10.2466/pr0.106.1.205-215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 682 |
Tsunoda M, Aoyama C, Nomura H, Toyoda T, Matsuki N, Funatsu T. Simultaneous determination of dopamine and 3,4-dihydroxyphenylacetic acid in mouse striatum using mixed-mode reversed-phase and cation-exchange high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 2010;51:712-5. [DOI: 10.1016/j.jpba.2009.09.045] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 683 |
Brown JM, Li JJ, Sinz MW. Antipsychotic Agents. Burger's Medicinal Chemistry and Drug Discovery 2010. [DOI: 10.1002/0471266949.bmc103.pub2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 684 |
Perez-Costas E, Melendez-Ferro M, Roberts RC. Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem 2010;113:287-302. [PMID: 20089137 DOI: 10.1111/j.1471-4159.2010.06604.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 104] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 685 |
Ishii D, Matsuzawa D, Kanahara N, Matsuda S, Sutoh C, Ohtsuka H, Nakazawa K, Kohno M, Hashimoto K, Iyo M, Shimizu E. Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. Neurosci Lett 2010;471:53-7. [PMID: 20083164 DOI: 10.1016/j.neulet.2010.01.010] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 686 |
Nagai T, Kitahara Y, Shiraki A, Hikita T, Taya S, Kaibuchi K, Yamada K. Dysfunction of dopamine release in the prefrontal cortex of dysbindin deficient sandy mice: an in vivo microdialysis study. Neurosci Lett 2010;470:134-8. [PMID: 20045719 DOI: 10.1016/j.neulet.2009.12.071] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 687 |
Swerdlow NR, Braff DL, Bakshi VP, Geyer MA. An Animal Model of Sensorimotor Gating Deficits in Schizophrenia Predicts Antipsychotic Drug Action. Antipsychotics 2010. [DOI: 10.1007/978-3-642-61007-3_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 688 |
Moghaddam B, Pehrson A. Disinhibition of Prefrontal Cortex Neurons in Schizophrenia. Advances in Schizophrenia Research 2009 2010. [DOI: 10.1007/978-1-4419-0913-8_5] [Reference Citation Analysis]
|
| 689 |
Ginovart N, Kapur S. Dopamine Receptors and the Treatment of Schizophrenia. The Dopamine Receptors 2010. [DOI: 10.1007/978-1-60327-333-6_16] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 690 |
Abi-dargham A, Laruelle M. In Vivo Imaging of Dopamine Receptors. The Dopamine Receptors 2010. [DOI: 10.1007/978-1-60327-333-6_15] [Reference Citation Analysis]
|
| 691 |
Young JW, Zhou X, Geyer MA. Animal Models of Schizophrenia. Behavioral Neurobiology of Schizophrenia and Its Treatment 2010. [DOI: 10.1007/7854_2010_62] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 692 |
Huang SY, Chen HK, Ma KH, Shy MJ, Chen JH, Lin WC, Lu RB. Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res 2010;116:68-74. [PMID: 19879111 DOI: 10.1016/j.schres.2009.10.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 693 |
Marazziti D, Baroni S, Masala I, Giannaccini G, Betti L, Palego L, Dell’osso MC, Consoli G, Castagna M, Lucacchini A. [3H]-YM-09151-2 binding sites in human brain postmortem. Neurochemistry International 2009;55:643-7. [DOI: 10.1016/j.neuint.2009.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 694 |
Chen DC, Wang J, Wang B, Yang SC, Zhang CX, Zheng YL, Li YL, Wang N, Yang KB, Xiu MH, Kosten TR, Zhang XY. Decreased levels of serum brain-derived neurotrophic factor in drug-naïve first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology (Berl) 2009;207:375-80. [PMID: 19787338 DOI: 10.1007/s00213-009-1665-6] [Cited by in Crossref: 110] [Cited by in F6Publishing: 112] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 695 |
Thompson JL, Urban N, Abi-Dargham A. How have developments in molecular imaging techniques furthered schizophrenia research? Imaging Med 2009;1:135-53. [PMID: 21243081 DOI: 10.2217/IIM.09.22] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 696 |
Seshadri AJ, Hayashi-Takagi A. Gene manipulation with stereotaxic viral infection for psychiatric research: spatiotemporal components for schizophrenia. Prog Brain Res 2009;179:17-27. [PMID: 20302814 DOI: 10.1016/S0079-6123(09)17903-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 697 |
Guillin O, Abi-Dargham A, Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol. 2007;78:1-39. [PMID: 17349856 DOI: 10.1016/s0074-7742(06)78001-1] [Cited by in Crossref: 214] [Cited by in F6Publishing: 79] [Article Influence: 15.3] [Reference Citation Analysis]
|
| 698 |
Meyers B, D'Agostino A, Walker J, Kritzer MF. Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats. Neuroscience 2010;165:850-62. [PMID: 19909795 DOI: 10.1016/j.neuroscience.2009.11.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 699 |
Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des 2009;15:2550-9. [PMID: 19689327 DOI: 10.2174/138161209788957528] [Cited by in Crossref: 166] [Cited by in F6Publishing: 174] [Article Influence: 11.9] [Reference Citation Analysis]
|
| 700 |
Peleg-Raibstein D, Yee BK, Feldon J, Hauser J. The amphetamine sensitization model of schizophrenia: relevance beyond psychotic symptoms? Psychopharmacology (Berl) 2009;206:603-21. [PMID: 19326100 DOI: 10.1007/s00213-009-1514-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 701 |
Qiu M, Qu W, Xu X, Yan M, Urade Y, Huang Z. D1/D2 receptor-targeting L-stepholidine, an active ingredient of the Chinese herb Stephonia, induces non-rapid eye movement sleep in mice. Pharmacology Biochemistry and Behavior 2009;94:16-23. [DOI: 10.1016/j.pbb.2009.06.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 702 |
Adams W, Ayton S, van den Buuse M. Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia. Psychopharmacology (Berl) 2009;206:665-76. [PMID: 19629448 DOI: 10.1007/s00213-009-1617-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 703 |
Guo Y, Zhang H, Chen X, Cai W, Cheng J, Yang Y, Jin G, Zhen X. Evaluation of the antipsychotic effect of bi-acetylated l-stepholidine (l-SPD-A), a novel dopamine and serotonin receptor dual ligand. Schizophr Res 2009;115:41-9. [PMID: 19744833 DOI: 10.1016/j.schres.2009.08.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 704 |
Scornaiencki R, Cantrup R, Rushlow WJ, Rajakumar N. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness. Int J Neuropsychopharmacol 2009;12:1195-208. [PMID: 19275776 DOI: 10.1017/S1461145709000121] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 705 |
Llewellyn S. In two minds? Is schizophrenia a state ‘trapped’ between waking and dreaming? Medical Hypotheses 2009;73:572-9. [DOI: 10.1016/j.mehy.2009.05.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 706 |
Fumagalli F, Frasca A, Racagni G, Riva MA. Cognitive effects of second-generation antipsychotics: current insights into neurochemical mechanisms. CNS Drugs 2009;23:603-14. [PMID: 19552487 DOI: 10.2165/00023210-200923070-00005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 707 |
Zhang XY, Chen DC, Xiu MH, Wang F, Qi LY, Sun HQ, Chen S, He SC, Wu GY, Haile CN, Kosten TA, Lu L, Kosten TR. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients. Schizophr Res 2009;113:151-7. [PMID: 19540723 DOI: 10.1016/j.schres.2009.05.016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 708 |
Moncrieff J. A critique of the dopamine hypothesis of schizophrenia and psychosis. Harv Rev Psychiatry 2009;17:214-25. [PMID: 19499420 DOI: 10.1080/10673220902979896] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 709 |
Dyck BA, Skoblenick KJ, Castellano JM, Ki K, Thomas N, Mishra RK. Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. Synapse. 2009;63:662-672. [PMID: 19360855 DOI: 10.1002/syn.20643] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 710 |
Labrie V, Roder JC. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neurosci Biobehav Rev 2010;34:351-72. [PMID: 19695284 DOI: 10.1016/j.neubiorev.2009.08.002] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 711 |
Coppa-Hopman R, Galle J, Pimkine D. D1 receptor antagonist-induced long-term depression in the medial prefrontal cortex of rat, in vivo: an animal model of psychiatric hypofrontality. J Psychopharmacol 2009;23:672-85. [PMID: 18635697 DOI: 10.1177/0269881108091256] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 712 |
Tuppurainen H, Kuikka JT, Viinamäki H, Husso M, Tiihonen J. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine. Psychiatry Clin Neurosci 2009;63:529-37. [PMID: 19496999 DOI: 10.1111/j.1440-1819.2009.01982.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 713 |
Baeza I, Castro-Fornieles J, Deulofeu R, de la Serna E, Goti J, Salvà J, Bernardo M. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Psychiatry Res 2009;168:110-8. [PMID: 19501918 DOI: 10.1016/j.psychres.2008.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 714 |
Llewellyn S. Is 'bipolar disorder' the brain's autopoietic response to schizophrenia? Med Hypotheses 2009;73:580-4. [PMID: 19589644 DOI: 10.1016/j.mehy.2009.05.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 715 |
Colzato LS, van den Wildenberg WP, Hommel B. Reduced attentional scope in cocaine polydrug users. PLoS One 2009;4:e6043. [PMID: 19557181 DOI: 10.1371/journal.pone.0006043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 716 |
Tost H, Alam T, Meyer-Lindenberg A. Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes. Neurosci Biobehav Rev 2010;34:689-700. [PMID: 19559045 DOI: 10.1016/j.neubiorev.2009.06.005] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 717 |
Kessler RM, Woodward ND, Riccardi P, Li R, Ansari MS, Anderson S, Dawant B, Zald D, Meltzer HY. Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol Psychiatry 2009;65:1024-31. [PMID: 19251247 DOI: 10.1016/j.biopsych.2008.12.029] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 718 |
Totah NK, Kim YB, Homayoun H, Moghaddam B. Anterior cingulate neurons represent errors and preparatory attention within the same behavioral sequence. J Neurosci 2009;29:6418-26. [PMID: 19458213 DOI: 10.1523/JNEUROSCI.1142-09.2009] [Cited by in Crossref: 84] [Cited by in F6Publishing: 101] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 719 |
McLean SL, Idris NF, Woolley ML, Neill JC. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia. Eur Neuropsychopharmacol 2009;19:440-50. [PMID: 19268547 DOI: 10.1016/j.euroneuro.2009.01.009] [Cited by in Crossref: 59] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 720 |
Colzato LS, van den Wildenberg WP, van Wouwe NC, Pannebakker MM, Hommel B. Dopamine and inhibitory action control: evidence from spontaneous eye blink rates. Exp Brain Res 2009;196:467-74. [PMID: 19484465 DOI: 10.1007/s00221-009-1862-x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 721 |
Featherstone RE, Burton CL, Coppa-Hopman R, Rizos Z, Sinyard J, Kapur S, Fletcher PJ. Gestational treatment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine. Pharmacol Biochem Behav 2009;93:382-90. [PMID: 19467255 DOI: 10.1016/j.pbb.2009.05.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 722 |
Kellendonk C, Simpson EH, Kandel ER. Modeling cognitive endophenotypes of schizophrenia in mice. Trends Neurosci 2009;32:347-58. [PMID: 19409625 DOI: 10.1016/j.tins.2009.02.003] [Cited by in Crossref: 111] [Cited by in F6Publishing: 117] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 723 |
Mathalon DH, Jorgensen KW, Roach BJ, Ford JM. Error detection failures in schizophrenia: ERPs and FMRI. Int J Psychophysiol 2009;73:109-17. [PMID: 19414043 DOI: 10.1016/j.ijpsycho.2009.02.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 724 |
Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull 2009;35:549-62. [PMID: 19325164 DOI: 10.1093/schbul/sbp006] [Cited by in Crossref: 1683] [Cited by in F6Publishing: 1771] [Article Influence: 120.2] [Reference Citation Analysis]
|
| 725 |
Ohgake S, Shimizu E, Hashimoto K, Okamura N, Koike K, Koizumi H, Fujisaki M, Kanahara N, Matsuda S, Sutoh C, Matsuzawa D, Muramatsu H, Muramatsu T, Iyo M. Dopaminergic hypofunctions and prepulse inhibition deficits in mice lacking midkine. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:541-6. [PMID: 19217924 DOI: 10.1016/j.pnpbp.2009.02.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 726 |
Lee KH, Bhaker RS, Mysore A, Parks RW, Birkett PB, Woodruff PW. Time perception and its neuropsychological correlates in patients with schizophrenia and in healthy volunteers. Psychiatry Res 2009;166:174-83. [PMID: 19278734 DOI: 10.1016/j.psychres.2008.03.004] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 727 |
Erhardt S, Olsson SK, Engberg G. Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 2009;23:91-101. [PMID: 19173370 DOI: 10.2165/00023210-200923020-00001] [Cited by in Crossref: 113] [Cited by in F6Publishing: 120] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 728 |
Walker EF, Neumann CC, Baum K, Davis DM, Diforio D, Bergman A. The developmental pathways to schizophrenia: Potential moderating effects of stress. Dev Psychopathol 1996;8:647-65. [DOI: 10.1017/s0954579400007343] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 729 |
Colzato LS, Slagter HA, van den Wildenberg WP, Hommel B. Closing one’s eyes to reality: Evidence for a dopaminergic basis of Psychoticism from spontaneous eye blink rates. Personality and Individual Differences 2009;46:377-80. [DOI: 10.1016/j.paid.2008.10.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 730 |
Kellendonk C. Modeling excess striatal D2 receptors in mice. Genetic Models of Schizophrenia. Elsevier; 2009. pp. 59-65. [DOI: 10.1016/s0079-6123(09)17907-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 731 |
Kristiansen LV, Cowell RM, Biscaia M, Mccullumsmith RE, Meador-woodruff JH. Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies. Handbook of Neurochemistry and Molecular Neurobiology 2009. [DOI: 10.1007/978-0-387-30410-6_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 732 |
Angelucci F, Ricci V, Spalletta G, Caltagirone C, Mathé AA, Bria P. Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity. Int Rev Neurobiol 2009;88:1-24. [PMID: 19897072 DOI: 10.1016/S0074-7742(09)88001-X] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 733 |
Fischer BA, Kirkpatrick B, Carpenter WT. The Neurobiology of Negative Symptoms and the Deficit Syndrome. Handbook of Neurochemistry and Molecular Neurobiology 2009. [DOI: 10.1007/978-0-387-30410-6_16] [Reference Citation Analysis]
|
| 734 |
Abi-dargham A. Cortical Dopamine in Schizophrenia. Handbook of Neurochemistry and Molecular Neurobiology 2009. [DOI: 10.1007/978-0-387-30410-6_1] [Reference Citation Analysis]
|
| 735 |
Chen Y, Norton D, Mcbain R. Trait and State Markers of Schizophrenia in Visual Processing. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 2009. [DOI: 10.1007/978-1-4020-9464-4_14] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 736 |
Messer T, Tiltscher C, Schmauss M. Polypharmazie in der Behandlung der Schizophrenie. Polypharmazie in der Behandlung psychischer Erkrankungen 2009. [DOI: 10.1007/978-3-211-79826-3_2] [Reference Citation Analysis]
|
| 737 |
Colzato LS, Huizinga M, Hommel B. Recreational cocaine polydrug use impairs cognitive flexibility but not working memory. Psychopharmacology (Berl) 2009;207:225-34. [PMID: 19727676 DOI: 10.1007/s00213-009-1650-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 738 |
Meyers B, Kritzer MF. In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience 2009;159:271-82. [PMID: 19138725 DOI: 10.1016/j.neuroscience.2008.12.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 739 |
van Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008;34:1095-105. [PMID: 18718885 DOI: 10.1093/schbul/sbn101] [Cited by in Crossref: 326] [Cited by in F6Publishing: 336] [Article Influence: 21.7] [Reference Citation Analysis]
|
| 740 |
Opgen-Rhein C, Neuhaus AH, Urbanek C, Hahn E, Sander T, Dettling M. Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test. Schizophr Bull 2008;34:1231-9. [PMID: 18199630 DOI: 10.1093/schbul/sbm155] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 741 |
Colzato LS, Slagter HA, Spapé MM, Hommel B. Blinks of the eye predict blinks of the mind. Neuropsychologia 2008;46:3179-83. [DOI: 10.1016/j.neuropsychologia.2008.07.006] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 742 |
Lavigne F, Darmon N. Dopaminergic neuromodulation of semantic priming in a cortical network model. Neuropsychologia 2008;46:3074-87. [DOI: 10.1016/j.neuropsychologia.2008.06.019] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 743 |
Karlsgodt KH, Sun D, Jimenez AM, Lutkenhoff ES, Willhite R, van Erp TGM, Cannon TD. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 2008;20:1297-327. [DOI: 10.1017/s095457940800062x] [Cited by in Crossref: 109] [Cited by in F6Publishing: 115] [Article Influence: 7.3] [Reference Citation Analysis]
|
